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Context of this thesis
A strong call can be heard for a major reform of health care for older adults as we know it today 
1. Several steps along this path have already been taken 2-7. Among the many reasons that signal 
the need for this reform, some are of special interest in the context of this thesis: population 
ageing, an increasing focus on continuing participation, the presence of co-morbidity and vul-
nerability in a substantial part of the older population, and a scarcity of integration and quality 
of care. Some of the possible solutions and related problems will be briefly summarised. These 
considerations ground the choices we have made, when we developed our study model: a 
model of nurse home visits for vulnerable community-dwelling older people to evaluate aspects 
of effectiveness, cost-effectiveness, and caregiver burden. A description of the features of our 
study model will end this analysis of the context of this thesis. We need to have effective methods 
to study the effects of different types of health care for vulnerable older people. The second part 
of this context analysis describes which problems were important in the context of our study.
Defining the target population
Before describing the background against which this thesis is set, it is important to identify 
the target population. The subjects who this thesis focuses on are primarily vulnerable 
or frail older people. Despite discussions one may have on the exact definition of 
vulnerability, vulnerable older persons are a distinct group of older adults, with many 
features that distinguish them from other older adults, as will be explained later. These 
people can be vulnerable due to (a combination of) multiple chronic conditions, 
disabilities, or frailty. The compensation capacities of these persons are diminished, 
and this implies that relatively small changes in or around the patient can have large 
consequences for the individual’s functioning 8. This thesis further restricts the target 
population to those frail older persons who still live independently: either in their own 
homes or in a retirement home.
Reasons for rethinking health care for older adults
The arguments driving health care reform can be grouped into three clusters. These are 
societal factors, characteristics of older persons, and factors that are inherently related to 
the way health care is currently conducted.
Societal changes: population ageing and an increasing focus on continuing 
participation
The first societal development to be mentioned is population ageing. In the next 50 
years western societies will face an important demographic change. By the year 2050 
16.1% of the world population will be aged 65 and over, and 4.3% will be aged 80 
and over. This means more than a doubling for people 65 years and older, and even 
a threefold increase for octogenarians, compared to 2005 9. In particular, the rising 
proportion of octogenarians will “contribute to the large subset of older adults that are 
highly vulnerable to adverse health outcomes, including disability, dependency, and 
death” 10. Despite some publicists minimising the consequences 11, 12, it is a generally 
held view that this demographic transition will have a major impact on health care needs 
and will thus also affect health care delivery. The basic idea behind the necessary change 
of our health care systems is that we have neither the workforce nor the resources to 
carry on as usual 13.
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Another important societal development is the increasing attention which is given to 
continuing participation. In more or less explicit terms, this striving for continuing 
participation can be recognised in many health care reforms. For instance, in the new 
Dutch Social Support Act (Wet Maatschappelijke Ondersteuning) that took effect from 1 
January  2007, this right is translated into a compensation principle: our (local) authorities 
are obliged to compensate for limitations their citizens may experience in functional 
abilities and participation in society 5. The World Health Organization has adopted the 
term “active ageing” to express its ambitions with respect our ageing societies 3. In this 
expression, the word “active” refers to continuing participation in social, economic, 
cultural, spiritual, and civic affairs. This striving for continuing participation has – more 
indirectly – also influenced our approaches to health care delivery, think for instance 
of the many primary care and intermediate care alternatives to hospital care and long 
term care (care follows the patient). Partly, this development is the consequence of our 
policy to let people themselves decide where they prefer to live and to be cared for, 
which is very often their own home 14. However, based on the principle of continuing 
participation, policy makers also make an appeal to a person’s accountability out of 
efficiency considerations. As such, continuing participation is not only a granted right; it 
is also an obligation society lays on its citizens.
Older people: growing numbers of co-morbid conditions and vulnerability
Two characteristics of the older population which have changed over the years are 
relevant for this thesis: the presence of co-morbidity and vulnerability. Often these 
two characteristics coexist in one person. Nevertheless, this thesis will judge their 
implications for health care provision to older people separately. Co-morbidities are 
indeed an important indicator of vulnerability; however, also in persons with co-
morbidity who cannot be classified as vulnerable, health care provision should take 
the occurrence of co-morbidity into account. In the Netherlands, around two thirds of 
persons aged 75 and over have one or more chronic conditions, and more than 40% 
have two or more chronic conditions 15, 16. This was not the reality decades ago 17, when 
health care developed as a system with a strong focus on the treatment of acute illnesses; 
diseases such as infections, or acute myocardial infarction, from which persons died or 
were cured.
Another important issue is the large group of older persons who are vulnerable 
because of a combination of co-morbidities, disabilities, or frailty. Although there are 
distinctions between the concepts of co-morbidity, disability, and frailty as indicators of 
vulnerability 18-20, this refinement is not needed in the context of this thesis. Therefore, 
the terms vulnerability and frailty will be used interchangeably throughout this thesis. 
Vulnerable older people are not simply adults with a higher age, just as children are 
not simply “petit” adults (a fact long recognised). Vulnerable older people are a distinct 
group of older people, who deserve special attention and care, just as our children. 
The compensation capacities of these persons are diminished, and this implicates that 
relatively small changes in or around the patient can have large consequences for the 
individual’s functioning 8.
Health care systems: fragmented care leads to substandard care
Two problems in health care stand in the way of adequate health care delivery to the 
group of vulnerable older people. The first problem is that health care today is very 
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fragmented as well as focused on treatment of single diseases 21. We have single-disease 
management programmes, disease-based clinical practice guidelines, organ-specific 
specialists, etc. As a result we fail to see the interactions at biological, psychological, and 
social levels, lack understanding of how to deal with diseases in the light of co-morbidity 
22, and are blind for the vulnerability of the older person in front of us. Individuals 
cannot rely on an integrated system of facilities tailored to their needs; instead they have 
to find their way through fragmented settings of care. This approach was and is very 
successful in fairly fit, independent, assertive, (cognitively) healthy adults experiencing 
one single problem, but can be a disaster for the vulnerable, cognitively impaired older 
adult with co-morbidity. A recent study has shown how binding to the several single-
disease guidelines may lead to unintended and undesirable effects in older persons with 
several co-morbidities 23.
The quality of care for people aged 65 and over has been studied previously 23-25. 
The results leave little room for discussion: “care for vulnerable elders falls short of 
acceptable levels for a wide variety of conditions. Care for geriatric conditions is much 
less optimal than care for general medical conditions” 24. Several causes can be identified: 
lack of (dissemination of) knowledge, pessimistic expectations about outcomes, and 
organisational barriers 10.
Strategies to improve quality of care for vulnerable older people
Several solutions have been proposed at different levels. In many of these strategies one 
can identify aspects of attitude, knowledge, and structure as a means to provoke changes 
at a behavioural level in professionals as well as patients.
Change of “attitude” strategies are for instance strategies that try to increase patient-
centredness by increasing the health care professionals’ awareness of the importance of 
patients’ involvement as partners in care, or to make persons aware of the fact that they 
can try themselves – with some help from their family – first, before requesting help from 
the authorities or professionals. The problem with “attitude” changes is how to enforce 
them and have them widely implemented in health care. With respect to enforcement, 
to increase knowledge is an easier target, for instance through a formalised system of 
continuing medical education, continuing professional development and knowledge 
translation 26. The last is an example of a structural change of health care systems.
Patient-centred care: a popular but difficult concept
Of all strategies, the strategies to improve patient-centred care rely the most on changing 
“attitude”, and therefore the problem of enforcement is extremely relevant for this type 
of health care reform. To what extent professionals perform patient-centred care is highly 
dependent on their individual judgement of “good care”. Patient-centred care still is a 
poorly understood, rather intuitively defined concept 27 that is not easily accessible for 
empirical study. As a result, the extend to which of patient-centred care can contribute 
to a better primary care for vulnerable older people is largely unknown.
Care models for vulnerable older people
Programmes of integrated care focus on the structural level. Integrated care programmes 
for chronic diseases seem to have positive effects on quality of care 28. Although Ouwens 
et al did not look specifically at vulnerable older people, vulnerable older people were 
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an important target group of the interventions under study in this systematic review.
If we look in more detail at the group of vulnerable older people, we can observe that 
this group has shown to benefit from inpatient geriatric care models, such as inpatient 
geriatric evaluation and management at a specialised geriatric ward 29. However, the 
effectiveness of in-home or outpatient alternatives is much more controversial. These are 
models such as preventive home visits, in-home comprehensive geriatric assessment, 
and intermediate care, which may provide effective care. However, literature is not 
unequivocal about the question to which type of older persons geriatric primary care 
should be directed. While some authors exclude the frailest participants, because 
these persons have too few possibilities for reversibility, others stress the importance of 
including the frailest 30-35. Although the above discussion focuses primarily on preventive 
home visits, because the boundaries between community intervention models such 
as preventive home visits, in-home geriatric evaluation and management as well as 
intermediate care are so vague, this discussion is of relevance for all these models. 
The models that can be gathered under the term community intervention models show 
much heterogeneity as well considerable overlap 36. The lack of detailed insight into the 
content of these care models further complicates comparison 31, 37.
However, we can try to distil elements that may be associated with beneficial patient 
outcomes 32, 38. A detailed description these elements is given in the background section 
of chapter 3, which describes the design of our randomised trial. One element to be 
mentioned here is the involvement of the general practitioner in these models. Direct 
involvement of the general practitioner has been identified as a criterion for success 32, 
also because providers’ cooperation is a determinant of patient adherence to programme 
recommendations 39. Another element that may be related to increased effectiveness is 
the use of targeting 32, 38. Several approaches to targeting are available, such as population 
screening 40, targeting on the basis of patients’ (medical) history 41, or a problem-based 
approach where incident problems are used to start an intervention.
Costs: does primary care geriatrics provide value for money?
A related issue that deserves our attention is the economics of all the strategies of 
improvement. Referring to the rising health care costs – a consequence of technological 
innovations as well as population ageing – the Dutch Council for Public Health and 
Health Care (Raad voor volksgezondheid en zorg; RVZ) has highlighted the urgency 
of making choices42. This council suggested a budgeting ceiling of 80,000 euros per 
Quality Adjusted Life Year (QALY), and NICE (National Institute for Health and Clinical 
Excellence) – an important UK institute that provides information to guide health care 
technology choices – has stated that their guidance has to “explain, explicitly, reasons 
for recommending – as cost effective – those interventions with an incremental cost-
effectiveness ratio in excess of £20,000 to £30,000 per QALY” 42, 43. These thresholds 
are given because they can help making choices between several health care types 
more objectively. These choices are now made on an ad hoc basis 42. In this circus of 
boosting opinions and bold language, the marketing of older people’s interests and care 
has proven to be difficult. Therefore, these threshold values – as they make the decision 
making more transparent and objective, may be a blessing for geriatric care, but only 
if information on cost-effectiveness is available. Regrettably, cost-effectiveness data are 
sparse in the field of geriatric primary care. The background section of chapter 7 – in 
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which the cost-effectiveness data of our intervention programme are presented – will go 
into this matter in more detail.
Considerations on the design of DGIP: 
why did we design our study model as we did?
The Dutch Geriatric Intervention Programme (DGIP) was a multidisciplinary community 
intervention model, consisting of house calls for frail older patients. An extensive 
description of the model can be found in the background section of chapter 2 and 
the methods sections of chapter 6. The core was a multidisciplinary team intervention, 
carried out by general practitioner, geriatrician, and specialist geriatric nurse, who had 
a pivotal role in the intervention.
The reason to have nurses conducting our intervention is they are able to deliver high 
quality primary care 44, which provides a good complement to the care delivered by 
physicians. Also, in the field of chronic disease management and coordination of care, 
nurses are highly effective 44. Multidisciplinarity itself is related to positive outcomes of 
geriatric (primary) care 38.
We hypothesised that the effectiveness of community intervention models for frail older 
people could be enhanced using a problem-based participant selection performed by 
their general practitioner. General practitioners were asked to initiate the intervention 
when a geriatric condition arose that required further intervention. This procedure 
promised continuity of care through better timing and targeting of the intervention, 
and more engagement of the general practitioner. Moreover, patient selection is no 
longer dependent on an expensive population screening procedure, which enhances 
implementation chances. Problems had to relate to cognition, behaviour, mood, mobility, 
or nutrition, which are important geriatric syndromes.
Research issues in studying geriatric primary care
Along with the compelling need for effective health care for older people, comes the 
increasing need for effective methods for their study. Several challenges are attached to 
performing research on complex interventions for vulnerable older people in a primary 
care setting. How to motivate general practitioners, who have many other tasks and 
priorities? How to engage vulnerable, cognitively impaired, and sometimes mentally 
ill persons, in follow-up visits packed with strange, difficult, and often very private 
questions? How to compare results of research projects, identify gaps in our current 
knowledge, or critically appraise the ascribed benefits, if there is much disagreement on 
definitions of the object under study? The three main research challenges of this study are 
related to the fact that we aimed to study the effects of a complex intervention for frail 
older people in a primary care setting. Each aspect has individual difficulties attached.
Older people are excluded from research because of a multitude of reasons, reflecting 
the diversity of the older population: legal incompetence, the presence of co-morbidity, 
the use of competing medication, etc. 45. Some important work on improving the 
methodology of doing research with older people has been done by The Interventions on 
Frailty Working Group 46. Important challenges they identified related to eligibility criteria 
(too strict limits generalisability), consent procedures (related ethical difficulties in the 
legally incompetent), self reports (may be problematic), attrition, competing morbidity, 
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mechanism of the intervention (maybe unclear), and outcome measures (improvements 
in functional status may not translate into well-being and quality of life).
Some of the problems involved in doing research in a primary care setting are rather 
prosaic: high workloads, financing problems, and sometimes fewer academic interests, 
or less organised environments than in hospital care 47. As a result, research may not rank 
high on the list of priorities. More fundamental difficulties are that primary care works 
with less selected populations (this may be judged an advantage as well, though still a 
challenge) with often multimorbidity, and compliance and motivation to participate may 
be problematic, etc. 47, 48.
The evaluation of complex or pragmatic interventions has difficulties because there is 
often no complete consensus on the definition, or the exact content of the intervention 
under study. Both problems harms scientific appraissal of the available evidence. A 
paper on the methodology of the evaluation of complex interventions by Campbell et al 
puts it like this: “the evaluation of complex interventions is difficult because of problems 
of developing, identifying, documenting, and reproducing the intervention” 49.
Currently, the double blind, placebo-controlled, randomised controlled trial is widely 
accepted as the most reliable tool to study the efficacy of new treatment. However, 
this method cannot readily be used in the study of complex interventions. For instance, 
in evaluations of complex interventions patients and the professionals who deliver the 
interventions hardly ever can be blinded to the treatment they are assigned to receive or 
provide. Even though patients are randomised, selective drop out mechanisms may cause 
distortion of the results. For the same reason, contamination may occur. Contamination 
occurs when some elements of one treatment mix into the other treatment, and vice 
versa. Some of the problems and difficulties described above were more relevant to our 
trial than others. Next, the most relevant problems will be discussed.
Loss-to-follow-up
Loss-to-follow-up can be an important threat to the validity and generalisability of 
our study. Firstly, because we aimed to study frail older people who probably have an 
increased susceptibility to dropping out because of their vulnerability. Secondly, because 
we studied a complex intervention, the delivery of which cannot be blinded, selective 
drop outs may occur. We took several precautionary measures to deal with the problems 
of potential dropping out. While we accounted for some loss-to-follow-up in our sample 
size considerations, our primary goal was to prevent the occurrence of loss-to-follow-up 
as much as possible. We did so, because this is the best safeguard against differential 
attrition after all.
In advance we decided on a set of outcome measures which were not too burdensome for 
vulnerable persons, and identified an alternative strategy to acquire data for patients who 
felt this was too troublesome after all. In order to minimise the problems of unblinding 
of the assessor, we made sure that the primary outcome measures were collected using 
a written questionnaire that was filled out before each follow-up visit (if necessary with 
help from a relative).
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Length of follow-up
The length of follow-up is another issue we considered. The following elements were 
taken into account.
Generally, longer follow-up periods are of more relevance than shorter time periods (if 
one can show that an intervention has longlasting effects, this intervention is probably 
more clinically relevant than an intervention with only short term effects). However, the 
frail population we included had many competing risks, and a fairly limited life span. 
Improving quality of life in the short term therefore is important as well. These effects 
would have been missed if we had only looked at the longer term (by that time the 
effects of the intervention might already have been diminished due to other competing 
risks). One can of course decide to establish the effect at multiple time points, during 
a longer follow-up period. However, this might again become too burdensome for our 
frail subjects. Also, one still has to decide which time point is of most clinical relevance: 
earlier, or later during follow-up. Given the above considerations, we judged the short 
term effects to be of prime importance. Therefore, we decided to use fairly short term 
follow-up measurements of three and six months.
Outcome measures
Interventions directed at the very old and vulnerable should focus primarily on increasing 
autonomy and quality of life. For successful ageing, adding life to years seems of more 
relevance than adding years to life. Therefore we gave priority to health-related quality of 
life measures over survival measures. Unfortunately, it was difficult to find valid outcome 
measures that were applicable to a very diverse, yet very frail population of older adults, 
and were also well-known. Another hurdle was to find information on the clinical 
relevance of effects and changes, especially for a group of vulnerable older adults 50. 
Another area that requires further development is the area of responder analysis: when 
to call a treatment a success 51. This information provides an important addition – yet no 
alternative – to numeric outcome measures, for doctors who want to understand – and 
value the clinical relevance of – a difference.
Unable to double blind: threats of selection bias, recruitment problems, and 
contamination
A specific issue we were confronted with concerned an important methodological 
dilemma: how to prevent the occurrence of contamination bias in a randomised 
controlled trial of an intervention that cannot be administered blindly (as with many 
complex interventions), while at the same time ensuring comparability of intervention 
and control group? Contamination is dilution of contrast between study arms, because 
the treatment alternatives somehow get mixed up. In our study, the general practitioners’ 
exposure to the intervention resulting from their participation could lead to contamination 
of control patients and thus introduce contamination bias, when their patients had been 
randomised individually. However, the widely-used solution to avoid contamination 
bias, cluster randomisation – randomising all patients of one general practitioner to 
the same study arm –, risked selection bias and recruitment problems. No ready-made 
solutions to this dilemma were available. We solved the problem by combining cluster 
and individual randomisation in a new randomisation method called pseudo cluster 
randomisation.
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Research aims
The overall aim of this thesis is to describe the effects of a new multidisciplinary model of nurse-
led, house call based health care provision for independently living vulnerable older people on 
patient, caregiver, and cost-effectiveness outcomes.
The research questions are:
What are the effects of the Dutch Geriatric Intervention Programme (DGIP) compared 
to usual care in improving health-related quality of life in independently living elderly 
persons, on caregiver burden, on health care use of frail older people, and on patient 
survival? What is the cost-effectiveness compared to usual care from a health care 
system’s point of view? With respect to the dilemma of contamination versus selection 
bias, we described the method of pseudo cluster randomisation, the sustainability of the 
premises underlying the use of pseudo cluster randomisation, and the effect of pseudo 
cluster randomisation on study recruitment and validity.
Outline of this thesis
The main findings of our studies are presented in chapter 6, 7, and 8. Chapter 6 presents 
the results for the patient outcomes health-related quality of care, and survival. Chapter 7 
describes the effects on health care utilisation and cost-effectiveness. Chapter 8 provides 
a detailed overview of the effect on caregiver burden. Chapter 2 applies the example 
of intermediate care to go in more detail into the matter of disagreeing definitions and 
how this hampers scientific appraisal of the available knowledge. Chapter 3 is a detailed 
description of the study design of our main study. Chapters 4 and 5 go in more detail 
into pseudo cluster randomisation; chapter 4 describes the application of the method, 
chapter 5 the results of the evaluation. The final chapter 9 summarises the results and 
puts them in a broader methodological, scientific, and societal context.
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Chapter 2
What is intermediate care? 
An international consensus on what constitutes 
intermediate care is needed
R.J.F. Melis, S.G. Parker, M.I.J. van Eijken, M.G.M. Olde Rikkert 
BMJ 2004;329:360–1 
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Intermediate care is an emerging concept in health care, which may offer attractive alternatives 
to hospital care for elderly patients. As little scientific evidence exists on the benefits of 
intermediate care, research is especially important.1-3 A prerequisite for research is agreement 
on the definition of a concept, which is lacking for intermediate care. The term intermediate 
care is often used as if its meaning is clear, but it conveys little meaning other than being about 
care that is “in between”. Commonly used definitions of intermediate care do not help much, 
and several very different definitions are in use. What is needed at the outset is a consensus on 
what constitutes intermediate care. Until this is agreed on, the concept of intermediate care will 
remain a mirage and its possibilities unknown. 
The term intermediate care was introduced in the United Kingdom’s NHS Plan and 
refined in the national service framework for older people.4, 5 The concept seems to 
arise out of a policy imperative, rather than an analysis of the scientific evidence 
about effective models of care. Objectives such as “promotion of independence” and 
“prevention of unnecessary hospital admission” were to be achieved through providing 
a new range of services between hospital and home. Specific targets (for example, the 
number of service users, prevented admissions) accompanied these objectives. However, 
no particular models of service delivery were defined.
Professional statements of good practice followed the political decision that 
reconfiguration of the health service would include investment in intermediate forms of 
care. The British Geriatrics Society listed three definitions in its statement on intermediate 
care.1 The broadest definition is the one shared with the Royal College of Physicians 
of London, according to which intermediate care is delivered by those health services 
that do not require the resources of a general hospital but are beyond the scope of the 
traditional primary care team.2 
Recently, Andrea Steiner published as many as eight definitions of intermediate care.6 
Five of them (partly) focused on facilitating the transition from hospital to home. Other 
aims include avoidance of admission and improvement of pre-acute and post-acute 
care. A systematic review on the best place of care for older people after acute illness 
concluded that service models were best described in terms of the objectives of care.7 
Definitions from the databases Medline and CINAHL narrow intermediate care in the 
direction of nursing home care. For example, in Medline “intermediate care facilities” 
are institutions that provide health-related care and services to individuals who do 
not require the degree of care which hospitals or skilled nursing facilities provide, but 
require care and services above the level of room and board. This probably results 
from the existence of intermediate care facilities in the United States and Japan, which 
closely resemble nursing homes. Further difficulty arises because individual authors also 
use the term intermediate care when describing a less advanced type of intensive care 
medicine.8 
This inventory of definitions shows that the term intermediate care currently does not 
present imply a specific, well defined type of health care (box). This worrying conclusion 
has important consequences. To compare results of research projects will be difficult if not 
impossible, as will be identifying gaps in our current knowledge or critically appraising 
the benefits attributed to intermediate care. These difficulties will only increase because 
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of the growing popularity of alternatives to hospital inpatient care across Europe and the 
rest of the world. 
To deal with this Babel of voices we suggest a formal process to develop a consensus of 
the key elements of intermediate care. The aim of this debate should not be to arrive at a 
uniform definition of intermediate care, for our inventory on the definitions of intermediate 
care has shown that it is impossible to define intermediate care unequivocally at the 
highest conceptual level. For reasons of simplicity, this debate should be limited to 
defining intermediate care for the purpose of scientific appraisal. It would also be helpful 
if bibliographers were able to establish a consensus for terminology, such as medical 
subheadings.9 For the time being we believe that intermediate care models can be best 
classified according to their objectives of care and not by their names. If we do not 
clearly define key elements of the concept of intermediate care, then it will remain a 
concept with unfulfilled promise.
box Definitions of intermediate care
British Geriatrics Society1
An approach to health care intended to facilitate patients’ transitions from •	
illness to recovery, or to prevent their transition from home managed chronic 
impairment to institution-based dependence, or to help terminally ill people be 
as comfortable as possible at the end of their lives
That range of services designed to facilitate transition from hospital to home, and •	
from medical dependence to functional independence, where the objectives of 
care are not primarily medical, the patients’ discharge destination is anticipated, 
and a clinical outcome of recovery (or restoration of health) is desired
Those services that do not require the resources of a general hospital, but are •	
beyond the scope of the traditional primary care team. These can include 
“substitutional care” and “care for people with complex needs” 
(The last definition is the same as the one the Royal College of Physicians uses in its 
statement2)
Medical subject heading (MeSH)9
Intermediate care facilities are institutions that provide health-related care and •	
services to individuals who do not require the degree of care that hospitals 
or skilled nursing facilities provide, but because of their physical or mental 
condition require care and services above the level of room and board
CINAHL subject headings
Intermediate care (see subacute care) is care provided to acute care patients •	
who are medically stable but too unstable to be treated in alternative healthcare 
settings such as home, ambulatory, or traditional skilled long term care
Intermediate care facilities: entered here are materials on nursing home facilities. •	
For care given in a nursing home, see long term care
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Background: Because of their complex clinical presentations and needs frail elderly people 
require another approach than people who age without many complications. Several inpatient 
geriatric health services have proven effectiveness in frail persons. However, the wish to live 
independently and policies that promote independent living as an answer to population 
ageing call for community intervention models for frail elderly people. Maybe models such as 
preventive home visits, comprehensive geriatric assessment, and intermediate care qualify, but 
their efficacy is controversial, especially in frail elderly persons living in the community. With 
the Dutch EASYcare Study Geriatric Intervention Programme (DGIP) we developed a model to 
study effectiveness of problem-based community intervention models in frail elderly people. 
Methods: DGIP is a community intervention model for frail elderly persons where the general 
practitioner refers elderly patients with a problem in cognition, mood, behaviour, mobility, and 
nutrition. A geriatric specialist nurse applies a guideline-based intervention with a limited number 
of follow-up visits. The intervention starts with the application of the EASYcare instrument for 
geriatric screening. The EASYcare instrument assesses (instrumental) activities of daily life, 
cognition, mood, and includes a goal setting item. During the intervention the nurse regularly 
consults the referring general practitioner and a geriatrician. Effects on functional performance 
(Groningen Activity Restriction Scale), health-related quality of life (MOS-20), and caregiver 
burden (Zarit Burden Interview) are studied in an observer blinded randomised controlled trial. 
151 participants were randomised over two treatment arms – DGIP and regular care – using 
pseudo cluster randomisation. We are currently performing the follow-up visits. These visits 
are planned three and six months after inclusion. Process measures and cost measures will 
be recorded. Intention to treat analyses will focus on post intervention differences between 
treatment groups.
Discussion: The design of a trial evaluating the effects of a community intervention model for 
frail elderly people was presented. The problem-based participant selection procedure satisfied; 
few patients that the general practitioner referred did not meet our eligibility criteria. The use of 
standard terminology makes detailed insight into the contents of our intervention possible using 
terminology others can understand well.
Background 
In frail elderly persons chronic conditions and loss of function challenge their autonomy. 
This harms their well-being, and often leads to institutionalisation and high health care 
costs.
There is much heterogeneity in the degree to which frailty affects older people. While 
some have many problems, others age successfully 1. The introduction of the concept 
of successful ageing voiced a change in our thinking about “age-related” decline 2. It 
marked the awareness that we cannot simply regard functional loss and dependency as 
consequences of the ageing process itself when disease is absent. With this understanding 
these “age-related” deficits became amenable to intervention. Of course, intervention 
should take the heterogeneity of the population into account; because of their complex 
clinical presentations and needs frail persons require another approach than people who 
age without many complications 3. Although special services for frail older people have 
proven effectiveness in the form of inpatient geriatric health services 4, several societal 
developments ask for community equivalents. People prefer to stay at home, even 
with considerable disability 5. Another drive behind the development of community 
intervention models comes from policies that promote independent living as an answer 
to the questions raised by population ageing 6. Possibly, models such as preventive home 
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visits, in-home comprehensive geriatric assessment, and intermediate care provide 
effective health services for frail older people in the community. Unfortunately, both 
the definition and efficacy of these community intervention models remain subject of 
a vivid debate 7-10. The debate stems from the fact that the models gathered under these 
names show much heterogeneity as well as considerable overlap 11. The lack of detailed 
insight into the content of these care models further complicates comparison 12, 13. One 
of the major issues is the effectiveness of these models in the expanding group of frail 
older people. 
Despite the diversity, from literature we can distil certain elements that are used in 
many community intervention models. These are elements such as multidimensional 
and multidisciplinary working, person centred care, participant selection, and treatment 
adherence. Empirical evidence is available for some of these elements. 
In this paper we will briefly summarise this knowledge on multidimensional assessment 
and management of elderly people in the community. This information grounds the 
choices we have made in designing a new community intervention model for frail elderly 
people living at home. Then, we will present the outlines of our intervention model and 
the design of the randomised trial in which we are currently evaluating the model. At this 
moment the recruitment period is already completed, and we are performing the follow-
up visits. Therefore, in addition to the details of the design, we will highlight some results 
of the conduct of the recruitment phase of our study.
Evidence on intermediate care models
Most research has been done on preventive home visits and comprehensive geriatric 
assessment, less scientific knowledge is available for intermediate care models.
The studies that have been evaluating intermediate care focused mainly on the 
evaluation of intermediate care alternatives (e.g. rapid response teams, hospital at 
home, early discharge schemes) in direct comparison with hospital care 11, 14. For most 
of the models that are not intended as direct alternatives to hospital care (e.g. residential 
rehabilitation, and community assessment and rehabilitation services) only descriptive 
data are available 15.
(Evidence-based) elements of community intervention models
Virtually all community intervention models for older people share a similar 
multidimensional nature covering a variety of medical, psychological, functional, and 
social domains. As multidimensional working is a ubiquitous feature of these models, it 
is in itself not thoroughly studied. There are some discussions on which domains are to 
be included 8.
Both in preventive home visits and comprehensive geriatric assessment it is suggested 
that models with a multidisciplinary team are more effective than models with a 
unidisciplinary approach 8, 16. Effectiveness is also claimed for longer follow-up and 
more home visits, although a recent trial did not confirm this 16, 17.
Many models provide person centred care. Some even argue that “patient-centred, 
problem-driven, goal-oriented management” is a “key minimum specification” 16.  
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Another element that might strengthen the effectiveness of comprehensive geriatric 
assessment is to secure control over the implementation of the recommendations done 
in the programme 4. Models implemented in regular care often do not have complete 
clinical control over the enforcement of the recommendations following from the 
programme. In this scenario, it is very important to involve the primary care provider who 
will be responsible for the implementation of the proposed plan 8. This is also important 
because providers’ cooperation is a determinant of patient adherence to programme 
recommendations 18. It is difficult to change physicians’ behaviour and this urges the use 
of high intensity programmes. Furthermore, programme effectiveness might benefit from 
stronger emphasis on direct recommendations to participants, and should not rely too 
much on the uptake of recommendations by the primary care provider 8.
Participant selection is a feature of community intervention models for elderly people 
that received much attention in literature. This discussion focuses on two matters: 
participant selection on the basis of age and on the basis of participants’ needs. Age as 
a selection criterion is not discussed much, but causes controversy. Some authors state 
that home visits are more effective in persons aged 75 and over, compared to younger 
individuals 19. One meta-analysis did not find an age effect, and another meta-analysis 
concluded most benefits are to be expected in the youngest old 13, 20. Frailty has received 
much more attention than age with respect to targeting these health services models 
to those who will benefit most. Most authors agree that too healthy elderly persons 
should be excluded, because both preventive home visits and comprehensive geriatric 
assessment are ineffective in these sprightly people 13, 21. There is more dispute about 
the effectiveness of these models in frail older persons. While some exclude the frailest 
participants, because in these persons there are too few possibilities for reversibility, other 
authors stress the importance of including the frailest 8, 13, 21, 22. Combining the evidence 
on the relevance of both age and frailty for participants selection Stuck concludes that 
health risk appraisal with individual reinforcement is beneficial to healthy persons aged 
60 to 75, preventive home visits should focus on independent people aged 75 and over, 
and that other types of (institutional) services are needed for the frailest 23. 
Unfortunately, considered this is true, this conclusion still disregards the population of 
frail elderly persons living in their own home. 
Considerations on designing the Dutch EASYcare Study 
We wonder whether the effectiveness of community intervention models for frail elderly 
people can be enhanced using an alternative way of participant selection. In addition 
to selecting participants on the basis of age and frailty criteria, we ask the general 
practitioner to initiate the intervention when a problem requiring action emerges. This 
problem-based approach may enhance effectiveness because of better timing of the 
intervention. Others have shown this type of targeting can be effective, albeit in a non-
randomised design 24. General practitioner’s and participant’s compliance may also 
benefit, because both have discussed and agreed on the involvement of another health 
provider. The general practitioner is directly involved in the intervention model which 
realises more control over the clinical management. Direct involvement of the general 
practitioner also provides feedback possibilities to better tailor the intervention and it 
safeguards continuity of care. We presume this continuity prevents the occurrence of 
negative effects that could result from discontinuation of the intervention. Hypothetically, 
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the result is that the intensive involvement of health workers than other the general 
practitioner and regular home care is needed only temporarily. 
If an informal caregiver was involved, we actively engaged this person in our intervention. 
We believe this involvement is a precondition for an effective community intervention 
model focusing on frail elderly people. However, to our knowledge, this caregiver 
involvement has not received much attention in the empirical studies of community 
intervention models. 
Objectives
The objective of our study is to determine the effects of the Dutch EASYcare Study 
Geriatric Intervention Programme (DGIP) compared to regular medical care in improving 
health-related quality of life in independently living elderly persons and in improving 
caregiver burden. Moreover, we want to determine the costs of the Dutch EASYcare 
Study Geriatric Intervention Programme.
Methods/Design
Study design and setting
The study is an observer blinded randomised controlled trial. Pseudo cluster randomisation 
was used to randomly allocate the participants to the DGIP or to a regular care group. 
Pseudo cluster randomisation is a randomisation method that aims to prevent both the 
occurrence of selection bias and contamination in a single design. We will discuss it in 
more detail below. The Ethical committee of the Radboud University Nijmegen Medical 
Centre approved of the study.
Study population
54 general practitioners from 36 primary care practices in and around Nijmegen, the 
Netherlands, were willing to recruit subjects. We started with 38 general practitioners, 
but increased this number during the recruitment period because of disappointing 
inclusion rates. During the inclusion period of 21 months 155 eligible participants were 
randomised. We decided not to include in follow-up and analysis those participants 
who experienced severe intercurrent disease necessitating hospital admittance, were 
admitted to a nursing home, died, or withdrew informed consent within one week 
after randomisation. The possibility of the study to have effect within one week after 
randomisation was judged as negligible, because it took about a week before nurses 
started the intervention, and the follow-up visits were judged to be too strenuous for 
these seriously ill patients. Therefore 151 participants were included in follow-up and 
analysis; 85 were included in the group that received the intervention model, and 66 
were included in the regular care group. 
Eligibility criteria
Subjects had to be eligible for participation in our intervention model (table 1). All 
participants had to be living in their own home or in a home for the aged and had to be 
70 years or older. 
When we started recruiting participants we applied an age criterion of 75 years or older. 
Unfortunately, seven months after the start of the recruitment the inclusion rates fell 
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short of expectations. We decided we were able to broaden the age criterion, because 
the combination of frailty criteria and a problem driven approach safeguarded selection 
of eligible participants. 
We restricted participant inclusion to those who scored below maximum (indicating 
good performance) on at least one of the following instruments: Mini Mental State 
Examination (MMSE), MOS-20 subscale mental health, or Groningen Activity Restriction 
Scale (GARS) 25-27. For the MMSE the cut-off was equal to or less than 26 out of 30, for 
MOS-20 mental health equal to or less than 75 out of 100, and for GARS the cut-off 
was equal to or greater than 25. The GARS score ranges 18 to 54, where 18 indicates 
best functional performance. We excluded participants with an MMSE of less than 20 
or a proved moderate to severe dementia (Clinical Dementia Rating scale [CDR] > 1, 0) 
and no informal caregiver, because we expected serious problems in the acquisition of 
research data in these persons. 
table 1 Eligibility criteria for Dutch EASYcare Study
Inclusion criteria
70 years of age and over • 
The patient lives independently or in a home for the aged • 
The patient has a health problem that was recently presented to the general • 
practitioner by the patient or informal caregiver 
The request for help is related to the following problem fields: cognitive • 
disorders, behavioural and psychological symptoms of dementia, mood 
disorders, mobility disorders and falling, or malnutrition 
The patient/informal caregiver and general practitioner have determined a goal • 
they want to achieve 
Fulfil one or more of these criteria: MMSE (Mini Mental State Examination) • 
equal to or less than 26, GARS (Groningen Activity Restriction Scale) equal to 
or greater than 25 or MOS-20/subscale mental health equal to or less than 75 
Exclusion criteria
The problem or request for help has an acute nature, urging for action (medical • 
or otherwise) within less than one week 
The problem or request for help is merely a medical diagnostic issue, urging for • 
action only physicians (general practitioner or specialist) can offer 
MMSE < 20 or proven moderate to severe dementia (Clinical Dementia Rating • 
scale [CDR] > 1, 0) and no informal caregiver (no informal caregiver is defined 
as: no informal caregiver who meets the patient for at least once a week on 
average) 
The patient receives other forms of intermediate care or health care from a • 
social worker or community-based geriatrician 
The patient is already on the waiting list for a nursing home because of the • 
problem the patient is presented with in our study 
Life expectancy < 6 months because of terminal illness• 
study designchapter 3 33
Persons already receiving forms of intermediate care or health care from a social worker 
or community-based geriatrician were also excluded, because this made it difficult 
to establish which effect was measured. Receiving home care, however, was not an 
exclusion criterion. 
Persons already on the waiting list for a nursing home, or who had a life expectancy of 
less than six months, because of terminal illness, were excluded as well.  
As a result of a mistake, in one case the age criterion was violated. However, the 
intervention team agreed that this younger case (age of this participant was 69 years) 
fitted well into the model. As exclusion was judged to be in disagreement with the ethical 
treatment of participant data, this participant was kept in follow-up and analysis. 
Treatment arms and randomisation
Participants were randomly allocated over two treatments arms: DGIP and regular care. 
No restrictions were imposed on the care participants were allowed to receive in the 
regular care group. 
Given the nature of our intervention we considered the use of two different allocation 
procedures available in literature: cluster randomisation or individual randomisation 28. 
The use of a cluster randomised design may have had an advantage over the use of an 
individual randomised design, because of the possible occurrence of contamination 
in our trial when individual randomisation was applied 29. On the other hand a cluster 
randomised design had several disadvantages. The general practitioner would have 
known the allocation outcome for his cluster after the first patient in a fully cluster 
randomised design. This might have caused selection bias resulting in incomparability 
of treatment arms 30, 31. At the same time we presumed it likely that the recruitment of 
subjects in the control clusters would progress slowly. Why should a general practitioner 
bother to refer a patient to a study, when the general practitioner knows already that the 
patient will enter the control group? There is also evidence for differential recruitment 
rates in cluster randomisation 32.
We therefore choose to use an innovative two-step pseudo cluster randomisation 
procedure 28, 33. First the general practitioners were randomised into two groups; group 
I and group C. The results of this randomisation were not revealed. Then within each of 
these groups randomisation at the patient level was carried out. This randomisation was 
stratified by general practitioner and performed in such a way that in group I the majority 
(approximately 80%) of the participants received the intervention treatment, while the 
others received standard treatment. In group C the dysbalance was reversed: the majority 
received standard treatment and the others got the intervention treatment. 
This approach had important advantages. The general practitioner did not know in 
advance which treatment a patient was going to get, so this reduced the chance of 
selection bias. It also prevented the occurrence of negative recruitment effects that might 
have resulted from being randomised to a control cluster. Had the general practitioners 
known in advance the group they were assigned to (I or C), the predictability of an 
individual randomisation decision had been larger than in an individually randomised 
trial. However, the randomisation of general practitioners occurred blinded. In such 
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a situation, the general practitioner can only gain knowledge on the randomisation 
proportion through the recruitment of participants. As the number of enrolled patients 
per practice was expected to be no more than 10, the chances to correctly guess the 
odds for each individual treatment are limited.
We expect the contamination due to the intervention treatment to be negligible in 
group C, because there are only a limited number of participants in this group on the 
experimental treatment. As the majority of the patients is on intervention treatment, the 
contamination may be a problem in patients in group I who are on standard treatment, 
but then it probably affects only a small portion of the patients. 
A randomisation procedure with adaptive weights (minimisation) was used to ensure a 
balanced distribution of high versus low percentage of elderly per  primary care practice 
and of the availability of a nurse practitioner in primary care practice in the two groups 
I and C 34. The patients were randomised with adaptive weights to get evenly distributed 
numbers of sex, and presented health problem. A person not related to the study conduct 
performed the randomisation.
Intervention model: DGIP
General practitioners referred independently living older patients to our model when 
there was a problem in cognition, nutrition, behaviour, mood, or mobility. The problem 
had to urge for nursing assessment, coordination of care, or therapeutic monitoring and 
case management. Requests were rejected if they had an acute nature or if they were 
purely medical diagnostic requests. 
A suitable case is for example a widow living on her own in a flat on the second floor 
with no elevator. The general practitioner has doubts about her cognitive abilities and 
she has depressive symptoms as well. This seems to affect her daily functioning, although 
to what extent is unclear. She has only a daughter to look after her. 
After negotiating a preliminary goal with the patient, the referring general practitioner 
contacted the geriatrician involved in the study. Within two weeks a geriatric specialist 
nurse visited the patient at home. The instrument EASYcare was applied during this first 
visit 35. EASYcare is an instrument for geriatric assessment that consists of items about 
(instrumental) activities of daily life, cognition, mood, and ends with a goal setting item. 
The goal initially negotiated by patient and general practitioner was further elaborated 
in an operational objective. If an informal caregiver was present, the nurse provided 
this person a caregiver burden assessment and the results were implemented in the care 
plan.
During maximum three months up to five follow-up visits for additional geriatric 
evaluation and management were planned. The nurse, geriatrician, and general 
practitioner frequently discussed the necessary nursing interventions, the effect of the 
interventions, the level of care that was needed, and the possibilities for reversibility. If 
necessary the nurse consulted and advised other involved health care workers, such as 
home care or physical therapist. 
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We had two nurses and two geriatricians available for the execution of our intervention. 
We developed guidelines based on best nursing practice for each health problem to 
structure activities, because literature has pointed at the possibility that the effects of 
home visiting programmes are related to the home visitor’s performance in conducting the 
visits 36. Therefore, we structured the intervention in order to diminish this effect, without 
harming the flexibility of the model. Our guidelines divided the nursing process into four 
phases: nursing diagnosis, definition of expected outcomes, nursing interventions and 
assessment of outcomes. Secondly, the guidelines used standardised NANDA (North 
American Nursing Diagnosis Association), NOC (Nursing outcomes classification) and 
NIC (Nursing interventions classification) terminology for nursing diagnosis, nursing 
outcomes and nursing interventions respectively 37-39.
We piloted our intervention model in a feasibility study 40. With some minor changes, 
this model was judged to be applicable in the current study.
Data collection and outcome measures
Within one week after referral a researcher (RM, ME) interviewed patients at home to 
obtain written informed consent and to collect baseline demographic characteristics 
and data on general health conditions. If the participant was not able to give informed 
consent we asked a proxy to do so. The participants always gave verbal assent and did 
not reject the measurements. Before the interview the participant received a written 
confirmation of the appointment and a questionnaire. We asked the participant to fill 
out the questionnaire before the appointment. If the participant was unable to fill out the 
questionnaire independently, we allowed help from another person. In some cases the 
interviewer filled out the questionnaire during the interview. We recorded the amount of 
help the participant received in filling out the questionnaire.
The participants provided data on the following measures: age, gender, type of residence, 
and the use of home care. Also, data were collected on functional abilities, cognitive 
condition, mobility, health-related quality of life, and loneliness. 
If an informal caregiver was available we collected data on informal caregiver 
characteristics using a questionnaire. We collected data on type and amount of care 
provided, time spent on caring, and caregiver burden. 
These measurements are repeated three and six months after inclusion. The same 
researcher that performed the baseline visit carries out these interviews. This researcher 
is not involved in the intervention nor does the researcher know the allocation decision. 
After each follow-up visit the researcher indicates whether blinding remained intact or 
not. 
Primary outcome measures relating to participant characteristics are functional 
performance in (independent) activities of daily living measured using Groningen 
Activity Restriction Scale and mental health using subscale mental health MOS-20. 
Primary outcome measure in informal caregivers is caregiver burden using the Zarit 
Burden Interview (ZBI) 41. An overview of secondary outcomes and a complete list of all 
measurements are provided in table 2.  
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 Process evaluation
We collect data on the following set of process variables: the content of the intervention 
programme, the adherence of participants and informal caregivers in the intervention 
group to advices given during an intervention, experiences of participants and informal 
caregivers with the intervention model, and data on general practitioner care and care 
of other involved professionals in both treatment arms. 
table 2 Outcome measures
Variable Instrument
Background variable
Secondary outcome
Primary outcome Measured at T0 T1 T2
Functional performance (ADL/
IADL)
   GARS-3 27   
Mobility •	    Timed up and go test 44   
Health-related quality of life    MOS-20 26   
Mood    Subscale mental health MOS-20   
Well-being    Cantril self-anchoring ladder 45   
Dementia Quality of Life 
questionnaire46
  
question general life satisfaction   
Cognition    MMSE 25   
Social functioning    Loneliness scale de Jong-Gierveld 
47
  
Mortality      
Housing conditions/sort of 
residence
   Own questionnaire   
Subjective treatment effects 
(participant, informal caregiver)
   Patient Enablement Instrument 48   
Burden informal caregiver    Zarit Burden Interview 41   
   Questions taken from 
“Zorgkompas Mantelzorger” 49 
  
Time spend on care (informal 
caregiver)
   Own questionnaire   
Age (participant, informal 
caregiver)
   Own questionnaire   
Sex (participant, informal 
caregiver)
   Own questionnaire   
Socio-economic status    Own questionnaire, classify using 
ISEI-92 50
  
(Former) occupation•	    Own questionnaire, classify using 
SBC-92 50
  
Nativity    Own questionnaire   
Co-morbidity    Cumulative Illness Rating 
Scale-Geriatrics (CIRS-G) 51 
from medical history in general 
practitioner Information System
  
Use of home care    Own questionnaire   
T0 is baseline measurement
T1 is first follow-up measurement, after 3 months
T2 is second follow-up measurement, after 6 months
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We collect data on the content of the intervention process, because this may help to 
identify which programme characteristics are most beneficial. An abstract form is used 
to extract this information from the nursing records after completion of all individual 
interventions. We extract information on treatment goals, nursing diagnoses (NANDA)37, 
nursing interventions (NIC)38, nursing outcomes (NOC)39, and the employed diagnostic 
instruments.
Compliance of participants and informal caregivers is an important determinant of 
carrying out a successful intervention. When an individual intervention is finished the 
nurse that executed the intervention indicates in an MS Access form which of a number 
of pre-specified advices were given. Another nurse calls the participant or informal 
caregiver one month later to check compliance on these advices.
We score subjective treatment effects in treatment group using a questionnaire that 
participants and informal caregivers filled out after the first follow-up visit.
Data on general practitioner care will be collected in both treatment arms from the 
information that is routinely available from the General Practice’s Information System 
(Huisartsen Informatie Systeem). We collect the following data: medical history 
using ICPC-2 (International Classification of Primary Care) 42, number and content 
of contacts during six months of follow-up using ICPC-2, number and nature of 
referrals, and medication using ATC classification (Anatomical Therapeutic Chemical 
drug classification) 43. Data on the use of home care are collected in the participant 
questionnaire. The data on general practitioner care will be collected at the end of the 
follow-up period. These data are collected in order to be able to clarify the observed 
intervention effect and to establish costs.
Costs
To be able to calculate costs, data will be collected on the following cost variables. 
Nurses will register the time spent on the intervention using the MS Outlook agenda. 
They will register the number of visits per participant. They also register the time spent 
on consultation, phone calls, travelling, and administration.
Data on the workload of the general practitioner and the geriatrician will be extrapolated 
from the workload of the nurses. The data we collect on the care provided were already 
described in the paragraph “process evaluation”. Finally, we will derive salary costs, 
administrative costs, and costs for materials.
Sample size considerations
A change in the primary outcome measure of functional performance (GARS-3) of 4.5 
points on a scale ranging from 18 (complete independence) to 54 (complete dependence) 
can be found with a power (1-β) of 0.80 and α (two sided) of 0.05 in comparing two 
groups of 77 subjects, when pseudo cluster randomisation is applied. We use a standard 
deviation of 8.5, which we calculated from a pilot study. This standard deviation is well 
in the range of the measures of spread other studies have found 27. A mean increase of 
4.5 points is chosen as clinically relevant, because a 4.5 point increase of the overall 
score indicates an improvement of 25% of all items by one functional class (each item’s 
score is classified as follows: completely dependent 3 point, partly dependent 2 points 
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and completely independent 1 point). Cluster size is estimated to be approximately 
10 participants per general practitioner. The exact calculations and considerations are 
extensively described in Teerenstra et al 33.
Statistical analysis
Descriptives will be used to assess comparability of both intervention and control group 
for background and confounding variables. Our primary analysis will focus on the 
treatment arms’ differences in the primary outcome measures’ changes from baseline 
(GARS, MOS-20 subscale mental health, and Zarit Burden Interview) at three months 
of follow-up (T1). This will be done in intention-treat-analysis. We will use mixed linear 
model analysis (Proc Mixed in SAS 8) to quantify these differences. We will account 
for clustering at the level of the general practitioner through the addition of a random 
intercept for general practitioner to the three models. The baseline measurements of 
GARS, MOS-20 subscale mental health, and Zarit Burden Interview will be added to 
the respective models as a covariate. The factors we stratified for in the randomisation 
(general practitioner characteristics, sex of participant, and participant’s presented health 
problem) will also be added to the models as covariates. No further corrections will be 
made. A conditional analysis of the treatment arms’ differences in changes from baseline 
at six months (T2) will be performed if there is a significant effect at T1. Apart from 
replacing the scores at three months with those at six months the same three models 
will be used. 
The secondary analyses will be performed on the treatment arms’ differences in time 
trend of the primary outcome measures GARS, MOS-20 subscale mental health, and 
Zarit Burden Interview during follow-up. Secondary analysis will further focus on the 
differences between treatment arms of the secondary outcome measures at three and six 
months of follow-up. Kaplan-Meier estimates and hazard ratios will be used to quantify 
the intervention’s effect on living conditions and mortality. Subgroup analyses will be 
performed for the following subgroups: living in one’s own home versus living in a home 
for the aged, and higher versus lower levels of cognitive function. All analyses will be 
performed in SAS 8.
Discussion 
In this paper we presented the design of a randomised controlled trial that evaluates the 
effects of a community intervention model for frail elderly people living on their own. 
The design of this study has shown to be very challenging. 
Although the recruitment of the participants took much effort, we have included a 
number of subjects that should be large enough to provide reliable answers to our 
research questions (figure 1). 
Our participants were selected using a problem-based approach in which the general 
practitioners decided in cooperation with the geriatrician which patients were suitable 
for this intervention model. This participant selection procedure satisfied; only a minor 
number of the referred patients did not meet our eligibility criteria based on frailty and 
age. Probably, piloting our intervention model was important to achieve this.
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figure 1 Flow chart Dutch EASYcare Study
This flow chart summarises the progress through the phases of the Dutch EASYcare Study until the allocation of participants to 
each treatment arm
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As discussed earlier, there is a lack of insight into the content of most community 
intervention models studied. We decided to use standard terminology such as ICPC, 
NANDA, NIC, NOC and ATC codes to provide insight into our intervention when used 
in practice. This makes detailed insight possible using terminology others can understand 
well. 
The selection of the best randomisation method was a final major issue we had to deal 
with and that took much of our time. We think this randomisation procedure satisfies. 
Nevertheless, we will closely monitor and report in future papers how the randomisation 
procedure performs in practice. 
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Chapter 4
Pseudo cluster randomisation dealt with selection 
bias and contamination in clinical trials
S. Teerenstra, R.J.F. Melis, P.G.M. Peer, G.F. Borm 
J Clin Epidemiol 2006;59:381-6 
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Objective: When contamination is present, randomisation on a patient level leads to dilution 
of the treatment effect. The usual solution is to randomise on a cluster level, but at the cost of 
efficiency and more importantly, this may introduce selection bias. Furthermore, it may slow 
down recruitment in the clusters that are randomised to the “less interesting” treatment. We 
discuss an alternative randomisation procedure to approach these problems. 
Study design and setting: Pseudo cluster randomisation is a two-stage randomisation procedure 
that balances between individual randomisation and cluster randomisation. For common 
scenarios, the design factors needed to calculate the appropriate sample size are tabulated. 
Results: A pseudo cluster randomised design can reduce selection bias and contamination, 
while maintaining good efficiency and possibly improving enrolment. To make a well-informed 
choice of randomisation procedure, we discuss the advantages of each method and provide a 
decision flow chart. 
Conclusion: When contamination is thought to be substantial in an individually randomised 
setting and a cluster randomised design would suffer from selection bias and/or slow recruitment, 
pseudo cluster randomisation can be considered. 
Introduction 
The golden standard for randomisation is assigning individuals at random to experimental 
conditions (individual randomisation). This maximises the probability that (un)known 
confounding variables will be evenly distributed over treatment groups. However, when 
such an allocation procedure is applied, the subjects on one treatment may come into 
contact with elements of the other treatment and vice versa. Consequently, we may 
not observe the pure treatment effect, but a contaminated one: some elements of one 
treatment mix into the other treatment and vice versa. If such contamination is thought to 
be strong enough to pull the observed treatment difference below statistical significance, 
there are two options. Firstly, the panacea of increasing the sample size 1. This can 
endow the contaminated effect with statistical significance, but it cannot prevent the 
contamination from pulling the observed effect below clinical relevance.
Secondly, contamination can be avoided altogether by using cluster randomisation. 
Subjects who are likely to contaminate each other are grouped into clusters and entire 
clusters are randomised to one of the treatments. However, this clustering decreases the 
effective sample size due to the positive correlation between the subjects within the 
clusters. 
Two caveats are attached to cluster randomisation. Often, it is impossible to recruit all 
the subjects before the clusters are randomised. As a result, it is known in advance which 
treatment the patients in a certain cluster will receive and this may lead to selection 
bias 2. The other problem is the risk of slow or stagnating patient recruitment in the 
clusters that are going to receive what the patients or recruiters consider to be the “less 
interesting” treatment. 
To avoid the above-described objections to cluster randomisation, Borm et al. 3 devised 
a randomisation procedure that balances between individual randomisation and cluster 
randomisation. 
In the two sections below, we describe the method of pseudo cluster randomisation, 
while in section 4, we present a formula for sample size calculation. In the discussion, 
we compare the merits and demerits of pseudo cluster randomisation to those of ordinary 
cluster randomisation and individual randomisation and provide guidelines to make a 
well-informed choice between them. 
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Pseudo cluster randomisation 
Pseudo cluster randomisation is a two-stage randomisation procedure that combines 
randomisation on a cluster level with randomisation on a patient level. Suppose that 
a trial is set up to evaluate two treatments, T and S. In the first step, the clusters are 
randomised into two groups: half of the clusters go into cluster group t and the other 
half go into cluster group s. The allocation of each cluster is not revealed. In the second 
step, subjects are allocated to treatment T or S in the following way: within each cluster 
in cluster group t, subjects are randomised in such a way that the majority, say a fraction 
f x 100%, receive treatment T and the remainder, (1-f) x 100%, receive treatment S. 
In cluster group s, the fractions are reversed, i.e. the majority of each cluster receive 
treatment S and the remainder receive treatment T. 
The Dutch EASYcare trial 
Pseudo cluster randomisation is being employed in the Dutch EASYcare trial to address 
the problems associated with individual randomisation and cluster randomisation 4. This 
is an observer-blinded trial that aims to compare an intermediate care programme for 
elderly people with geriatric problems to the traditional care as provided by general 
practitioners. General practitioners recruited elderly patients with a geriatric problem for 
the study. The intermediate care programme is performed by a specialist geriatric nurse 
and consists of up to six home visits for geriatric evaluation and management. general 
practitioner participation in this treatment arm is limited to regular case evaluations with 
the nurses. 
In a design with individual randomisation, the general practitioner would have as many 
patients on the new treatment as on the standard treatment. Contamination may then 
arise on a general practitioner level: due to feedback from the nurses about the elements 
and effects of the intermediate care programme, the general practitioner may gradually 
acquire knowledge and skills to implement (parts of) the intermediate care programme 
in the care of other patients, including those originally allocated to traditional care. On 
the other hand, contamination on a patient level is unlikely, because the patients are not 
likely to meet each other. 
The above-described contamination can be avoided if each general practitioner is 
concerned with one treatment only (cluster randomisation). However, in this trial, as 
is often the case with cluster randomised designs, it was not possible to recruit all the 
patients before the clusters were randomised. The treatment of a geriatric problem could 
not be postponed until after completion of recruitment. Therefore, (after the first patient) 
the general practitioner would know which treatment all the following patients would 
be assigned to and this might influence the general practitioner’s choice of patients 
(selection bias). Also, as the main motivation for general practitioners to take part in 
this trial was their interest in the new treatment, the general practitioners in the control 
clusters may be less motivated to recruit patients and they might produce data of poorer 
quality 5. Thus, recruitment may be poor in the control clusters, which can jeopardise 
the power of the study 6. 
We decided to use pseudo cluster randomisation to deal with this dilemma. First the 
general practitioners were randomised into two groups on a 1:1 basis: t (treatment) or s 
(standard). The results of this randomisation were not revealed. Then, within clusters of 
group t (or s), patients were randomised to the new treatment or standard care at a ratio of 
0.8 : 0.2 (0.2 : 0.8, respectively). One of the merits of this procedure compared to cluster 
randomisation was that none of the general practitioners ended up with only patients 
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on the uninteresting (standard) treatment, which may have improved recruitment. In 
addition, the general practitioner did not know in advance which treatment the next 
patient would receive, which tempered selection bias. As recruitment proceeded, the 
general practitioner might have noticed the imbalance in treatment ratio and tried to 
guess the chance of either treatment, but predictability would always be lower than 
in cluster randomisation. Predictability was further reduced in this trial by keeping the 
clusters small. Thus, it was harder to guess the treatment ratio before the end of the 
recruitment period.
In comparison with individual randomisation, pseudo cluster randomisation may lead to 
less contamination in the Dutch EASYcare Study. At the start of the study there was no 
contamination, because the general practitioners did not have the knowledge or skills 
to apply (elements of) the invention. During the study, the general practitioner does 
not execute the intervention and is only provided with information about the treatment 
through the evaluations with the nurse. As the EASYcare intervention is a multi-faceted, 
tailored treatment, the general practitioner must have had feedback concerning 
several intermediate care patients before he or she has any grasp of the elements of 
the intervention. Moreover, not only passive knowledge will have to be acquired, but 
also new skills and attitudes will have to be learned in order to copy the intervention 
successfully 7. Therefore, it is unlikely that having 2 patients allocated to intermediate 
care within a general practice would cause any substantial contamination, but having 
5-8 patients allocated to intermediate care could be a concern. In other words, there 
will be hardly any contamination of the results of the patients on the majority treatment 
within a cluster, whereas there may be substantial contamination in the patients on the 
minority treatment. The latter contamination, however, would only affect a relatively 
small number of the participants. Therefore, we considered pseudo cluster randomisation 
to be an appropriate means to reduce contamination. 
Sample size calculations 
Sample size calculations for pseudo cluster randomised designs follow the same 
procedure as those for ordinary cluster randomised designs. 
First, calculate the sample size N with the usual formula for an individually randomised 
trial: 
 (1) N= 2(zα/2 + zβ)
2σ2/δD
2
where zα/2 and zβ are the quantiles of the normal distribution, given that the type I error 
rate is α (two-sided) and the type II error rate is β. In addition, σ is the standard deviation 
and δD is the treatment difference expected in the chosen design. 
Second, multiply the above sample size by the appropriate design factor, which not only 
depends on the intracluster correlation ρ, but also on the majority fraction f and cluster 
size n. For f=0.8, the design factors of pseudo cluster randomisation are tabulated in 
Table 1. 
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For other values of f, n and ρ, the following formula can be used:  
(2)
  
)1/()1(41
)1(1
rr
r
−−+
−+=
nff
n
pcFactor Design
                                       
which is derived from the minimal variance estimator for pseudo cluster randomisation 
in 3. The total sample size for the trial will be 2×N× Design Factorpc. Half of this sample 
size will be allocated to treatment T and the same number to treatment S. The total 
number of subjects in each cluster group (i.e. t or s) is N× Design Factorpc  by design, 
while both cluster groups contain N× Design Factorpc/n clusters. 
The analysis may be performed with methods used for cluster randomised trials 8-10.
Impact of the choice of randomisation procedure on sample size 
The Dutch EASYcare study 4 was powered on GARS-3, a functional performance measure 
for daily life activities that ranges from 18 to 54 11. A pilot study on the target population 
showed that the GARS had a standard deviation of σ=8.5 (and a mean µ=35). It was 
expected that the intermediate care programme would improve a patient’s capacity to 
perform daily life activities and result in a higher average score on the GARS that could 
amount to δ=4.5 in the absence of contamination. At a two-sided significance level of 
5% (α=0.05), the objective was to achieve a power of  80% (β=0.2). Below, we describe 
the impact of each randomisation scenario on the total sample size.
Impact of cluster randomisation 
In a cluster randomised setting, contamination is absent and the expected treatment 
difference is δD =4.5. However, clustering introduces a positive correlation between the 
patients in a cluster. This is expressed by the intracluster correlation coefficient, which 
was anticipated to be ρ=0.05 in this trial. Following the usual procedure, the sample 
size of each treatment arm is calculated using formula (1), which yields 56. This value is 
then corrected by multiplying it with the design factor 1+(n-1) ρ (see 8). As the maximum 
cluster size expected was n= 10, the result was a total sample size of 164. 
Impact of individual randomisation 
In an individually randomised design, contamination is substantial and it is anticipated 
to dilute the expected treatment difference to δD =3.5. However, no clustering takes 
table 1 Design factors based on the minimal variance estimator in Borm et al3 
by cluster size n and by intracluster correlation ρ
Intracluster correlation ρ
Cluster 
size n 
0.005 0.01 0.05 0.1 0.2 0.3 0.4
10 1.01 1.02 1.08 1.11 1.08 0.99 0.87
20 1.03 1.05 1.17 1.20 1.14 1.03 0.90
30 1.04 1.08 1.22 1.24 1.17 1.05 0.91
40 1.06 1.10 1.26 1.27 1.19 1.06 0.92
50 1.07 1.13 1.29 1.30 1.20 1.07 0.92
80 1.11 1.18 1.34 1.33 1.22 1.08 0.93
100 1.13 1.21 1.36 1.34 1.22 1.08 0.93
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place and using (1), the sample size of each treatment arm is 93, i.e. the total sample 
size is 186. 
Impact of pseudo cluster randomisation 
Pseudo cluster randomisation was used in the EASYcare trial. Thus, the rate of 
contamination was expected to decrease compared to the individually randomised 
situation, although not as far as the uncontamined level (δD =4.5) of a cluster randomised 
setting. An expected treatment difference of δD =4 was deemed realistic. Following the 
procedure outlined in section 4, the sample size of each treatment arm was calculated 
to be 71 using (1).
After correction with the appropriate design factor 1.08 in Table 1 (n=10, ρ=0.05, f=0.8), 
the total sample size was 154. 
The above calculations showed that pseudo cluster randomisation had an additional 
advantage in the Dutch EASYcare trial. The sample size was smaller than that of cluster 
randomisation and individual randomisation. This is not uncommon as shown by the 
calculations in 3. 
Discussion 
It is necessary to carefully weight selection bias, contamination and practical 
considerations in the decision whether to use individual, pseudo cluster or cluster 
randomisation. 
Choice of randomisation method 
In some cases, there are compelling reasons to use a particular randomisation procedure. 
For instance, if a few subjects in a cluster on one treatment are already capable of 
contaminating all the other subjects on the other treatment, then it may be wiser to rely on 
cluster randomisation. Other examples in which cluster randomisation may be mandatory 
occur when new working protocols or nursing methods are introduced on hospital 
wards, as these cannot be split up. Also, cluster randomisation is sometimes needed 
to ensure compliance with protocols, for example when pseudo cluster or individual 
randomisation involves such high (administrative) workload and strict discipline that 
compliance becomes questionable. Finally, the lower expense of administering only one 
treatment condition at all sites may encourage the use of a cluster randomised design. 
In cases in which both individual and cluster randomisation are feasible options, 
we present some guidelines that may help to choose between the different types of 
randomisation (Figure 1). 
Consider the comparison of two treatments that have an uncontaminated difference δ in 
the outcome of interest. 
(1) Suppose that in individual randomisation, contamination occurs that dilutes 
the treatment difference by a factor C, i.e. the treatment difference expected in the 
individually randomised situation drops to δ(1-C). Slymen et al. 12  showed that the 
sample size has to be increased by factor 1/(1-C)2 to compensate for the loss of power 
due to this contamination. Thus, if the contamination rate is C=10% the sample size 
has to be increased by 23%; for C=20% the increase would be 56%. Therefore, small 
contamination rates of up to 10% (C=0.1) may be compensated for by increasing the 
sample size by factor 1/(1-C)2. If contamination rates are substantial (20% or more), 
the sample size also has to be increased substantially and (pseudo) cluster alternatives 
become attractive. 
(2) When contamination is large, but recruitment in the “less interesting” clusters or 
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selection bias is not an issue, ordinary cluster randomisation is the preferred method. 
(3) When recruitment and selection bias pose a problem, however, pseudo cluster 
randomisation may be the recommended choice, especially when contamination of the 
majority in a cluster (on the one treatment) by a minority in the same cluster (on the 
other treatment) is considerably smaller than vice versa. 
The size of the cluster may play a role in improving recruitment speed and reducing 
selection bias and contamination. Consider, for instance, the situation in the Dutch 
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EASYcare trial. As recruitment progresses, the general practitioner might be able to 
guess with increasing precision how big the chance is of a particular treatment in his 
or her cluster. At the point where the general practitioner is convinced that most of the 
patients are on one of the treatments, he or she may still become demotivated to recruit 
if this is the treatment that he or she finds uninteresting. An even worse effect of this 
conviction is that it may influence the general practitioner’s choice of patients, which 
may reinduce selection bias. Furthermore, if the cluster size increases, the number of 
patients on the minority treatment also increases and eventually this may still cause 
substantial contamination of the majority by the minority. Therefore, pseudo cluster 
randomisation seems to be feasible for moderate cluster sizes of say between 6 and 50 
(which also depends on the enrolment speed). Another good reason not to use pseudo 
cluster randomisation for large clusters is that individual randomisation is more efficient 
than pseudo cluster randomisation for large clusters, even though the contamination rate 
in individual randomisation is larger 3. 
(4) If pseudo cluster randomisation is not expected to reduce contamination substantially, 
three options are available. If reducing contamination is more important, then cluster 
randomisation is the preferred procedure. In the case of slow recruitment or selection 
bias, the best choice would be individual randomisation. In cases in which it is unclear 
what is the most important, efficiency may be the main lead. As in section 4.1, the sample 
sizes for the different randomisation scenarios can then be worked out and compared. 
Choice of f
There are two counterbalancing requirements for f. On the one hand, the imbalance 
between the two treatments has to be relatively small (i.e. f is close to 0.5) to avoid the 
selection bias that might arise because of predictability. On the other hand, in order 
for pseudo cluster randomisation to reduce contamination, the treatment given to the 
majority of patients in each cluster must be (much) less contaminated by the presence of 
a minority on the other treatment than vice versa. The latter means that f must be closer 
to 1. Therefore, the value chosen for f should be as small as possible as long as the above 
assumption can still be sustained. In most cases, f=0.8 seems to be a good choice 3. 
Reduction of contamination
To reduce contamination by means of pseudo cluster randomisation, the condition 
mentioned in question box 3 (flow chart 1) needs to be fulfilled i.e. if only a few people in 
a cluster receive a certain treatment, the outcome of the much larger group who receive 
the other treatment is much less affected than vice versa. Whether this assumption is 
reasonable in a specific trial, has to be judged on a case-by-case basis. However, some 
general remarks can be made. 
When contamination is absent at the start of the study, contamination can only result from 
exposure to the “other” treatment. The relationship between exposure and contamination 
will follow a certain response or learning curve whose shape depends on the nature 
of the treatment and exposure. For example, simple information, interventions, and 
advices are easily transferred verbally or visually which suggests that slight or a single 
exposure might already result in severe contamination. On the other hand, complex 
multi-dimensional treatments have a gradual learning curve, as several stages have to be 
gone through: from acquiring knowledge, via competence and performance to actual 
successful application of the complex treatment (cf. Miller’s pyramid 7 and Reynolds’s 
learning model 13, 14).  Therefore, limiting the driving force of this learning process, which 
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in our context is the exposure, may limit the contamination effect. 
Another aspect is the level at which the contamination arises: this may be the subject 
level (e.g. patients) or the cluster level (e.g. general practitioners).
In the first case, if there is intense contact between the patients within a cluster (such as 
within families), contamination by a small proportion of the patients may be considerable 
and pseudo cluster randomisation would not reduce contamination. In situations with 
less intensive contacts, pseudo cluster randomisation may be useful. An example is the 
evaluation of a training programme for the prevention of falls in people living in homes 
for the elderly. Participants enter the study after their first fall and the treatment may 
consist of assessment by a physiotherapist who sets up a training programme and advice 
from an ergotherapist about removing obstacles in the living area and using walking 
aids, e.g. a walker or a rollator. If only a few people in a home take part in the training, 
this may not affect the others, so contamination of the large subset may be negligible. 
Vice versa, if only a few people in another home do not have the training, this may not 
influence the results of the majority who do take the training.
The Dutch EASYcare trial (section 3) is an example of a trial in which contamination 
resides on the cluster level. In this trial, general practitioners do not provide the geriatric 
intermediate care treatment, but may learn the method in the process of several feedback 
meetings. The more patients who are randomised to the intermediate care at their 
practice, the more likely these general practitioners are to reach the stage of mastering 
the intervention and applying it to other patients, which results in contamination. 
More trials such as these are likely to be conducted in view of the current trend in care 
towards multi-disciplinary, individually tailored treatments 15. These treatments often deal 
with (multiple) chronic diseases, multiple co-morbidities and often aim to optimally use 
the capabilities that are still available. Another example is coaching after heart failure by 
a specialist cardiology nurse, physiotherapist, dietician and social worker in addition to 
the usual contact with a cardiologist and/or the patient’s own general practitioner. The 
standard care in these contexts is usually provided by mono-disciplinary specialists or 
all-round medical doctors (general practitioners at practices, nursing homes or homes for 
the elderly), who use mostly specific, complaint-centred ad-hoc treatments.  Although 
these doctors do not execute the complex interventions themselves, they still supervise 
them and therefore receive feedback. Consequently, they may unintentionally learn and 
then use the method on other patients, which results in contamination. In such cases, 
pseudo cluster randomisation may be well worth considering.
Conclusion 
When the risk of selection bias or slow recruitment in a cluster randomised setting 
competes against contamination arising in individual randomisation, pseudo cluster 
randomisation may be a good alternative. It can simultaneously minimise both selection 
bias and contamination and help to improve enrolment.
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Chapter 5
Pseudo cluster randomisation performed well 
when used in practice
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Objective: Pseudo cluster randomisation (PCR) randomised researchers in two groups (H 
and L). Accordingly, patients of one researcher were randomised in majority to intervention 
or to control arm. We verified the assumptions basic to the use of PCR in a services evaluation 
trial: 1) researchers had treatment arm preferences 2) that would have affected recruitment 
when cluster randomisation had been applied, 3) individual randomisation would have caused 
contamination, and that PCR prevented 4) allocation predictability, 5) selection bias, and 6) 
enrolment rate differences.
Study Design and Setting: Researchers indicated treatment arm preferences, recruitment 
behaviour in a cluster randomised design, possible contaminating behaviour, and their 
estimation of the allocation ratio used to allocate their patients. We compared patients’ baseline 
characteristics and individual researchers’ recruitment rates.
Results: Researchers favoured the intervention arm (Visual Analogue Scale 14.5 (SD 15.6); 
0-100). 58% expected to recruit fewer patients, had every participant been allocated to the 
control group. 67% estimated that a 50:50 randomisation ratio was used. 65% of researchers 
used elements of the intervention in control patients. H- and L-researchers recruited a median 
number of three patients who were comparable at baseline. 
Conclusion: The assumptions underlying PCR largely applied in this study.
Introduction
Conventional research methodology does not always satisfy when designing an 
individual  intervention study. While designing a randomised trial on the effects of a 
problem-based intervention model for community-dwelling elderly people, the authors 
ran into the limitations of the accepted methods for randomisation 1. Randomisation at 
the level of the individual patient was expected to lead to contamination bias, while 
the accepted solution for contamination bias, cluster randomisation, would probably 
introduce selection bias and recruitment problems 2, 3. In order to deal with this dilemma 
we designed an alternative randomisation method called pseudo cluster randomisation 4, 
5. The aim of this paper is to evaluate the performance of this randomisation procedure.
The principal objective of the services evaluation study in which pseudo cluster 
randomisation was used was to determine the effects of a nurse-led home visiting 
programme compared to usual care in improving health-related quality of life in 
independently living older people with common geriatric problems. In this care 
programme the general practitioner recruited patients on a problem base. 
In this paper the recruiting general practitioner will be further addressed as “researcher”, 
while the physician with recruited patients will be referred to as “cluster”. In our study 
blinding of patients was impossible due to the character of the intervention. The exposure 
to the intervention resulting from the researcher’s participation in the model probably 
would lead to contamination of control patients, when patients were randomised 
individually. If we had used cluster randomisation 6-8, the researcher would have known 
the randomisation decision after the inclusion of the first patient. We anticipated this 
would have influenced the rate of recruitment and the selection of the patients in the 
control group 9. Different selection of patients in the therapy arms would have led to 
selection bias and incomparable treatment arms.
In the pseudo cluster randomisation method we used, the researchers were first 
randomised into two types of clusters; clusters H (High) and clusters L (Low). In the 
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second step randomisation at the patient level was carried out within these clusters. In 
H-clusters the majority of the subjects received the intervention, while the smaller rest 
received usual care. In L-clusters the randomisation ratio was reversed.
This approach had important advantages, directed towards selection bias and 
contamination. The researchers did not know in which cluster group they were, nor did 
they know in advance what treatment a patient would be on. This reduced the chance 
of selection bias. No longer half of the researchers were caught in a cluster that was 
randomised to usual care for all patients. Researchers may be more willing to recruit, 
when every patient has the prospect of participation in the innovative treatment with 
expected benefit over regular care. 
In L-clusters most of the patients received usual care and only few patients were on 
the intervention programme. Contamination was expected to be smaller compared to 
individual randomisation, because there were limited possibilities for the researchers 
to change their behaviour as a result of contact with the intervention treatment. The 
controls in H-clusters might be contaminated, as the majority of the patients was on 
the intervention programme, but the number of controls in these clusters are relatively 
small. 
While these assumptions sound reasonably, they need empirical evaluation. In this pa-
per we will carefully scrutinise the performance of pseudo cluster randomisation in our 
trial. We will investigate the sustainability of the following underlying assumptions: 
the researchers preferred a certain treatment arm (in which case cluster randomisation • 
would have led to recruitment bias); 
advance knowledge of the outcome of the randomisation would have influenced the • 
researchers’ inclusion behaviour (in which case cluster randomisation would have 
led to recruitment bias);  
the researchers used elements from the intervention treatment in their treatment of • 
control patients or learnt from their involvement in the intervention treatment (in 
which case individual patient randomisation would have led to contamination);
the researchers remained blind for the randomisation proportions they were assigned • 
to (i.e. no allocation disclosure in case of pseudo cluster randomisation);
the two types of clusters included equal numbers of patients (i.e. no recruitment • 
problems in case of pseudo cluster randomisation); and 
the two types of clusters included the same type of patients (i.e. no selection bias in • 
case of pseudo cluster randomisation). 
Methods
The evaluation of pseudo cluster randomisation was executed within the setting of a 
services evaluation study. All recruiting researchers were randomly assigned to one of 
two groups: clusters H and clusters L. In clusters H recruited patients were randomly 
assigned using randomisation proportions assigning 80% to the intervention arm and 
20% to the control arm. In clusters L recruited patients were randomly assigned using 
randomisation proportions assigning 20% to the intervention arm and 80% to the control 
arm.
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For the randomisation of the researchers, a minimisation algorithm was used to balance 
for the factors: 1) high versus low percentage of elderly per practice and 2) the availability 
of a nurse practitioner. 
In the evaluation of the performance of the pseudo cluster method we used of the 
following assessments: 
Baseline characteristics of researchers
We assessed the baseline characteristics of the researchers using a questionnaire 
researchers filled out before the inclusion of the first patient from their practice. This 
questionnaire provided data on the following measures of researcher and practice: 
age, sex, experience, sideline activities, working hours, type and location of practice, 
number of patients registered at the practice, the proportion of registered older people, 
and the availability of a practice nurse. The questionnaire also assessed the self-reported 
competence in geriatrics using the questionnaire of Robinson et al 10.
End of trial characteristics of researchers
When the services evaluation study was ended all researchers received a questionnaire 
that assessed aspects of their appreciation of the intervention under study, treatment arm 
preferences when including a participant, their estimation of the randomisation ratio 
used in their cluster, and the certainty of their estimation, using Visual Analogue Scales. 
The questionnaire also addressed their alleged inclusion behaviour had they known 
in advance that all their patients would be in the intervention or in the regular care 
group, respectively. Finally, the questionnaire investigated once more the self-reported 
competence in geriatrics using the Robinson questionnaire 10.
Baseline characteristics of patients
We used a written questionnaire and an interview to collect baseline patient data. These 
instruments provided data on: age, gender, and functional abilities (Groningen Activity 
Restriction Scale (GARS))11. Also, data were collected on cognitive status (Mini Mental 
State Examination)12, mobility (Timed Up Go Test)13 and (health-related) quality of life 
(MOS-20 14 , Cantril’s self anchoring ladder 15, Dementia Quality of Life 16). Moreover, 
we collected data on Socio Economic Status, living conditions, loneliness (Loneliness 
scale de Jong Gierveld) 17, availability of informal caregiver, and informal caregiver 
burden (Zarit Burden Interview) 18.
Results 
A number of 55 researchers agreed to recruit patients for the services evaluation study. 
The researchers were 47 years of age on average and had been working a mean of 16 
years as a general practitioner. Forty-six% of researchers were male. Many researchers 
had sideline activities, among which educational activities (69%, mainly supervising 
general practitioner registrars) and management tasks (15%) were most mentioned. 
Reasons to participate were multiple; important motivators were the expectation that the 
intervention model would serve as a supplement to regular primary care (69%) and the 
expected benefits for their patients (62%). The researchers worked in 36 practices that 
served a mean number of 4145 patients of whom approximately 10% were 75 years of 
age and over.
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Differences between clusters at baseline
In the group of H-clusters were 28 researchers and 27 researchers were in the group 
of L-clusters. Researchers in L-clusters were less experienced (13 versus 19 years 
experience, p = 0.03). 
When comparing researchers who actually recruited (n = 40) with researchers who did 
not recruit (n =15), the differences were more prominent. Non-recruiting researchers 
were younger (43 versus 48 years of age, p = 0.01), less experienced (11 versus 18 years 
of experience as general practitioner, p = 0.01) and working more often in practices that 
employed less general practitioners (p = 0.01).
Recruitment
All researchers together recruited 151 patients of whom 85 (56%) were allocated to the 
intervention and 66 to regular care. In the H-clusters (n = 28) 20 researchers recruited 
85 patients (56%) and in the L-clusters (n = 27) 20 researchers recruited 66 patients 
(table 1). On average, the H-clusters recruited 4.2 patients and the L-clusters recruited 
3.4 patients. The number of patients recruited per cluster varied widely: 10 researchers 
recruited only one patient, eight researchers recruited two patients, and one researcher 
recruited 15 patients. Both type of researchers recruited a median number of three 
patients (p = 0.19). On average, a proportion of 0.77 was allocated to the intervention 
arm in clusters H, in clusters L this proportion was 0.27.
Differences between patients at baseline
Loneliness and MOS-20 role functioning scores showed statistically significant 
differences at baseline for patients recruited by H- and L-clusters (table 2). L-cluster 
patients had better role functioning (MOS-20 subscale) scores with at the same time 
worse loneliness scores.  
Treatment arm preferences
Researchers strongly favoured inclusion in the intervention arm. The score was 14.5 on 
a VAS where zero indicates strongly favouring the intervention arm and 100 indicates 
strongly favouring the regular care arm (table 3). (p < 0.001 [one sample t-test comparing 
the value with a value 50 implicating no effect])
table 1 Recruitment characteristics for all clusters and per cluster type
All clusters 
(n = 55)
H-clusters* 
(n = 28)
L-clusters* 
(n = 27)
p
No. of researchers that 
actually recruited (%)
40 (73) 20 (71) 20 (74) 0.91
No. of included patients 
(% of  all included pa-
tients)
151 85 (56) 66 (44) 0.12
No of patients per re-
searcher
(mean + sd)
(median + IQR)
3.8 (3.2)
3 (1.5 – 5)
4.2 (4.0)
3 (2 – 4)
3.4 (2.3)
3 (1 – 5.5)
0.17
* Clusters had a high (H-clusters) or low (L-clusters) proportion of patients randomised to intervention group
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Alleged inclusion behaviour
We asked the researchers how it would have influenced their recruitment behaviour 
when they would have known about treatment assignment in advance: all their patients 
allocated to either intervention or control group. Of the researchers 58% responded that 
they probably would have included fewer patients than they did when they had been 
certain every participant was allocated to the control group. Of them 2% indicated they 
would have recruited more patients (table 3). 
The others (40%) would not have changed their inclusion behaviour. Of the researchers 
48% researchers indicated they would have recruited more patients when they had 
known with certainty that all patients were allocated to the intervention. The others 
(52%) indicated this would not have influenced their recruitment.
table 2 Baseline characteristics of patients
L-clusters†
(n = 66)
H-clusters†
(n = 85)
p
Age – yr 82.5 (5.9) 81.9 (6.4) 0.38
Female sex – no. (%) 48 (71.6) 65 (77.4) 0.96
Marital status – no. (%)
Married
Divorced
Widow(er), partner deceased
Single
Living together unmarried
20 (30.3)
2 (3.0)
36 (54.6)
8 (12.1)
0
22 (26.5)
5 (6.0)
47 (56.6)
8 (9.6)
1 (1.2)
0.64
Living in home for the aged – no. (%) 9 (13.6) 14 (16.7) 0.99
Informal caregiver – no. (%) 55 (82.1) 59 (70.2) 0.78
Receiving home care – no. (%) 35 (52.2) 42 (50.6) 1.00
Groningen Activity Restriction Scale§ 34.2 (8.7) 35.3 (8.1) 0.83
MOS-20 subscale mental health|| 54.1 (19.5) 53.0 (19.5) 0.76
MOS-20 subscale physical functioning|| 16.7 [0 – 50.0]‡ 16.7 [0 – 33.3]‡ 0.09
MOS-20 subscale role functioning|| 0 [0 – 50]‡ 0 [0 – 0]‡ 0.01
Cumulative Illness Rating Scale-Geriatrics¶ 10.0 (4.5) 10.1 (3.5) 0.89
Timed Up and Go – seconds 15.0 [12.0 – 22.0]‡ 17.0 [13.0 – 26.0]‡ 0.32
Mini Mental State Examination** 22.4 (5.6) 22.5 (5.9) 0.69
Cantril’s self anchoring ladder†† 6.0 (1.9) 5.6 (2.3) 0.36
Dementia Quality of Life positive affect‡‡ 3.1 (0.7) 3.2 (0.7) 0.17
Dementia Quality of Life negative affect§§ 2.7 (0.73) 2.7 (0.6) 0.72
Loneliness Scale De Jong-Gierveld|||| 5.7 (3.8) 4.4 (3.1) 0.04
* Values are means (SD) unless otherwise stated
† Clusters had a high (H-clusters) or low (L-cluster) proportion of patients randomised to intervention group
‡ For skewed variables median and interquartile range are presented. 
§ Groningen Activity Restriction Scale ranges from 18 to 54, with 18 indicating best score
|| MOS-20 subscales ranges from 0 to 100, with 100 indicating best score
¶ Cumulative Illness Rating Scale-Geriatrics ranges from 0 to 20, with 0 indicating no co-morbidity
** Mini Mental State Examination ranges from 0 to 30, with 30 indicating best score
†† Cantril’s self anchoring ladder ranges from 0 to 10, with 10 indicating best score
‡‡ Dementia Quality of Life positive affect ranges from 0 to 5, with 5 indicating best score
§§ Dementia Quality of Life negative affect ranges from 0 to 5, with 0 indicating best score
|||| Loneliness Scale De Jong-Gierveld ranges from 0 to 11, with 0 indicating best score
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Predictability of the next treatment allocation
We asked the researchers to estimate which randomisation ratio we used to allocate 
their patients over intervention and control arm. They could choose nine possibilities 
ranging from 90:10 / intervention:control arm to 10:90 / intervention:control. There were 
no differences between the two cluster types, neither with respect to the estimates of 
the treatment ratios (p = 0.91) nor the degree of certainty (p = 0.65). Of the H-cluster 
researchers 63% and 71%  of the L-cluster researchers indicated that the ratio 50:50 
table 3 Treatment arm preferences and alleged inclusion behaviour when 
researchers would have had prior knowledge on treatment assignment
All researchers (n =55)
Preference for treatment arm when including a participant*  – mean (SD) 14.5 (15.6)
Inclusion behaviour when all patients in regular care group – number (%)
More• 
Less• 
No effect• 
1 (2)
29 (58)
20 (40)
Inclusion behaviour when all patients in intervention group – number (%)
More• 
Less• 
No effect• 
24 (48)
0
26 (52)
* Visual analogue Scale ranges from 0 = strongly in favour of intervention group to 100 = strongly in favour of control group
figure 1 Bubble plot of the relation between the number of inclusions by the re-
searchers and their estimation of the randomisation ratio used to allocate 
the researcher’s patients over the treatment groups
The grey circles represent researchers randomised to a low number of intervention patients (L-clusters), the black circles repre-
sent researchers randomised to a high number intervention patients (H-clusters). The size of the bubble represents the certainty 
of the estimate; the bubble size decreases with decreasing certainty
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was used. Randomisation ratios favouring the intervention arm were indicated in 
approximately 30% and 20% of the H and L clusters, respectively. About 10% of the 
researchers in both cluster types indicated randomisation ratios in favour of the control 
group. The certainty of their estimation was 42.0 on a VAS where zero indicated a 
complete guess and 100 indicated absolute certainty. Figure 1 shows there was no 
clear relation between the recruitment numbers and the estimated randomisation ratio. 
Researchers who estimated randomisation ratios that strongly differ from 50:50, tended 
to be less certain about their estimation than the researchers who estimated more equal 
figure 2 Bubble plot of the relation between a researcher’s observed randomisa-
tion ratio and their estimation of the randomisation ratio used to allocate 
their patients over the treatment groups
The grey circles represent researchers randomised to a low number of intervention patients (L-clusters), the black circles repre-
sent researchers randomised to a high number intervention patients (H-clusters). The size of the bubble represents the certainty 
of the estimate; the bubble size decreases with decreasing certainty
*n.a. No randomisation proportion available: of researchers without inclusions no randomisation proportions could be calcu-
lated, these researchers were presented separately
table 4 The presence of sources of possible contamination among researchers 
(n = 23) having patients in both intervention and control arm
All clusters (n =55)
Self-perceived effect of having intervention patients on researcher’s behaviour 
when treating control patients – number (%)*
Used elements• 
Made more referrals to other health care services• 
I learnt• 
No effect• 
Other• 
(n = 23)
6 (26)
7 (30)
9 (39)
5 (22)
1 (4)
Score change in Robinson’s self-perceived competence in geriatrics scale – 
mean (SD)†
6.5 (10.8)
* Only in researchers (n = 23) who had patients in both treatment arms (intervention and control arm)
† Scale ranges from 24 to 120, where the higher score indicates more competence
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numbers. Although we found a significant relation between the observed randomisation 
ratio and the estimated randomisation ratio (p = 0.02), the strength of this relation was 
small: the observed randomisation ratio only explained 15% of the variance in the 
estimated randomisation ratios (R2 = 0.15) (figure 1).
Indications of potential contamination
Of all researchers having patients in both the control and the intervention arm (n = 23), 
15 (65%) indicated that they either used elements of the new intervention, made more 
referrals to other health care services, or learnt from their participation in the model (table 
4).  After the study the researchers scored 6.5 points higher on the Robinson competence 
in geriatrics questionnaire, a scale that ranges from 24 to 120, where a higher score 
indicates more competence. The score of the recruiting researchers increased almost 8 
points, the non-recruiting researchers improved 2.6 points (p = 0.23).
Discussion
This study showed that the assumptions underlying the use of pseudo cluster 
randomisation largely applied when we used this randomisation method in the services 
evaluation study.  We will interpret  the results of the current study for each of these 
assumptions below.
Performance of pseudo cluster randomisation
Assumptions 1 and 2: the researchers preferred to be in the intervention arm of the study 
and advance knowledge of the randomisation outcome would have influenced the researchers’ 
inclusion behaviour.
Our data show that the researchers in our study strongly favoured allocation of their 
patients to the intervention arm. This appreciation probably served as an important 
determinant of the researchers’ inclusion behaviour. The majority said they would have 
included fewer patients when all their patients had been allocated to the control group, 
as is the case for half of the clusters in a cluster randomised trial. This is in line with other 
reports that showed that cluster randomisation suffers from lower recruitment rates in the 
control clusters 9.
Assumption 3: individual patient randomisation would have led to contamination.
Many researchers reported that they used elements of the new intervention in the control 
group or made more referrals to other health care services for control patients. Also 
the researchers’ self-perceived competence in geriatrics increased. This might point at 
a learning effect, because this effect that was not present in researchers who did not 
recruit. These results showed that sources of potential contamination were present in 
our study and that contamination may have occurred. Individual randomisation would 
probably have led to even stronger contamination.
Assumption 4: the researchers remained blind for the randomisation proportions they were 
assigned to.
Most researchers estimated that equal numbers were randomised to both therapy arms. 
They were not very certain about their estimation and the researchers who estimated 
an unequal randomisation ratio were even less sure. There was a significant relation 
between the estimated and observed randomisation proportions. However, the strength 
of this relation was  small, only 15% of the variation in the estimated randomisation 
performance of pseudo cluster randomisationchapter 564
proportions was explained by the observed randomisation numbers. In our study 
researchers had no or very little knowledge of the randomisation proportions. 
Assumption 5 and 6: The two types of clusters included the same number and type of patients.
The H-clusters recruited 85 patients and the L-clusters  recruited 66. Coincidentally, also 
85 and 66 patients were randomised to intervention and control group respectively. There 
were large differences in the number of patients researchers included. The H-clusters 
recruited nearly one participant more than the L-clusters. However, the observations 
were positively skewed and the numbers varied widely. Most researchers included no 
more than three patients; only two researchers recruited more than 10. Our control 
group was smaller than the intervention group, but it is unlikely that lack of allocation 
concealment has caused the difference; researchers were in majority not aware of the 
allocated randomisation proportions. Patients were comparable at baseline as well, 
giving no indication of selection bias.
Study limitations
We used the EASYcare trial to evaluate the performance of pseudo cluster randomisation. 
The best way to evaluate pseudo cluster randomisation would have been to conduct the 
trial three times: once using individual randomisation, once using cluster randomisation, 
and once using pseudo cluster randomisation. This was clearly impossible, and we 
had to settle for weaker sources of evidence such as information on what researchers 
believed they would have done, had the trial been of a different design. Pseudo cluster 
randomisation is an innovative design and more studies are required to judge its 
performance. Nevertheless, pseudo cluster randomisation performed satisfactorily in the 
services evaluation study.
The assumptions underlying PCR largely applied to the services evaluation study. PCR 
is a good alternative when individual randomisation risks contamination and cluster 
randomisation differential recruitment. As such, pseudo cluster randomisation can be 
added to the range of trial designs investigators can choose from.
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Background: The effectiveness of community-based geriatric intervention models for vulnerable 
older adults is controversial. We evaluated a problem-based multidisciplinary intervention 
targeting vulnerable older adults at home which promised efficacy through better timing and 
increased commitment of patients and general practitioners. This study compared the effects of 
this new model to usual care.
Methods: General practitioners referred older people for problems with cognition, nutrition, 
behaviour, mood, or mobility. 151 participants (mean age 82.2 years, 74.8% female) were 
included in a pseudo cluster randomised trial with six months follow-up for the primary outcomes. 
Eighty five participants received the new intervention, and 66 usual care. In the intervention 
arm, geriatric nurses visited patients at home for geriatric assessment and management in 
cooperation with general practitioners and geriatricians. Modified intention-to-treat analyses 
focused on differences between treatment arms in functional abilities (Groningen Activity 
Restriction Scale-3) and mental well-being (subscale mental health MOS-20), using a mixed 
linear model.
Results: After three months, treatment arms showed significant differences in favour of the new 
intervention. Functional abilities improved 2.2 points (95% CI 0.3 to 4.2) and well-being 5.8 
points (0.1 to 11.4). After six months the favourable effect increased for well-being (9.1 (2.4 to 
15.9)), but the effect on functional abilities was no longer significant (1.6 (-0.7 to 3.9)).
Conclusions: This problem-based geriatric intervention improved functional abilities and 
mental well-being of vulnerable older people. Problem-based interventions can increase the 
effectiveness of primary care for this population.
Introduction
The autonomy of vulnerable older people is continuously challenged. Chronic diseases, 
associated functional decline, and erosion of social support systems reduce well-being, 
and often lead to institutionalisation and high health care costs. Primary health care 
professionals will care for a substantial part of this expanding group. However, there are 
significant time limitations in primary care, and there is much room for improvement 
in quality of geriatric care 1. This means that developing and evaluating models that 
enhance primary care for vulnerable older people is an important priority of geriatric 
primary care research, policy, and practice 2. 
Unfortunately, we know little about the effects of geriatric primary care in vulnerable 
older adults. Critical appraisal of the available evidence is difficult, because the models 
that can be gathered under the term “community intervention models” show much 
heterogeneity as well as considerable overlap 3. We know that preventive home visits 
can work if they provide multidimensional, high intensity follow-up with clinical control, 
but there is much debate about effectiveness in vulnerable older people 4, 5. While some 
exclude the frailest participants, because of reduced likelihood of reversibility, other 
authors stress the importance of including the frailest 4-8. The evidence also suggests that 
comprehensive geriatric assessment models can work, but this evidence is strongest for 
inpatient models 9, 10. Evidence for equivalent community-based interventions is more 
controversial: in a meta-analysis non-institutional programmes had no effect on hospital 
re-admission, physical function, or cognitive function 9. Moreover, most of the included 
non-institutional programmes are concerned with a general population of older people. 
The applicability of these results to vulnerable older people is unclear.
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A large recent controlled trial of inpatient and outpatient geriatric evaluation and 
management found significant improvement in mental health of frail persons with 
outpatient geriatric evaluation and management following a hospitalisation, but not in 
functional abilities 11.
Case management approaches – a type of care showing overlap with preventive home 
visiting programmes and comprehensive geriatric assessment – have also been tested in 
older people 12. The outcomes are often measures of health care utilisation instead of 
health outcomes or quality of life 12. These case management interventions probably have 
favourable impacts on hospital and long term care utilisation 12, 13, although the recent 
evaluation of Evercare in the United Kingdom showed no effect on the hospitalisation 
rate 14. The study by Bernabei also found beneficial effects on health-related quality of 
life 15.
In general, the evidence suggests that targeting suitable patients is a key factor in 
achieving effectiveness 4, 10. Population screening is a popular approach to targeting 
16, but it is expensive and not easy to implement in daily practice. Another important 
criterion for success is direct involvement of the primary care provider 4. 
Therefore, we studied the effectiveness of community intervention models using a 
problem-based participant selection process performed by the general practitioner. 
The Dutch Geriatric Intervention Programme (DGIP) is a multidisciplinary community 
intervention model, consisting of nurse home visits for frail older patients. General 
practitioners were asked to initiate the intervention when a geriatric condition arose that 
required further intervention. This procedure promised efficacy through better timing and 
targeting of the intervention, more engagement of the patient, and more commitment 
of the general practitioner. The effect of community intervention models for frail older 
people with this type of targeting has not been rigorously assessed.
In this paper we describe the effects of the Dutch Geriatric Intervention Programme 
(DGIP) compared to usual care in improving health-related quality of life and promoting 
successful aging in independently living frail older patients.
Methods
Design
The study design has been published previously 17. The study was an observer blind, 
randomised controlled trial that applied pseudo cluster randomisation to allocate the 
participants to DGIP or usual care [Clinicaltrials.gov Identifier NCT00105378]. The 
local ethical committee gave approval for the study.
Study population
Subjects lived in their own home or in a retirement home and were 70 years or older 
(table 1). Participants had one or more limitations in cognition, (instrumental) activities 
of daily life, or mental well-being.
Randomisation and sample size calculation
Participants were randomised to DGIP or usual care. The usual care group received 
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unrestricted care. We used a two-step pseudo cluster randomisation procedure, because 
both individual and cluster randomisation had major drawbacks 18, 19. Individual 
randomisation was discarded because it had a risk of contamination bias: the recruiting 
physician might learn from or use elements of DGIP. However, cluster randomisation 
would lead to selection bias and lower recruitment rates in the control clusters, because 
physicians would know the treatment arm their participants would be assigned to after 
recruiting the first participant 20. 
Pseudo cluster randomisation randomised physicians in two groups; group H (high) and 
group L (low) 18, 19. The participants recruited through physicians of group H were then 
randomised in an 80/20 ratio to respectively DGIP and usual care; in group L this ratio 
was reversed: 20% DGIP and 80% usual care. The physicians were not informed which 
table 1  Eligibility criteria of Dutch EASYcare Study
Eligibility criteria
Inclusion criteria
70 years of age and over • 
The patient lives independently or in a retirement home • 
The patient has a health problem that was recently presented to the physician • 
by the patient or informal caregiver 
The request for help is related to the following problem fields: cognitive • 
disorders, behavioural and psychological symptoms of dementia, mood 
disorders, mobility disorders and falling, or malnutrition 
The patient/informal caregiver and physician have determined a goal to • 
achieve 
Fulfil one or more of these criteria: MMSE (Mini Mental State Examination) • 
equal to or less than 26*, GARS-3 (Groningen Activity Restriction Scale) equal 
to or greater than 25† or MOS-20/subscale mental health equal to or less than 
75‡
Exclusion criteria
The problem or request for help has an acute nature, urging for action • 
(medical or otherwise) within less than one week 
The problem or request for help is merely a medical diagnostic issue, urging • 
for actions only physicians (general practitioner or specialist) can offer 
MMSE < 20 or proven moderate to severe dementia (Clinical Dementia Rating • 
scale [CDR] > 1) and no informal caregiver (no informal caregiver is defined 
as: no informal caregiver who meets the patient for at least once a week on 
average) 
The patient receives other forms of intermediate care or health care from a • 
social worker or community-based geriatrician 
The patient is already on the waiting list for a nursing home because of the • 
problem the patient is presented with in our study 
Life expectancy < 6 months because of terminal illness • 
* MMSE runs from 0-30, with 30 indicating best score
† GARS-3 runs from 18 to 54, with 18 indicating best score
‡ MOS-20 all subscales run from 0 to 100, with 100 indicating best score
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group they were in. In the second step of the pseudo cluster randomisation procedure 
minimisation was used to equally distribute participants for the factors ‘high or low 
percentage of older patients in primary care clinic’, ’availability of practice nurse in 
primary care clinic’, ‘sex of participant’, and ’geriatric condition for referral’. With 
minimisation the treatment allocated to the next participant enroled in the trial depends 
on the characteristics of those participants already enroled. This has the advantage, 
especially in small trials, that there will be only minor differences between groups 
in those variables used in the allocation process 21. Sample size calculation took 
account of the pseudo cluster randomised design. We used an uncontaminated minimal 
detectable difference (MDD) of 4.5 points in the primary outcome measure (GARS-3), 
with an expected standard deviation of 8.5 (pilot data). We expected that pseudo cluster 
randomisation would lessen the contamination, though not to the uncontaminated 
estimate. This means that the MDD has to be set sharper than the uncontaminated level; 
we used a MDD 4.0 points. Using the usual formula for individually randomised trials 
with α = 0.05 and 1-α = 0.80, and a design factor for pseudo cluster randomised trials of 
1.08 (cluster size n= 10, intra cluster correlation ρ= 0.05, randomisation fraction f=0.8) 
(see table 1, Teerenstra et al.19) this MDD of 4.0 could be found comparing two groups 
of 77 patients.
Intervention
The DGIP used a problem-based selection procedure performed by the general 
practitioner, rather than population screening to identify patients eligible for participation. 
The problems targeted concerned cognition, nutrition, behaviour, mood, or mobility, 
and had to require nursing assessment, coordination of care, therapeutic monitoring, 
or case management (table 1). Within two weeks after referral a geriatric specialist 
nurse visited the patient at home. Up to six visits for additional geriatric evaluation and 
management were planned within the next three months. The nurse conducted the main 
part of the intervention. The general practitioners continued their usual medical care. 
Moreover, they made referrals, medication changes, and other interventions as agreed 
upon during interdisciplinary consultations with the nurse and geriatrician on individual 
cases. The general practitioner kept prime responsibility for the care of the patient and 
made the final decisions. We developed guidelines for each of the five presenting health 
problems to structure activities, without losing the flexibility of tailoring the individual 
interventions.
Data collection and outcome measures
Researchers (RM, ME), not involved in the conduct of the intervention programme, 
visited patients at home to obtain written informed consent and to collect baseline (T0) 
demographic characteristics and data on general health conditions. If the participant was 
not able to give informed consent, we asked consent by proxy. Unaware of treatment 
assignment, the researcher repeated these measurements in the patients’ homes three and 
six months after inclusion. After each follow-up visit the researcher indicated whether 
blinding remained intact or not. 
Primary outcome measures were functional performance in (instrumental) activities 
of daily living measured using Groningen Activity Restriction Scale-3 (GARS-3) and 
mental well-being using subscale Mental Health of the Medical Outcome Study 
20-item short form (MOS-20 MH) 22. GARS-3 measures 11 basic activities of daily 
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Assessed for eligibility (n = 168) 
Randomised (n = 155) 
Excluded (n = 13) 
x Not meeting inclusion criteria (n = 5) 
x Refused to participate (n = 8) 
 
Allocated to usual care group (n = 67) 
x Received allocated intervention  (n = 66) 
x Did not receive allocated intervention (n = 
1) 
Severe disease (n = 1)  
Within 1 week after randomisation 
Allocated to DGIP (n = 88) 
x Received allocated intervention  (n = 85) 
x Did not receive allocated intervention (n = 
3) 
Severe intercurrent disease (n = 1), 
Reconsidering indication (n = 1), 
Withdrawal of informed consent (n = 1) 
Within 1 week after randomisation 
First follow-up visit T1 at 3 months: 
x Assessed (n = 81) 
Visited (n = 78) 
Only written data (n = 3)* 
x Lost-to-follow-up (n = 4) 
Dead (n = 3) 
Withdrawal informed consent (n = 1) 
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First follow-up visit T1 at 3 months:
x Assessed (n = 59) 
Visited (n = 53) 
Only written data (n = 6)* 
x Lost-to-follow-up (n = 7) 
Dead (n = 2) 
Withdrawal informed consent (n = 5) 
Analysis† 
x In primary analysis GARS-3 T1 (n = 56) 
x In primary analysis MOS-20MH T1 (n = 55) 
 
x In secondary analysis GARS-3 T2 (n = 51) 
x In secondary analysis MOS-20MH T2 (n = 
51) 
 
 
Analysis† 
x In primary analysis GARS-3 T1 (n = 75) 
x In primary analysis MOS-20MH T1 (n = 
76) 
 
x In secondary analysis GARS-3 T2 (n = 74) 
x In secondary analysis MOS-20MH T2 (n = 
73) 
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Second follow-up visit T2 at 6 months: 
x Assessed (n = 78) 
Visited (n = 72) 
Only written data (n = 6)* 
x Lost-to-follow-up (n = 3) 
Dead (n = 2) 
Withdrawal informed consent (n = 1) 
 
Second follow-up visit T2 at 6 months: 
x Assessed (n = 53) 
Visited (n = 44) 
Only written data (n = 9)* 
x Lost-to-follow-up (n = 6) 
Dead (n = 2) 
Withdrawal informed consent (n = 4) 
 
figure 1 Study flow chart
* A number of participants withdrew their consent for the visit for data acquisition by interview, but agreed to fill in the ques-
tionnaires.
† Differences between numbers assessed at follow-up and numbers included in the analysis result from the fact that although 
assessment was executed, participants not always completely filled the instruments and therefore no sum scores could be cal-
culated for everyone who was assessed.
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living and 7 instrumental activities of daily living on a three point scale (patient can 
do activities independently without any difficulty, independently but with difficulty, 
only with someone’s help, respectively). In advance we expected that the larger part 
of our study population would live in their own home, in whom both types of activities 
of daily living are very important. Therefore, we used the complete scale as primary 
measure for functional performance. Secondary outcomes were cognition (Mini Mental 
State Examination; MMSE 23), mobility (Timed Up and Go test; TUAG 24), loneliness 
(Loneliness Scale de Jong-Gierveld 25), health-related quality of life (other MOS-20 
subscales), Cantril’s self anchoring ladder for actual quality of life, Dementia Quality of 
Life (DQoL) 22, 26, 27, and survival.
Statistical analysis
The primary analysis was a modified intention-to-treat analysis on differences 
(Intervention – Control) in changes from baseline in GARS-3 and MOS-20MH at three 
months of follow-up (T1 – T0). A random effects model was used to account for clustering 
at the level of the physician 17. The other outcomes at three months follow-up were 
analyzed in a similar way. Similar analyses at six months follow-up were only performed 
if the outcome measure showed a significant effect at three months (conditional testing). 
Kaplan-Meier estimates were used to quantify the intervention effect on survival. We 
calculated 95% confidence intervals for the differences between treatment arms and 
used a two-sided alpha of 0.05 to test significance. The baseline characteristics were 
tested using a random effects logistic model for categorical values and a random effects 
linear model for continuous outcomes. For skewed variables these models were used 
with the log transformed scores. Preplanned subgroup analyses of the effects in the 
primary outcomes – adding the stratifying factor as a covariate and an interaction term 
of the stratifying factor with treatment arm to the models – were performed for living 
independently versus living in a retirement home, and higher versus lower levels of 
cognitive function measured with MMSE (≥ 21 versus <21) at three and six months 
follow-up.
Results
In and around Nijmegen, the Netherlands, 55 general practitioners participated. During 
a 21 months inclusion period that started April 1, 2003 155 eligible participants were 
randomised, of whom four participants did not receive the allocated intervention due 
to events that took place within one week after randomisation (figure 1). These four 
participants were excluded from further follow-up and analysis 17. 85 participants were 
included in the DGIP-group, and 66 in the usual care group. Mistakenly, one participant 
aged 69 years was included. This participant was kept in follow-up and analysis. Baseline 
characteristics and measures of primary outcomes showed no significant differences 
between study groups. Of secondary outcomes only loneliness differed significantly at 
baseline (table 2). Our study population mostly comprised widowed females born in 
the Netherlands, of whom 85% lived on their own. The participants had a mean age of 
82.2 years (range 69-99 years), much co-morbidity, MMSE scores suggesting cognitive 
deterioration, and low scores on mental well-being. Most people had difficulties with all 
of the (instrumental) activities of daily life measured. Approximately half the study group 
had home care available at baseline. 
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The participating general practitioners cared for a mean 1719 patients (SD 470) of whom 
170 (SD 131) were 75 years and older. Of this subgroup of older subjects 3% (SD 4) was 
included in this study. About 40% of participants were referred because of a problem 
relating to cognition. Mood and mobility problems were reason for referral both in 
20% of the cases. Behavioural and nutritional problems were referral reasons in 11 
and 6% respectively. The nurse visited intervention patients 3.8 times (SD 1.3). Problem 
analysis was an important component of these visits. The interventions focused mainly 
on therapeutic advices and coordination of care, less interventions focused on psycho-
education or therapy monitoring (table 3).
table 2 Demographic characteristics and outcome measures of the study popula-
tion at enrolment*
Usual care
(n = 66)
Dutch Geriatric 
Intervention Programme 
(n = 85)
p 
Age – yr 82.8±6.6 81.7±5.9 0.22
Female sex – no. (%) 49 (74.2) 64 (75.3) 0.99
Marital status – no. (%)
Married• 
Divorced• 
Widow(er), partner deceased• 
Single• 
Living together unmarried• 
19 (29.2)
2 (3.1)
36 (55.4)
8 (12.3)
0
23 (27.4)
5 (6.0)
47 (56.0)
8 (9.5)
1 (1.1)
0.31
Living in retirement home – no. (%) 11 (16.9) 12 (14.1) 0.56
Informal caregiver – no. (%) 49 (74.2) 65 (76.5) 0.71
Receiving home care – no. (%) 34 (51.5) 43 (51.1) 0.97
Groningen Activity Restriction Scale-3‡ 34.1±8.7 35.3±8.1 0.68
Medical Outcomes Scale-20 mental 
health§
53.8±17.7 53.3±20.9 0.87
MOS-20 physical functioning§ 16.7 [0 – 33.3]† 16.7 [0 – 36.7]† 1.00
MOS-20 role functioning§ 0 [0 – 50.0]† 0 [0 – 50.0]† 0.87
Cumulative Illness Rating Scale-Geriatrics|| 9.8±4.3 10.2±3.7 0.64
Timed Up and Go – seconds 16.0 [12.0 – 22.0]† 16.0 [12.0 – 25.0]† 0.60
MMSE¶ 22.0±6.0 22.8±5.5 0.22
Cantril’s self anchoring ladder** 5.9±2.1 5.7±2.1 0.78
Dementia Quality of Life positive affect†† 3.1±0.7 3.2±0.7 0.50
DQoL negative affect‡‡ 2.6±0.6 2.7±0.7 0.24
Loneliness Scale De Jong-Gierveld§§ 5.7±3.6 4.4±3.2 0.04
* For all – except skewed – variables means ± SDs are presented, for skewed variables (†) median and interquartile range are 
presented.
‡ GARS-3 runs from 18 to 54, with 18 indicating best score
§ MOS-20 all subscales run from 0 to 100, with 100 indicating best score
|| CIRS-G runs from 0 to 20, with 0 indicating no co-morbidity
¶ MMSE runs from 0 to 30, with 30 indicating best score
** Cantril’s self anchoring ladder runs from 0 to 10, with 10 indicating best score
†† DQoL positive affect run from 0 to 5, with 5 indicating best score
‡‡ DQoL negative affect run from 0 to 5, with 0 indicating best score
§§ Loneliness Scale De Jong-Gierveld runs from 0 to 11, with 0 indicating best score
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After three months of follow-up the primary outcomes functional performance and 
mental well-being showed significant treatment arm differences in changes from baseline 
(table 4). On GARS-3 this difference was -2.2 [95% confidence interval -4.2 – -0.3] and 
on MOS-20MH it was 5.8 points [0.1–11.4] both in favour of DGIP [table 3]. At six 
months of follow-up favourable effects still existed, although the effect on GARS-3 was 
slightly smaller and no longer significant: -1.6 [-3.9 – 0.7]. The effect on MOS-20MH 
increased to 9.1 [2.4 – 15.9]. In the usual care group the GARS-3 scores worsened from 
baseline, while during the first three months this decline is absent in DGIP (table 4). 
DGIP improved MOS-20MH scores over six months follow-up. The MOS-20MH scores 
remained approximately constant in the usual care group.
table 3 Content of the Dutch Geriatric Intervention Programme (DGIP) in 
intervention group patients (n=85)
Type of activity Number (%)
Diagnostic tests
EASYcare screening 85 (100)
Focused history taking and caregiver assessment 85 (100)
Mini Mental State Examination 40 (47)
Geriatric Depression Scale 30 (35)
Montgomery-Åsberg Depression Rating Scale 14 (16)
Body weight 23 (27)
Mini Nutritional Assessment – Short Form 2 (2)
Body Mass Index 1 (1)
Investigation of calorie- and fluid intake 3 (4)
Tinetti Balance and Mobility Scale 11 (13)
Blood pressure 4 (5)
Blood pressure spinal and standing position 21 (25)
Pulse 14 (16)
Visual acuity using Snellen chart 1 (1)
Mean number of diagnostic tests per case (SD; range) 2.0 (1.8; 0 – 9)
Interventions – care coordination
(Extra home) care 34 (40)
Consultation of other health care professional 31 (36)
Organise programme for daily structure 21 (25)
Mobilise voluntary care 25 (29)
(Extra) day care 12 (14)
Interventions – advices
Advices to professional handling behavioural difficulties 18 (21)
Advices to caregiver handling behavioural difficulties 28 (33)
Advice to patient 45 (53)
Referral to other health care professional 24 (28)
Medication change 22 (26)
Start using helping aid (cane etc.) 16 (19)
Interventions – psychoeducation
Patient 23 (27)
Caregiver 15 (18)
Intervention – monitoring the effect of therapy 26 (31)
Mean number of interventions per case (SD; range) 4.6 (2.3; 0 – 10)
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Secondary outcome measures Dementia Quality of life Positive and Negative Affect, 
subscales Physical Performance and Role Functioning of MOS-20, and Cantril’s Ladder 
showed a trend towards beneficial effects for DGIP. The effects on Mini Mental State 
Examination, De Jong-Gierveld Loneliness Scale, and Timed Up and Go test were close 
to zero (figure 2). DGIP survival at two years follow-up was higher (82% versus 73%, 
Log-Rank test p=0.40).
The results of a sensitivity analysis with loneliness score – the only baseline characteristic 
that differed between our treatment arms – added as covariate, were in line with the 
primary analysis.During the follow-up measurements treatment assignment was revealed 
to the researcher in 38% of cases at three months of follow-up and in 40% of cases at 
six months of follow-up. 
The total drop out in our study was 7% at three months and 13% at six months, and 
similar in both groups. Participants who were lost-to-follow-up were older and had 
worse GARS-3, MOS-20MH, and MMSE scores at baseline. The results of sensitivity 
analyses assigning the ‘mean of the other group’ 28 to the missing values did not differ 
essentially from the primary analyses. No significant statistical interactions with MMSE 
scores or living conditions were found.
table 4 The unadjusted scores on primary outcome measures at 3 and 6 months 
and the differences between treatments arms in outcome measures’ 
change from baseline
3 months follow-up (T1) 6 months follow-up (T2)*
Primary outcomes 
unadjusted scores
Usual care DGIP† Usual care DGIP†
Functional abilities – GARS-3 36.4 ± 10.3 34.7 ± 8.1 37.0 ± 9.5 35.9 ± 8.6
Well-being – MOS-20MH 55.5 ± 18.2 60.0 ± 20.5 53.2 ± 20.1 61.5 ± 20.4
Intervention effect‡ D 95% CI N D 95% CI N
GARS-3§ -2.2|| -4.2 –  -0.3 131 -1.6 -3.90 – 0.7 125
MOS-20MH§ 5.8|| 0.1 – 11.4 131 9.1¶ 2.4 – 15.6 124
DQoL Negative affect -0.21|| -0.37 – -0.04 114 -0.13 -0.32 – 0.06 103
DQoL Positive affect 0.15 -0.06 – 0.37 112
MOS-20 physical performance 4.3 -2.9 – 11.2 132
MOS-20 role functioning 4.7 -9.8 – 19.3 131
Cantril’s Ladder 0.39 -0.26 – 1.03 105
Loneliness de Jong-Gierveld 0.10 -0.80 – 0.99 109
MMSE - - 0 -0.5** -1.8 – 0.1 113
Timed Up And Go 1.60 -4.82 – 8.03 107
* Analysis per outcome measure at 6 months follow-up were only performed for the condition that the treatment arm difference 
calculated for 3 months was significant
† DGIP = Dutch Geriatric Intervention Programme
‡ Intervention effect: difference (D) and its 95% Confidence Interval (CI) in changes over time from baseline to three and six 
months, for the number of subjects (N) in analysis.
Model: Outcome Measure Change from baseline = β0 + β1*treatment arm + β2*baseline value Outcome Measure + βc*minisation 
factors  + random intercept physician
§ Primary outcomes
|| P < 0.05
¶ P < 0.01
** MMSE was only measured at baseline and at 6 months follow-up
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Discussion
This randomised controlled trial found benefits of a nurse-led, multidisciplinary 
intervention at home on frail older subjects’ functional performance and mental 
well-being at three months of follow-up. At six months the well-being scores had 
further improved and, the performance on functional abilities, while still better in the 
intervention group, had not further increased. Most secondary outcomes showed a trend 
towards advantageous effects. The results of the economic evaluation that accompanies 
this study showed that this intervention is an effective addition to primary care for frail 
older people at a reasonable cost 29.
The age, co-morbidity, and GARS-3 scores at baseline and the overall mortality during 
follow-up, show that a group of very old, vulnerable patients was sampled. The beneficial 
effects on disability and mental well-being represent a 5% and 10% better performance 
compared to control conditions, respectively. 
The results of our study show that it was possible to prevent deterioration of functional 
skills for about three months and to improve well-being for at least half a year in a 
vulnerable population with a fairly simple home-based intervention. The magnitude of 
these effects is in line with treatment effects of other positive studies incorporating frail 
populations 11, 15. An evaluation of outpatient geriatric evaluation and management 
found favourable differences in mental health and physical functioning scores of about 
5% and 2% at 12 months of follow-up respectively 11. A trial with a model of integrated 
care and case management for frail older people living in the community found favourable 
differences of 18.1% in basic activities of daily living, 6.9% in instrumental activities of 
daily living, and 6.8% in depression 15. Also, our results were above a (standardized) 
effect size of 0.2, which is considered to be the lowest threshold for a minimal clinically 
important difference 30. 
figure 2 Primary and secondary outcomes differences between study arms at three 
and six months as percentages of scale ranges and their 95% confidence 
intervals (for Timed Up and Go Test a denominator of 60 seconds was 
used, because Timed Up and Go Test has no scale range).
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Our control group was smaller than the intervention group, but it is unlikely that lack 
of allocation concealment has caused the difference; physicians were in majority not 
aware of the allocated randomisation proportions. Patients were comparable at baseline 
as well, giving no indication of selection bias. An explanation is offered by the variation 
in the number of patients each physician included. Two physicians included more than 
10 patients and both were assigned to the group of general practitioners whose patients 
were randomised to the intervention group in majority. This observation completely 
explains the unbalanced numbers of control and intervention group. 
The total drop out in our study was fairly high, but was similar in both groups and as 
expected when taking into account the frailty of the population. Drop outs occurred 
mainly because patients (or their caregivers) felt participation in follow-up visits for effect 
measurement was too burdensome while it provided no further benefit. Participants who 
were lost-to-follow-up differed from participants who completed follow-up. However, 
the results of sensitivity analyses – using a conservative strategy to impute missing values 
28 – did not differ essentially from the primary analyses. 
This study was observer blind. Despite several precautionary measures taken, disclosure 
of treatment assignment occurred frequently. However, our primary outcomes were 
collected using a written questionnaire that the patient (if necessary with help from a 
relative) filled before each study visit. The researcher could not influence this.
Given the type of patients included in this study, the study results can probably be 
generalized to a population of frail community-dwelling older people. General 
practitioners appeared to be very selective. Approximately 3% of all older patients 
cared for by one general practitioner were included in this study. However, we have to 
keep in mind that only a minority of older patients can be characterized as vulnerable, 
depending on the definition 31. This means that only a minority actually is eligible for 
this intervention that explicitly focused on frail subjects who also needed to have an 
incident geriatric problem. Unfortunately, we were unable to collect further details on 
the patients who were not included. This means that generalisation of these results to 
the general population of community-based older persons deserves further evaluation. 
However, generalisation benefits from the fact that study conditions were very similar to 
current practice. Even without much experience with the model, the general practitioners 
were able to select patients eligible for the intervention. As under regular conditions, the 
nurses had to cooperate with many different health care workers. The results of our trial 
show that multidimensional intervention for geriatric syndromes improves disability and 
mental well-being in frail older people who live at home. The results also indicate that 
this can be done by the general practitioner using a problem-based patient selection 
procedure to target suitable patients. As such, it promises to be a relevant supplement to 
primary health care for this population. This is important because population aging and 
increasing awareness of patient autonomy will increase the number of frail older people 
who rely on primary health care in reaching the aim of successful aging.
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Objectives: Caregiver effects of geriatric care models focusing primarily at the patient have not 
been consistently studied. We studied caregiver effects of a nurse-led comprehensive geriatric 
evaluation and management (GEM) programme for community-dwelling frail older people in 
comparison with usual care. 
Methods: This randomised trial included 110 caregiver/patient couples who were followed for 
six months. Primary analyses were intention-to-treat analyses of caregiver burden assessed with 
Zarit Burden Interview (ZBI; 0-88; higher means more burden). Preplanned subgroup analyses 
were conducted for cognition, living conditions, and household composition.
Results: Overall perceived caregiver burden showed no significant differences between study 
groups in changes over time. However, perceived burden was at baseline more than eight points 
higher in caregivers sharing a household with patients (n = 23) compared to caregivers living 
separately (n = 87). The intervention performed convincingly better in caregivers living together 
with the patient than in caregivers living separately (p for interaction = 0.04).
Discussion: GEM caregiver effects might be related to whether caregivers live with the patient 
or not. Baseline differences in perceived burden in both subgroups may offer an explanation: 
it is the most burdened group, sharing households with the patient, which benefits from the 
intervention.  
Introduction
Increasingly, community-based alternatives for institutional geriatric care are disseminated 
throughout health care 1, 2. There are very legitimate reasons for this up rise of primary 
care geriatric evaluation and management (GEM) models: as result of population aging 
and increasing awareness of patient autonomy more and more frail older people will 
rely on primary health care 3, 4. However, despite the promises this type of health care 
holds for vulnerable older people, these models will evidently affect the family and 
friends who care for them. This influence is not necessarily only positive. Caregivers are 
in a special position, because on the one hand they are  supporting the patient, whereas 
on the other they are in need of support for themselves 5. Although some of these models 
have an eye for the caregivers and their burden, successful intervention in patients often 
relies on the caregivers’ participation as well. This may increase the burden of caring. 
Many studies have evaluated the effect of interventions primarily aimed at caregivers 
6-9. These studies suggest that interventions aimed at that caregiver improve outcomes 
such as caregiver burden, depression, or subjective well-being. This is true both when the 
care recipient is an older adult in general as well as when the recipient has a cognitive 
disorder 8, 9. The increasing interest in dyadic modelling of the caregiving relationship 
shows how scientists increasingly appreciate the complexity and reciprocity of the 
relationships between caregivers and the patients. 10. This also affects how caregiver 
interventions are being evaluated. The focus has shifted from solely caregiver outcomes 
to also paying attention to how care recipients are affected in interventions focused on 
the caregivers. Despite the increasing attention given to the care recipient or patient in 
caregiving research, not many have studied this relationship while evaluating models 
aimed at the older patient in the first place 11. This may be the consequence of the 
intuitive expectation that improving the life of the patient also protects the informal 
caregiver from the increasing burden that often accompanies caring for a frail, aging 
person. However, these interventions could also increase the caregiver’s burden by 
recruiting even more of the caregivers assistance 11. These potential ‘side-effects’ of GEM 
models are often neglected in GEM evaluations, but have been evaluated in a few studies 
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11-14. These studies suggest positive effects of outpatient GEM on caregiver burden. The 
Dutch Geriatric Intervention Programme (DGIP) is a comprehensive geriatric assessment 
model, consisting of nurse home visits for frail older patients, that has shown to effectively 
improve functional abilities and well-being of frail older patients at a reasonable cost 
15. The objective of this paper is to describe the effects of this model of home visits that 
focuses primarily at the community-dwelling frail older people themselves on caregiver 
burden in comparison with usual care. Based on the limited findings available, we 
hypothesised that the intervention would have a beneficial effect on caregiver burden.
Methods
Design
We conducted an observer blind randomised controlled trial of which the design was 
previously published 16. The local Ethical committee approved of the study.
Study population
General practitioners referred independently living older patients to our model when 
there was a problem in cognition, nutrition, behaviour, mood, or mobility. The problem 
had to urge for nursing assessment, coordination of care, or therapeutic monitoring 
and case management. Referrals for acute problems or purely medical issues were not 
accepted. Patients had to live in their own home or in a home for the aged and should 
be 70 years of age or older. An informal caregiver was defined as a person who felt 
responsible for the care of the patient and who was the closest involved in that care as 
non-professional.
We restricted patient inclusion to those patients with one or more limitations in cognition, 
(instrumental) activities of daily life, or mental well-being. The exact cut-offs were on 
Mini Mental State Examination (MMSE): equal to or less than 26, on Groningen Activity 
Restriction Scale (GARS-3): equal to or greater than 25, and on MOS-20 subscale mental 
health (MOS-20MH): equal to or less than 75 17-19.  Moreover we excluded persons 
already receiving forms of intermediate care or health care from a social worker or 
community-based geriatrician, persons on the waiting list for a nursing home, and those 
who had a life expectancy of less than six months, because of terminal illness. 
Randomisation 
Patients/caregiver couples were randomised over two treatments arms: home visits 
and usual care. The usual care group received unrestricted care. We used a two-step 
pseudo cluster randomisation procedure; because individual randomisation risked 
contamination and cluster randomisation risked selection bias due to expected 
treatment arm preferences of recruiting physicians. We reported details of this novel 
design elsewhere 16, 20, 21. Pseudo cluster randomisation divided the general practitioners 
in two groups; a group H and a group L. The patients recruited through physicians of 
group H were randomised in an 80/20 ratio to home visits and usual care; while in 
group L this ratio was reversed: 20% home visits and 80% usual care. The occurrence of 
selection bias and poor recruitment is prevented, because treatment allocation remains 
concealed. Limited exposure of L-physicians to the home visits programme lowers risk 
of contamination of usual care.
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Intervention
The intervention (Dutch Geriatric Intervention Programme; DGIP) used a problem-
based selection procedure performed by the general practitioner. The problems targeted 
concerned cognition, nutrition, behaviour, mood, or mobility, and had to require 
nursing assessment, coordination of care, therapeutic monitoring, or case management. 
Within two weeks after referral a geriatric specialist nurse visited the patient at home. 
Up to six visits for additional geriatric evaluation and management were planned within 
the next three months. The nurse conducted the main part of the intervention. The 
general practitioners continued their usual medical care. Moreover, they made referrals, 
medication changes, and other interventions as agreed upon during interdisciplinary 
consultations with the nurse and geriatrician on individual cases. The general practitioner 
kept prime responsibility for the care of the patient and made the final decisions. We 
developed guidelines for each of the five presenting health problems to structure 
activities, without losing the flexibility of tailoring the individual interventions. Although 
not a standard intervention, the nurse also performed a caregiver burden assessment 
22, 23. The results were implemented in the care plan; the nurse gave for instance extra 
attention to psycho-education, organised extra adult day care, or taught the caregiver 
how to handle behavioural disturbances in dementia. Caregivers were involved in the 
conception and execution of the intervention to their capability. The nurse, geriatrician, 
and general practitioner had frequent consultations on individual cases.
Data collection and outcome measures
A researcher interviewed patients at home to obtain written informed consent and to 
collect baseline demographic characteristics, data on general health conditions, and 
data on use of home care. If the patient was not capable to give informed consent, 
we asked a proxy to do so. We collected data on age and sex of the caregiver, their 
relationship with the patient, type and amount of care provided, time spent on caring, 
and caregiver burden. Also data were collected on competing time demanding activities 
such as work, caring for a family, or leisure time activities.These measurements were 
repeated three and six months after inclusion. The primary outcome measure for the 
caregivers was caregiver burden measured with the Zarit Burden Interview (range 0-88, 
with burden increasing with the score). The secondary outcome is time spent on care.
Statistical analysis
The baseline characteristics were tested using a mixed logistic model for categorical 
values and a mixed linear model for continuous outcomes. The primary analysis was 
an intention-to-treat analysis on the difference in the change from baseline ZBI to three 
months of follow up, which is at the end of the nursing intervention. A mixed linear 
model was used to account for clustering at the level of the general practitioner with the 
baseline measurement of ZBI and the stratification factors used in the randomisation as 
covariates. In a secondary analysis the difference in change from baseline at six months 
using the same model was evaluated. The other outcome measures were analysed in 
a similar way. We calculated 95% confidence intervals for the differences between 
treatment arms and used a two-sided alpha of 0.05 to test statistical significance. 
Subgroup analyses will be performed for living independently versus living in a home 
for the aged, higher versus lower levels of cognitive function, and patient and caregiver 
living together or not. 
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Patients without informal caregiver  
(n = 42) 
 
Second follow-up visit T2: 
x Assessed (n = 43) 
x Lost to follow-up (n=2) 
Patient died (n=1) 
Withdrawal informed consent (n=1) 
Second follow-up visit T2: 
x Assessed (n = 56)  
x Lost to follow-up (n =2) 
Patient died (n=2) 
 
an
al
ys
is
 Analysis* 
x In primary analysis Zarit Burden Interview 
T1 (n = 53) 
x In secondary analysis Zarit Burden 
Interview T2  (n = 47) 
Analysis* 
x In primary analysis Zarit Burden Interview 
T1 (n = 39) 
x In secondary analysis Zarit Burden 
Interview T2  (n = 41) 
First follow-up visit T1: 
x Couples assessed (n=45)  
x Lost to follow-up (n=4) 
Patient died (n=1) 
Withdrawal informed consent (n = 3) 
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First follow-up visit T1: 
x Couples assessed (n=58) 
x Lost to follow-up (n=3) 
Patient died (n=3) 
 
Couples allocated to intervention group 
(n=64) 
x Received allocated intervention (n=61) 
x Did not receive allocated intervention 
(n=3);  
Severe disease (n=1) … 
Reconsidering indication (n=1) … 
Withdrawal of informed consent (n=1)  
within 1 week after randomisation 
 
Couples allocated to usual care group (n=49) 
x Received allocated intervention (n=49) 
 
 
Patients/caregivers excluded (n = 13) 
x Not meeting inclusion criteria (n = 5) 
x Refused to participate (n = 8) (P = 3, C 
= 5) 
Couples of patient and informal caregiver (n = 126) 
 
Couples randomised (n = 113) 
 
Patients (n = 168) assessed 
 
figure 1 Study flow chart of patient/caregiver couples participating in our study
*Differences between numbers assessed at follow-up and numbers included in the analysis result from the fact that although 
assessment was executed, participants not always completely filled the instruments and therefore no sum scores could be cal-
culated for everyone who was assessed.
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Results
In and around Nijmegen, the Netherlands, 55 general practitioners participated. 
During an inclusion period of 21 months that started at April 1, 2003, 155 patients 
eligible for the study were included as patients (Figure 1). In 113 of 155 patients an 
informal caregiver was identified. Three patient/caregiver pairs were not included in 
follow up and analysis because these patients experienced severe intercurrent disease 
necessitating hospital admittance, died, or withdrew informed consent within one week 
after randomisation. Therefore 110 patient/caregiver couples were included in follow 
up and analysis; 61 were included in the intervention group and received home visits, 
49 were included in the regular group. The caregivers who participated in this trial had 
a mean age of 56.3 years and 73% of them were females (Table 1). They cared for very 
frail patients, who were mostly females (72%) with a mean age of 82.2 years and who 
had much co-morbidity (table 2). Fifty-eight percent of the caregivers were daughters or 
sons of the patient. Nineteen percent of caregivers were spouses and 21% of caregivers 
lived together with the patient. Caregivers who did not share their household with the 
patient lived median only 5 kilometers away, and their travel time was approximately 
10 minutes by car. Patients experienced episodes of anxiety, wandering, or confused, 
restless or panicking behaviours, according to 96% of the caregivers. More than half 
the caregivers (52%) felt they always had to be watchful or could not leave their relative 
safely. Caregivers and patients spent a median six hours per week together. During this 
time the caregivers spent half an hour on personal care and two hours on assistive 
activities such as administration, organizing care, domestics etc. Another two hours 
were spent just visiting. These data were skewed; some caregivers spent more than a 
working week caring for their relative. 
Of the caregivers 11% indicated they could rely on no one else in the care for the 
patient. Offspring caregivers often shared caring for their parent with their siblings (44 
of 63 offspring caregivers) or their own spouses (9 of 63), spouse caregivers shared the 
caring with their children (12 of 20 spouse caregivers) or had no one else to help (6 of 
20). Sixty-two percent of the caregivers spent less time on other activities because of 
the care for the patient. Care for someone else than the patient (13 %), and leisure time 
activities (23 %) were most mentioned as activities they spent less time on. At baseline 
caregivers scored a mean ZBI score of 29.9. The age of the patient was higher in the 
usual care group (Table 1).
About 40% of patients were referred because of a problem relating to cognition. Mood 
and mobility problems were reason for referral both in 20% of the cases. Nutritional 
and behavioural problems were referral reasons in 6 and 11% respectively. The nurse 
visited intervention patients 3.8 times (SD 1.3). These visits lasted 1.3 hours on average. 
Problem analysis was an important component of these visits. The interventions focused 
mainly on advices and coordination of care. In 28 cases the nurses taught the caregiver 
how to handle a specific behaviour and in 15 cases they educated the caregiver. 
After three months of follow up the burden of caregivers in the intervention groups 
showed a non-significant improvement of 0.67 points [95% confidence interval -4.03 – 
2.69] compared to the change in burden over this period in the control caregivers. After 
six months the burden of caregivers in the intervention group showed a non-significant 
increase of 2.29 points [-1.61 – 6.19] compared with the change over this time period 
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in control caregivers (Table 3). 
The intervention increased the time spent on other assistive activities such as 
administration and housekeeping with 1.9 hours/week [-2.2 – 6.0] at six months follow 
up, but this increase was non-significant. No effect on the amount of time spent on 
personal care was found.
The burden of caregivers in the usual care group was approximately constant over 
time, in the intervention group burden tended towards an increase (Table 4). Caregivers 
sharing a household with their relative (n = 23) were older (mean age 73 vs 52 years for 
caregivers living separately), more frequently men (11 of 23 vs 16 of 75), almost always 
spouse (20 of 23 vs 0 of 85), and had higher ZBI scores at baseline (mean score 33,9 
(SD 15.0) vs 27.9 (12.8)) than caregivers living separately. Also caregivers sharing a 
household spent more time on personal care (median 7.0 vs 0.25 hours/week) and more 
time on other assistive activities (median 10.5 vs 2.0 hours/week) at baseline.
table 1 Demographic characteristics and outcome measures of the study popula-
tion at enrolment
Usual care
(n = 49)
Home visits
(n = 61)
P-value 
PATIENT
Age patient, mean  ± SD 83.5 ± 6.1 81.1 ± 5.7 0.03
Female sex patient, n (%) 35 (71.4) 44 (72.1) 0.98
Patient living in a home for the aged, n (%) 9 (18.8) 6 (9.8) 0.24
Mini Mental State Examination patient* 21.1 ± 5.6 21.9 ± 5.8 0.51
CAREGIVER
Age caregiver, mean  ± SD 56.3 ± 13.0 55.5 ± 12.6 0.52
Female sex caregiver, n (%) 33 (68.8) 46 (75.4) 0.39
Living together with the patient, n (%) 7 (14.3) 16 (26.2) 0.17
Travel distance (km), if living separately, me-
dian [Interquartile range]
4.7 [2.1 – 13.0]† 5.1 [2.4 – 9.3]† 0.21‡ §
Travel time by cars (min), if living separately, 
median [Interquartile range]
10.0 [5.0 – 21.0]† 11.0 [6.5 – 18.0]† 0.15‡ §
Relationship with patient, n (%)
Spouse• 
Son/daughter• 
Other• 
5 (10.2)
30 (61.2)
14 (28.6)
15 (25.4)
33 (55.9)
11 (18.6)
0.08
Time spent… (hours/week), median [Inter-
quartile range]
Together• 
On personal care• 
On assistive activities: housekeeping, • 
administration, etc.
5.5 [3.5 – 10.0]†
0.4 [0 – 2.0]†
2.0 [1.0 –4.0]†
6.0 [3.5– 168.0]†
0.5 [0 – 3.0]†
3.0 [1.0 – 7.0]†
0.06‡
0.83‡
0.15‡
Had no help from others in caring, n (%) 6 (12.2) 9 (14.8) 0.76
Had less time for other activities because of 
care for patient, n (%)
26 (53.1) 33 (54.1) 0.96
Zarit Burden Interview, mean ± SD§ 30.4 ± 14.5 27.9 ± 12.4 0.33
* MMSE ranges from 0 to 30, with 30 indicating best score.
† For skewed variables median and quartiles are presented.
‡ For skewed variables P-values were calculated using the square root transformed score.
§ Zarit burden interview ranges from 0 to 88, with zero indicating best score.
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table 2 Ten most frequently mentioned diseases in the patients’ medical history by 
study arms (information taken from the general practitioner’s information 
system using ICPC-codes*)
DGIP (n = 61) Usual care (n = 49)
Disease – n (%) Disease – n (%)
Cataract 14 (22.9) Essential hypertension 16 (32.6)
Dementia 14 (22.9) Cataract 15 (30.6)
Depression 13 (21) Diabetes 13 (26.5)
Essential hypertension 10 (16.3) Dementia 12 (24.4)
Diabetes 10 (16.3) Presbyacusis 8 (16.3)
Stroke 10 (16.3) Atrial fibrillation 7 (14.2)
Atrial fibrillation 9 (14.7) Stroke 7 (14.2)
Heart failure 9 (14.7) Cholecystitis/cholelithiasis 6 (12.2)
Other diseases urinary tract 8 (13.1) Depression 6 (12.2)
Diverticula/diverticulitis 7 (11.4) Macular degeneration 5 (10.2)
*International Classification of Primary Care31
table 3 The effect of the intervention on caregiver burden and time spent on car-
ing for the patient at three and six months follow-up*
3 months follow-up (T1) 6 months follow-up (T2)
Outcome measure D CI N D CI N
Zarit Burden 
Interview†
-0.67 -4.03 – 2.69 92 2.29 -1.61 – 6.19 88
Time spent on personal 
care (hours/week)
0.53 -3.23 – 4.29 80 0.97 -1.66 – 3.60 84
Time spent on other as-
sistive activities (hours/
week)
-0.14 -4.70 – 4.42 75 1.86 -2.23 – 5.95 81
* Intervention effect: difference (D) and its 95% Confidence Interval (CI) in changes over time from baseline to three and six 
months between intervention and control group, for the number of subjects (N) in analysis.
Model: Outcome Measure Change from baseline = β0 + β1*treatment arm + β2*baseline value Outcome Measure + β3*minimisation 
factors  + random intercept physician
† Primary outcome caregiver
table 4 Caregiver burden and time spent on caring for the patient at three and six 
months follow-up: unadjusted outcome measure scores
3 months follow-up (T1) 6 months follow-up (T2)
Outcome measure Usual care Home visits* Usual care Home visits*
Zarit Burden Interview, 
mean ± SD†
29.1 ± 14.0 28.0 ± 12.5 28.7 ± 13.6 30.7 ±12.5
Time spent on personal 
care (hours/week), 
median [Interquartile 
range]
0 [0 – 3.5]‡ 0.5 [0 – 6.5]‡ 1.0 [0 – 3.0]‡ 0.7 [0 – 7.0]‡
Time spent on other as-
sistive activities (hours/
week), median [Inter-
quartile range]
2.0 [1.0 – 7.0]‡ 2.0 [0.5 – 8.5]‡ 3.25 [1.0 – 6.0]‡ 2.0 [0.5 – 7.0]‡
* Treatment under study
† Primary outcome caregiver
‡ For skewed variables median and quartiles are presented
caregiver effects of nurse home visits programmechapter 7 89
The subgroup analyses showed that at six months the home visits programme improved 
burden with 6.2 points in caregivers living together, while burden worsened with 4.0 
points in caregivers in the intervention group sharing no household compared to the 
control caregivers (p-value for this interaction 0.04) (Table 5). No other significant 
interactions were found.
Discussion
Caregiver burden was high in the caregivers that participated in this study compared to 
reference populations 24, 25. The high burden scores remained roughly constant over time. 
The nurse-led intervention model for frail older people that was tested in this randomised 
controlled trial had no positive effect on caregiver burden and the time the caregiver 
spent on caring. 
Our initial hypothesis, based on previous studies, was that the intervention would 
have a beneficial effect on caregiver burden, despite the fact that our home visits 
programme was an intervention that aimed at the patient in the first place, not at the 
caregivers. Overall, the intervention did not show an improvement of caregiver burden. 
However, the interaction analyses showed that estimating an effect for all caregivers 
combined probably does not satisfactorily describe the effect of the intervention on 
caregiver burden (Table 5). The interaction between home visits and living arrangement 
modified the effect of the intervention. The intervention performed convincingly better 
in caregivers living together with the patient than in caregivers living separately. This 
observation certainly makes sense, because the involvement of the caregivers also 
depends on their living arrangement: burden at baseline was almost eight points higher in 
caregivers living together, and they spent more time on caring. Because their needs were 
higher, caregivers sharing a household probably were more sensitive to intervention. In 
caregivers not sharing their household with the patient the feeling that the intervention 
only implied extra tasks may have prevailed. The intervention may also have made them 
more conscious of the vulnerability and impairments of their relative; information they 
simple did not have or were able to “neglect” in advance. It turned out that caregivers 
sharing a household not only were more involved in the caregiving process, they also 
were almost always spouse, older, and more frequently men. These are all factors that 
might interact with the intervention independently of living arrangement. However, 
because these other possible explanatory factors coincided to a considerable extent with 
table 5 Subgroup analyses of the effect of the intervention on caregiver burden 
(ZBI) in association with possible effect modifiers*
3 months follow-up (T1) 6 months follow-up (T2)
Effect modifier D P interaction D P interaction
Patient MiniMental State Examination < 21 (n=42) vs 0.0 0.75 1.7 0.75
Patient MiniMental State Examination ≥ 21 (n=68) -1.1 3.0
Patient independent (n=94) vs -0.6 0.42 2.3 0.19
Patient in home for the aged (n=15) -5.2 -9.5
Patient and caregiver live together (n=23) vs -2.7 0.53 -6.2 0.04
Patient and caregiver live separately (n=85) 0.0 4.0
* Intervention effect: difference (D) in change over time in Zarit Burden Interview from baseline to three and six months between 
intervention and control group for each of the strata of the possible effect modifiers and the p-value for the interaction (P interac-
tion)
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the subgroups living together or not in our study, it is difficult to tell whether it was really 
living arrangement and not for example the caregiver’s sex that interacted with therapy. 
However, post-hoc subgroup analyses were performed on these separate factors, and 
neither showed a significant interaction effect on its own (data not shown). Our finding is 
in line with the results of a randomised study on caregiver support in dementia care that 
showed that beneficial effects were to be expected in  caregivers sharing a household 
with the demented patient 26. Other studies have also shown that caregiver burden and 
caregiver involvement may depend on living arrangement 27, 28. This interaction may 
also be an explanation for the – in contradiction to ours – positive results found in 
other studies. While our study included no more than 25% caregivers living together, 
other studies included numbers of around 40-50% 11, 13, 14. In our study, the intervention 
effect was significantly better in the group of caregivers sharing a household with the 
patients.
We used a robust design to evaluate the effect of home visits on caregiver outcomes. 
Nevertheless, there are some methodological issues that deserve attention. Our study 
arms were different in size. Numerical imbalance between study arms harms statistical 
efficiency, but this only occurs when the imbalance is larger than a factor 2 29. Patient 
randomisation minimised the possibility of selection bias. The comparison of patients’ 
baseline characteristics (Table 1) and the results of sensitivity analyses confirmed this 
statement. Patients in the usual care group were only slightly older. Therefore, we did 
perform a sensitivity analysis adjusting for age of patient, which showed approximately 
the same results as the uncorrected analysis (data not shown). Ten to 20% of the 
included caregivers were not included in the primary analysis of burden, because of 
missing values. A sensitivity analysis of the primary outcome assigning the mean of the 
other group to the missing values gave about the same results 30. While most caregivers 
cooperated enthusiastically, there was a group we failed to motivate. There are two 
reasons for this reluctance: the intervention is aimed at the patient in the first place, and 
we used a liberal definition of a caregiver in this study, identifying persons with a rather 
loose contact already as caregiver. 
Our trial results showed that the effect of geriatric evaluation and management in the 
community on caregiver burden probably depends on the living arrangement of caregiver 
and patient; the intervention performed convincingly better in caregivers living together 
with the patient – who suffer the highest burden – than in caregivers living separately. 
This difference is probably caused by different levels of involvement of the caregivers. 
This result deserves further attention in future research. With increasing popularity of 
primary care alternatives for vulnerable older people, attention for the caregiver is 
a necessity, both in developing health care interventions, as in their evaluation and 
implementation.
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Objective: There is growing interest in geriatric care for community-dwelling older people. There 
are, however, relatively few reports on the economics of this type of care. This paper reports 
about the cost-effectiveness of the Dutch Geriatric Intervention Programme (DGIP) compared 
to usual care in frail older people at six months follow-up from a health care system’s point of 
view.
Methods: We conducted this economic evaluation in an observer blind randomised controlled 
trial (Dutch EASYcare Study: ClinicalTrials.gov Identifier NCT00105378). Difference in treatment 
effect was calculated as the difference in proportions of successfully treated patients (prevented 
functional decline accompanied by improved well-being). Incremental treatment costs were 
calculated as the difference in mean total care costs. The incremental cost-effectiveness ratio 
(ICER) was expressed as total costs per successful treatment. Bootstrap methods were used to 
determine confidence intervals for these measures.
Results: The average cost of the intervention under study (DGIP) was 998 euros [95% CI  888 – 
1108]. The increment in total costs resulting from DGIP was little over 761 euros [-3336 – 4687]. 
Hospitalisation and institutionalisation costs were less; home care, adult day care, and meals-
on-wheels costs were higher. There was a significant difference in proportions of successful 
treatments of 22.3% [4.3 – 41.4]. The number-needed-to-treat was approximately 4.7 [2.3 – 
18.0]. The incremental cost-effectiveness ratio is 3418 euro per successful treatment [-21458 
– 45362]. The new treatment is cost-effective at a willingness-to-pay of 34000 euros.
Conclusions: The results of this economic evaluation suggest that DGIP is an effective addition 
to primary care for frail older people at a reasonable cost.
Introduction
There is growing interest in geriatric care for community-dwelling older people 1, 2. Both 
growing awareness of patient autonomy and population ageing drive this development 
3, 4. Community-based geriatric intervention models aim to improve functioning, well-
being, coping styles, and mortality among community-dwelling older persons. The 
idea is that increasing older people’s autonomy will also increase their quality of life. 
Despite some promising effects on disabilities, mood, and mortality, there is still much 
controversy about important determinants of success such as which patients to include, 
the setting and the intensity of intervention 1, 5, 6. However, for geriatric primary care to 
be truly valuable to society it needs to provide effective interventions that give ‘value for 
money’. There are relatively few reports on the economics of outpatient comprehensive 
geriatric assessment or preventive home visits 7, 8. A review on comprehensive geriatric 
assessment concluded that evidence suggests no increase of total costs of care 7. Another 
review about preventive home visits stated that there is a potential for produce net cost 
savings 8. 
From April 2003 until July 2005 we carried out a randomised comparison of a 
multidisciplinary home-based intervention programme for frail older people with usual 
care (Dutch EASYcare Study) 9. It showed that patients’ well being and functional abilities 
improved compared to control conditions 10. Subjective caregiver burden seemed to 
improve in caregivers who shared a household 11. This paper reports about health care 
utilisation and the cost-effectiveness of the Dutch Geriatric Intervention Programme 
(DGIP) compared to usual care in frail older people from a health care system’s point 
of view.
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Methods
Study design and setting
We conducted an economic evaluation in an observer blind randomised controlled 
trial (ClinicalTrials.gov Identifier NCT00105378) of which the design was previously 
published 9. We used a health care system’s perspective to identify all relevant costs. The 
local ethical committee approved of this study.
Patients
General practitioners referred frail older patients to our model when there was a problem 
in cognition, nutrition, behaviour, mood, or mobility. The problem had to call for nursing 
assessment, coordination of care, or therapeutic monitoring and case management. 
Patients were living in their own home or in a home for the aged and were 70 years or 
older. We restricted patient inclusion to those with limitations in cognition, (instrumental) 
activities of daily life, or mental well-being.
Randomisation
Patients were randomised over two treatments arms: DGIP and usual care. We used a 
two-step pseudo cluster randomisation procedure, because we expected methodological 
problems when using either individual randomisation or cluster randomisation 9, 12-14.
Interventions
A geriatric specialist nurse visited the patients randomised to the intervention arm. 
During a maximum of three months up to six visits for additional geriatric evaluation 
and management were performed. The nurse, geriatrician, and general practitioner had 
frequent consultations on individual cases. No restrictions were imposed on the care 
patients received in the usual care group. However, no model of care comparable to 
DGIP was regularly available in usual care.
Data collection
Effect measures
The patients were interviewed to obtain written informed consent and to collect 
baseline demographic characteristics, data on general health conditions, and data on 
use of home care. These measurements were repeated six months after inclusion. The 
outcome measures used for this economic evaluation were functional performance in 
(instrumental) activities of daily living measured using the Groningen Activity Restriction 
Scale and mental well-being using the subscale mental health of MOS-20.15, 16
Cost analysis
Costs were measured by registration of volumes of care consumed and multiplied by 
appropriate prices per unit of care. To be able to calculate the costs of DGIP, DGIP-
nurses registered the time spent on the intervention using an MS Outlook® agenda. 
They registered the visits per patient, and the time spent on consultation, phone calls, 
travelling, and administration. Data on the workload of the general practitioner and the 
geriatrician resulting from DGIP were derived from the workload of the nurses. We also 
established the amount of care consumed during the follow-up period of six months. In 
order to calculate incremental costs, data collection of cost measures focused on cost 
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drivers, i.e. these factors that were likely to cause the most important cost differences 
between strategies. These were: utilisation of family physician care (number of practice 
visits, house calls, and telephone calls), the number of referrals to other health care 
providers (outpatient specialist care, paramedical disciplines such as physical therapist, 
occupational therapist etc.), and the number of days in hospital. All the above information 
was taken from the general practitioner’s information system. The number of days 
hospitalised was crosschecked against the information provided by the patient using 
questionnaires at three and six months of follow-up. The patients provided information 
on the amount of home care, adult day care, and meals-on-wheels they used during 
follow-up. They also provided information on number of days institutionalised in nursing 
home or home for the aged; this information was crosschecked against the information 
available from the general practitioner’s information system. 
Cost prices per unit of care (Euros) were taken from Dutch guidelines for economic 
health care evaluations 17. In accordance with these guidelines, 45% overhead costs 
were added to the total direct costs to calculate a cost price per DGIP visit. Cost prices 
of referrals to outpatient specialist care, and paramedical disciplines were estimated 
because this information was not readily available. All prices were indexed to the price 
level of 2005, using the Dutch consumer price index figures for health care costs18.
table 1 Demographic characteristics and outcome measures of the study 
population at enrolment*
Usual care
(N = 66)
Dutch Geriatric Interven-
tion Programme  (N = 85)
P 
Age – yr 82.8±6.6 81.7±5.9 0.22
Female sex – no. (%) 49 (74.2) 64 (75.3) 0.99
Marital status – no. (%)
Married• 
Divorced• 
Widow(er), partner deceased• 
Single• 
Living together unmarried• 
19 (29.2)
2 (3.1)
36 (55.4)
8 (12.3)
0
23 (27.4)
5 (6.0)
47 (56.0)
8 (9.5)
1 (1.1)
0.31
Living in home for the aged – no. (%) 11 (16.9) 12 (14.1) 0.56
Informal caregiver – no. (%) 49 (74.2) 65 (76.5) 0.71
Receiving home care – no. (%) 34 (51.5) 43 (51.1) 0.97
Groningen Activity Restriction Scale-3 34.1±8.7 35.3±8.1 0.68
Medical Outcomes Scale-20 mental health 53.8±17.7 53.3±20.9 0.87
MOS-20 physical functioning 16.7 [0 – 33.3]§ 16.7 [0 – 36.7]§ 1.00
MOS-20 role functioning 0 [0 – 50.0]§ 0 [0 – 50.0]§ 0.87
Cumulative Illness Rating Scale-Geriatrics 9.8±4.3 10.2±3.7 0.64
Timed Up and Go – seconds 16.0 [12.0 – 22.0]§ 16.0 [12.0 – 25.0]§ 0.60
MMSE 22.0±6.0 22.8±5.5 0.22
Cantril’s self anchoring ladder 5.9±2.1 5.7±2.1 0.78
Dementia Quality of Life positive affect 3.1±0.7 3.2±0.7 0.50
DQoL negative affect 2.6±0.6 2.7±0.7 0.24
Loneliness Scale De Jong-Gierveld 5.7±3.6 4.4±3.2 0.04
* For all – except skewed – variables means ± SDs are presented, for skewed variables (§) median and interquartile range are 
presented.
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Statistical analysis
To obtain an interpretable effect measure, we considered the treatment a success if a 
patient’s MOS-20MH score increased by more than 10 points and GARS-3 score declined 
no more than 4.5 points. We used this definition because the course of GARS-3 scores 
showed a decline in our control group, while fairly steady MOS-20MH scores were 
observed over a six months period. Relative to the score range, both cut-offs represent 
approximately 10% change in score.
Difference in treatment effect was calculated as the difference in proportions of successfully 
treated patients. Incremental treatment costs were calculated as the difference in mean 
total care costs. The incremental cost-effectiveness ratio (ICER) was expressed as total 
costs per successful treatment. Bootstrap methods were used to determine confidence 
intervals for these treatment arms’ differences that take into account the clustering of 
patients within their general practitioner. From the bootstrap sample a cost-effectiveness 
acceptability curve (CEAC) was drawn. This curve gives an estimate of the proportion of 
the bootstrap distribution favouring one strategy over the other given a willing-to-pay 
(WTP) for a gained unit of effect 19. We performed a sensitivity analysis for missing data; 
missing values were substituted with the mean of the other group 20.
Results
In this study 151 patients were included. Our study population consisted in majority of 
widowed females born in the Netherlands. A majority (85%) lived in their own home; 
the rest lived in homes for the aged. The patients had a mean age of 82.2 years, a 
lot of co-morbidity, considerable cognitive deterioration, and low mental well-being. 
Approximately half the study group had home care available at baseline. 
table 2 Number of health care units used per patient during six months follow-up
Usual care (n = 66)
Mean ± SD
DGIP* (n = 85)
Mean ± SD
DGIP visits 0 3.8 ± 1.3
Hospitalisation (days) 6 ± 16 4 ± 14
Physician care (number)
Practice visits• 
House calls• 
Telephone contacts• 
Administrative contacts• 
Emergency practice visits• 
Emergency house calls• 
Emergency tel. contacts• 
Unspecified• 
Unspecified, emergency• 
10.7 ± 8.9
1.0 ± 1.9
2.2 ± 3.3
1.5 ± 2.3
3.4 ± 3.9
0
0.5 ± 0.6
0.2 ± 0.4
2.4 ± 3.3
0.1 ± 0.3
13.4 ± 8.2
1.0 ± 1.8
2.6 ± 3.5
2.4 ± 2.9
4.6 ± 3.6
0.1 ± 0.2
0.4 ± 0.7
0.7 ± 0.9
2.5 ± 2.9
0.1 ± 0.3
Institutionalisation (days)
Home for the aged• 
Nursing home• 
32 ± 65
5 ± 23
24 ± 58
4 ± 16
Home care (hours)
Domestic care• 
Personal care• 
Nursing care• 
63.4 ± 77.0
38.7 ± 44.5
22.7 ± 43.0
2.0 ± 9.3
88.6 ± 172.4
33.3 ± 39.0
52.4 ± 164.5
2.9 ± 11.5
Day care (days) 3 ± 10 6 ± 21
Meals-on-wheels (days) 33 ± 63 44 ± 66
* Dutch Geriatric Intervention Programme
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In the group that received DGIP 85 patients were included, and 66 were included 
in the usual care group. Baseline characteristics and baseline measures of primary 
outcomes showed no significant differences between study groups, except for the 
score on loneliness (table 1). Figure 1 shows the participant flow through the study. The 
nurse visited DGIP patients almost four times (table 2). Of all patients 34 patients were 
successfully treated: they experienced an improvement in well-being without a decline 
in functional performance (table 3). Of these patients 7 were in the control group, and 
27 in the intervention group. The significant difference in proportions of successfully 
treated patients was 22.3% [4.3 – 41.4] in favour of DGIP, and the number needed to 
table 3 Treatment effect and health care usage and costs per patient at six months 
of follow-up
Usual care 
(n = 66)
Mean ± SD
DGIP* 
(n = 85)
Mean ± SD
Difference 
[95% CI]
EFFECT
GARS-3†‡ -1.6 [-3.9 – 0.7]
MOS-20MH†§ 9.1 [2.4 – 15.6]
“Successful treatments” (%)
Number of missing values
7 (13.7)
15
27 (36.0)
10
22.3 [4.3 – 41.4]
Number needed to treat 4.7 [2.3 – 18.0]
COSTS||
Total care costs (euros) 8952 ± 9757 9713 ± 10205 761 [-3336 – 4687]
Intervention (DGIP) 0 998 ± 408 998 [888 – 1108]
Hospitalisation
Number (%)¶• 
Costs if used**• 
2291 ± 6449
14 (21.2)
10801 ± 10437
1616 ± 5480
11 (12.9)
12487 ± 10147
-675 [-3275 – 1375]
-8.3 [26.4 – 7.2]
1687 [8637 – 11592]
Physician care
Number (%)¶• 
239 ± 207
65 (98.5)
277 ± 209
83 (97.9)
38 [-43 – 117]
-0.8 [-6.3 – 5.4]
Outpatient care
Number (%)¶• 
Cost if used**• 
93 ± 264
16 (24.2)
382 ± 429
71 ± 207
22 (26.9)
275 ± 335
-21 [-130 – 68]
1.6 [-16.2 – 18.3]
-107 [-453 – 180]
Paramedical care
Number (%)¶• 
Cost if used**• 
43 ± 167
5 (7.6)
567 ± 289
65 ± 156
15 (17.7)
368 ± 164
22 [-58 – 78]
10.1 [-3.9 – 21.7]
-199 [-578 – 93]
Institutionalisation
Number (%)¶• 
Cost if used**• 
3727 ± 7279
17 (25.8)
14470 ± 7077
2886 ± 5802
19 (22.4)
12910 ± 4527
-841 [-3586 – 1655]
-3.4 [-20.2 – 13.5]
-1560 [-6274 – 3197]
Home care
Number (%)¶• 
Cost if used**• 
1880 ± 2483
40 (60.6)
3101 ± 2528
2832 ± 5887
61 (71.8)
3946 ± 6637
952 [-542 – 2799]
11.1 [-7.6 – 29.5]
845 [-1106 – 3241]
Day care
Number (%)¶• 
Cost if used**• 
380 ± 1084
10 (15.2)
2511 ± 1596
622 ± 2282
10 (11.8)
5383 ± 4607
241 [-294 – 1053]
-3.4 [-17.1 – 11.4]
2772 [-420 – 7028]
Meals-on-wheels
Number (%)¶• 
Cost if used**• 
299 ± 560
18 (27.3)
1098 ± 521
390 ± 595
34 (40.0)
976 ± 560
91 [-150 – 378]
12.7 [-6.9 – 34.6]
-122 [-475 – 329]
* Dutch Geriatric Intervention Programme
† Difference between study arms in outcome measures’ change from baseline at 6 months follow-up
‡ Groningen Activity Restriction Scale (GARS-3) runs from 18 to 54, with 18 indicating best score
§ Medical Outcomes Scale 20 subscale mental health (MOS-20MH runs from 0 to 100, with 100 indicating best score
|| Costs per patient were averaged over all patients in each group
¶ Number: number of patients who used a specific service
** Cost if used: costs of a specific service when averaged over these patients who actually used a certain service
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treat was 4.7 [2.3 – 18.0]. The DGIP intervention cost 998 euros per patient [95% CI 
888 – 1108]. The incremental cost of the nursing programme was 761 euros [-3336 – 
4687]. Hospitalisation (-675 euros) and institutionalisation in home for the aged and 
nursing home (-841 euros) cost less in the DGIP group, while home care (+952 euros), 
day care (+241 euros) and meals-on-wheels (+91 euros) were more expensive (table 3). 
The incremental cost-effectiveness ratio is 3418 euros per successful treatment [-21458 
– 45362]. The probability of DGIP being the “dominant” intervention was estimated 
to be 34.6% (figure 2: proportion of incremental cost-effectiveness ratios falling in the 
Southeast quadrant). The vertical axis of the CEAC represents the probability that the 
incremental cost-effectiveness ratio of DGIP compared with usual care is acceptable for 
Second follow-up visit T2 at 6 months: 
x Assessed (n = 53) 
Visited (n = 44) 
Only written data (n = 9)* 
x Lost-to-follow-up (n = 13) 
Dead (n = 4) 
Withdrawal informed consent (n = 9) 
 
Second follow-up visit T2 at 6 months: 
x Assessed (n = 78) 
Visited (n = 72) 
Only written data (n = 6)* 
x Lost-to-follow-up (n = 7) 
Dead (n = 5) 
Withdrawal informed consent (n = 2) 
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Allocated to DGIP (n = 88) 
x Received allocated intervention  (n = 85) 
x Did not receive allocated intervention (n = 
3) 
Severe intercurrent disease (n = 1), 
Reconsidering indication (n = 1), 
Withdrawal of informed consent (n = 1) 
Within 1 week after randomisation 
Allocated to usual care group (n = 67) 
x Received allocated intervention  (n = 66) 
x Did not receive allocated intervention (n = 
1) 
Severe disease (n = 1)  
Within 1 week after randomisation 
Excluded (n = 13) 
x Not meeting inclusion criteria (n = 5) 
x Refused to participate (n = 8) 
 
Randomised (n = 155) 
Assessed for eligibility (n = 168) 
figure 1 Study flow chart
* A number of participants withdrew their consent for the visit for data acquisition by interview, but agreed to fill in the ques-
tionnaires.
† Differences between numbers assessed at follow-up and numbers included in the analysis result from the fact that although 
assessment was executed, participants not always completely filled the instruments. Therefore, responder status could not be 
established for everyone assessed.
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a range of values of the willingness to pay per successful treatment (figure 3). If society 
is willing to pay 34000 euros or more for a successful treatment than there is a 95% 
probability that DGIP is efficient. During follow-up 25 patients had missing values for 
treatment success; 10 patients were in the intervention group, 15 in the control group 
(figure 1). However, the results from the sensitivity analysis for missing data did not 
essentially differ from the results presented (data not shown).
Discussion
In this group of frail patients the mean total care costs in the control group were 
approximately 9000 euros over a six months period. The yearly health care costs in the 
age group 75-84 year is 8408 euros in the Netherlands 21, but a vulnerable population 
– in which higher health care costs can be expected – was included in this study. 
The average cost of the intervention under study (DGIP) was almost 1000 euros. The 
increment in total costs resulting from DGIP was little over 750 euros. Hospitalisation 
and institutionalisation costs were less; home care, adult day care, and meals-on-
wheels costs were higher. There was a difference in proportions of successful treatments 
(prevented functional decline accompanied by improved well-being) of about 20%. The 
number-needed-treat was approximately 5. The cost-effectiveness ratio is roughly 3500 
euros per successful treatment. The new treatment is cost-effective at a willingness-to-
pay of 34000 euros.
Comparison of these results with literature is difficult, because there are not many cost-
effectiveness studies in this field. Most papers only provide data on incremental costs 
without calculating cost-effectiveness ratios 7. The available reviews of literature hint at 
the possibilities of cost savings, but request more research into this matter at the same 
time 7, 8. One paper on preventive home visits concluded that the visits produced net 
cost savings in the third year 22. However, no information on the uncertainty for this 
estimation was given, which limits interpretation. A sound cost-effectiveness evaluation 
of outpatient geriatric evaluation and management estimated a cost-effectiveness ratio 
of 10600 dollars per QALY, and 26500 per QALY if the time horizon of five years was 
limited to the follow-up period of 64 weeks 23. Another randomised study of outpatient 
geriatric evaluation and management concluded there were no increases in costs 24. 
Our study did show a small increment in costs, although the cost-effectiveness seems 
reasonable. The uncertainty in the estimation is large, because the differences in total 
care costs are large. Total care costs were less than 50 euros for some patients, for others 
the amount was larger than 40000 euros. This reflects the heterogeneity in the care 
needed.
An explanation for the positive results in some of the earlier studies might be that these 
studies focused on certain aspects of health care, such as hospital costs 7. Our study 
took a wide health care system’s perspective as starting point. Our study showed lower 
hospital and institutionalisation costs, but home care and adult day care costs were 
higher. This is probably a direct intervention effect, because often nurses organised more 
home and adult day care. As independent living is considered an important aim 3, these 
increases seems reasonable and justifiable.
We focused on all cost drivers relevant for the viewpoint taken. Medication, laboratory, 
and diagnostics costs were not taken into account, because the influence of DGIP on these 
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figure 2 Cost-effectiveness plane for the incremental costs and effects of DGIP 
compared to usual care
figure 3 Cost-effectiveness acceptability curve of DGIP compared to usual care
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cost parameters was judged to be negligible. For the same reason no societal perspective 
was used. Given their age, the effect of the intervention on patients’ productivity is very 
limited. The effect on caregivers’ productivity is probably fairly small as well; caregiver 
burden and time spent on care was hardly affected by the intervention.
No QALY’s were used in our study, which limits comparability with other interventions. 
On the other hand, the use of QALY’s in gerontological research is delicate and its 
interpretation difficult. Generic instruments like EuroQoL from which QALY’s can be 
calculated probably show floor effects in frail patients as in our study. Also health states 
of frail older people are complex and often not sufficiently graded in terms of QALY’s.
Of course, every operationalisation of “successful treatment” is arbitrary to a certain 
degree. However, the difference in successfully treated patients, which was 22.3% in 
favor of DGIP with the currently used dichotomisation, is rather insensitive to change 
of cut-offs. Varying the cut-offs on GARS-3 and MOS-20MH in different combinations, 
resulted in differences in treatment success rates roughly ranging from 15 to 25% all in 
favour of DGIP (data not shown).
This economic evaluation was conducted alongside a randomised trial, which is an 
important safeguard against threats to internal validity. Study arm sizes were somewhat 
different, but patients were very comparable at baseline. The number of missing values 
(20%) was expected given their frailty. Participants who were lost-to-follow-up were 
older and had worse GARS-3, MOS-20MH, and MMSE scores at baseline. Moreover, 
when we used a conservative imputation strategy – assigning “mean of the other group” 
to missing patients, a sensitivity analysis showed about the same results 20. 
External validity benefited from the wide health care system perspective this evaluation 
used. The study conditions were very similar to current practice; as in usual care many 
physicians were involved in referring patients. Also, no strict treatment protocols were 
used; the control group received usual medical care without any restrictions, and 
guidelines led the DGIP intervention without restraining free selection from the available 
treatment options. 
The results of this economic evaluation suggest that DGIP is an effective addition to 
primary care for frail older people at a reasonable cost. However, there is a need for 
larger and more rigorously designed economic evaluations of this type of health care 
models, because uncertainty in the cost-effectiveness of these models is still large.
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Principal findings
This thesis aimed to study the effects of the multidimensional Dutch Geriatric Intervention 
Programme (DGIP), consisting of a home visiting programme for vulnerable older people living 
in their own home. To enable us to study these objectives in a valid way, a methodological 
innovation of the randomisation procedure was deemed necessary. The second aim of this thesis 
was therefore to describe and evaluate the method of pseudo cluster randomisation.
This study followed 151 patients and 110 caregivers for six months. 85 patients (and 61 caregivers) 
were randomly included in the intervention programme, and 66 patients (and 49 caregivers) 
received usual care.  Patients were very vulnerable, and caregivers highly burdened.
The new intervention model showed positive effects on self-reported functional abilities and 
mental well-being of vulnerable older people. These positive effects persisted after discontinuing 
the home visits. This problem-based care model might have implied some extra burden for 
caregivers living separately. On the other hand, in caregivers sharing a household the intervention 
seemed to improve caregiver burden. Possibly, this difference is explained by baseline differences 
in perceived burden of both subgroups: the intervention decreased caregiver burden in the 
most burdened group of caregivers. Problem-based nursing care can effectively support primary 
health care for vulnerable older people, and does so at reasonable cost.
Methodological aspects of the Dutch EASYcare Study
Despite the careful design of this study, several methodological aspects deserve 
consideration; how did these aspects influence the validity and generalisability of the 
results? The most important issues are the validity of the application of pseudo cluster 
randomisation, and the effect of attrition. 
Studying frail older people: 
missing values, and unblinding the outcome assessment
We aimed to study the effect of this intervention in frail older people, because – for 
reasons pointed out in detail in chapter 1 – it is for this group in particular that new 
primary care strategies have to be developed for 1. The age, co-morbidity, and GARS-3 
scores at baseline and the overall mortality during follow-up showed that in this study 
a group of very old, and vulnerable patients was indeed sampled. The CIRS-G score 
was comparable to the score inpatients had at admission to the geriatric ward of our 
hospital 2. Studying a frail older population has proven to be difficult, and specific 
procedures are needed to ensure the conduct of a valid and useful study 1. Several 
precautions were taken in the Dutch EASYcare Study: we accounted for attrition in 
the sample size considerations, visited the patients at home for baseline- and outcome 
assessment, included a specific consent procedure for patients with impaired decision-
making capacities, balanced the number, intensity, and length of the assessment visits 
and questionnaires, and defined a limited data set for patients for whom the complete 
assessment turned out to be too demanding. 
As could be expected, attrition occurred. Drop outs occurred mainly because patients 
(or their caregivers) felt participation in follow-up visits for effect measurement was 
too burdensome while it provided no further benefit. No patients declined follow-up 
because of a reason that related to the intervention that was studied. Another more 
disguised mechanism of attrition occurred when patients were willing to participate, but 
were unable to complete the assessment instruments for instance because of cognitive 
impairments. 
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To study the effect of attrition on the outcomes, we performed a sensitivity analysis 
assigning the “mean of the other group” to the missing values, which is a conservative 
method 3. “Replacing missing data by the mean of the other group has very good 
properties in regard of the type I error, the losses of power are acceptable if the drop-
out rates are moderate and the drop-outs are not completely equal in the groups” 3. A 
drawback is that imputing the mean of the competing group seems rather irrational from 
a clinical point of view. However, the use of “last-observation-carried-forward” was not 
an option either, because of the trend of decline which many outcomes show in an 
ageing population 3. Multiple imputation is a very popular technique, but it is important 
to remember that most techniques used for multiple imputation assume that missing 
values are “missing at random” 4. In other words, missing values are replaced with values 
of other non-missing subjects of the same group. As such, multiple imputation ignores an 
important source of potential bias: what was the reason for the subjects to drop out?
This trial was observer blind, because double blinding was impossible given the type 
of intervention under study. In a fairly high number of cases treatment assignment was 
revealed to the assessor during follow-up visits. Two strategies were tested in a pilot 
study phase: 1. the assessors explicitly asked the participants not to mention to the 
assessor whether a nurse visited them or not, and 2. the assessor avoided the subject 
of the house calls. The first approach did not work well, because participants often did 
not quite understand what they were asked. Having touched upon the subject of the 
house calls, participants often revealed their treatment assignments. One participant 
responded: “you mean I am not allowed to tell you that I was visited by nurse A?” 
This again shows how complicated research can be in frail subjects, who are not easily 
instructed. We decided to use the second strategy, but this was not very successful either 
because treatment assignment was for instance revealed through subtle hints such as 
a programme for day structure lying on the table. Maybe we should accept that an 
observer blind trial is impossible, if the outcome measures require the use of an assessor. 
Our primary outcome measures were taken using a written questionnaire which was 
filled out before each follow-up visit; the assessor has little influence on this. 
Studying caregivers: difficult to engage
Between 10 and 20% of the included caregivers were not included in the primary 
analysis of burden, because of missing values. While most caregivers cooperated 
enthusiastically, there was a group we failed to motivate. There are two reasons for this 
reluctance: the intervention is aimed at the patient in the first place, and we used a 
liberal definition of a caregiver in this study, identifying persons with a rather loose 
contact already as caregiver. The definition we used for an informal caregiver was: a 
significant other person who felt responsible for the well-being of the patient. We used 
this rather liberal definition because informal caregivers are a very heterogeneous group 
of people and more strict definitions might fail to identify persons as caregivers when 
they actually feel they are.
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Pseudo cluster randomisation: 
assumptions justifying the use of pseudo cluster randomisation and the effect on 
contamination and study validity
Pseudo cluster randomisation was used in our trial because we assumed that randomisation 
at the level of the individual patient risked contamination bias, and that the accepted 
solution to avoid contamination bias, cluster randomisation, risked selection bias and 
recruitment problems. As these were the assumptions we had in advance, we considered 
the evidence we could find for these assumptions during the conduct of our trial. We 
found that general practitioners had strong preferences for randomisation of their patients 
to the intervention, and they also indicated that these are treatment preferences which 
influence their inclusion behaviour. 
As randomisation occurred asymmetrically, general practitioners might get an idea about 
randomisation proportions, when recruitment in their own cluster advances. We found 
little evidence that general practitioners had this knowledge. Our general practitioners 
included only four patients on average, but even those with up to ten inclusions were not 
able to estimate accurately the randomisation ratio used. It seems that for cluster sizes of 
up to ten inclusions, asymmetrical randomisation in a 20:80 (= ratio intervention:control) 
or 80:20 does not lead to predictability of the randomisation sequence. We only had two 
general practitioners with more than ten patients in the study, therefore it is impossible 
to reach conclusions about the predictability of randomisation ratios with inclusion 
numbers over ten. 
Unfortunately, the intervention group was somewhat larger than our control group. One 
might speculate whether this was a sign of some predictability of treatment assignment 
after all.  The variation in the number of patients each physician included was very 
large. The two physicians who included more than 10 patients were assigned to the 
group of general practitioners whose patients were randomised to the intervention group 
in majority. This observation completely explains the unbalanced numbers of control 
and intervention group. One might not be satisfied and argue that these two general 
practitioners probably knew most of their patients were randomised to the intervention 
and be even more convinced about the occurrence of treatment predictability. However, 
the presence of these two physicians in the group where patients were randomised to the 
intervention group in majority, might just as well be a result of chance, as the number 
of often-recruiting physicians is so small. It would have been much more disturbing, if 
for example a majority out of ten or twenty often-recruiting general practitioners had 
been assigned to the group where patients were randomised to the intervention group 
in majority. Further reassurance is offered by the fact that patients in both study arms 
showed no signs of selection bias.
While we were able to evaluate the effect of pseudo cluster randomisation on the 
occurrence of selection bias with empirical information, we cannot judge whether 
contamination was effectively prevented or whether contamination was absent from the 
start. There are some indirect examples of the possible occurrence of contamination. 
One example is the fact that general practitioners indicated that they used elements from 
the intervention treatment when treating control group patients. Also the physicians’ 
self-perceived competence in geriatrics increased. This might point to a learning effect, 
because it was not present in general practitioners who did not recruit.
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Outcome measures: 
how to define clinical relevance in vulnerable older people
We considered the treatment a success if a participant’s MOS-20MH score increased 
by more than 10 points and GARS-3 score declined no more than 4.5 points. We used 
this definition because GARS-3 scores showed a decline in our control group, while 
fairly steady MOS-20MH scores were observed over a six months period. Of course, 
every responder definition is arbitrary to a certain degree. However, the difference in 
successfully-treated participants, which was 22.3% in favour of the new treatment using 
our dichotomisation, is rather insensitive to change of cut-offs. Varying the cut-offs on 
GARS-3 and MOS-20MH in different combinations, resulted in differences in treatment 
success rates roughly ranging from 15% to 25% all in favour of the new intervention 
treatment (table 1).
A final problem with health-related quality of life measures of the kind we used, is that 
they are criticised by patients with regard to their relevance in daily life 5. Individualised, 
patient-centred goal setting based on patient preferences might provide a more sensitive 
and meaningful outcome measure 6. In a trial conducted by Rockwood et al no effects 
were found using health-related quality of life measures 7, while goal attainment scaling 
showed effect 6. Unfortunately, the application of these clinometric instruments in the 
practice of clinical trials can be difficult. In our study a comparison was made with usual 
care, a condition we wanted to be left unaffected by our study. However, the application 
of the instrument of goal attainment scaling requires the definition of individualised 
treatment goals, which is an intervention in itself.
Follow-up: 
what is the optimal study length?
Our study applied a maximum follow-up of six months for the primary outcomes and up 
to two years (depending on whether patients were included early or late in the recruitment 
period) for survival, and institutionalisation. Six months of follow-up may be fairly short, 
but it is important to remember that there are many competing events in these vulnerable 
older people that cause a lot of “noise”, this “noise” causes increasing variances in 
the outcome measures. Maybe a combination of short term as well as longer term (for 
instance 1 year) follow-up is useful. However, any study is a compromise between the 
most ideal study design and feasibility: much longer follow-up periods would not have 
been acceptable to the patients, or only at the expense of large numbers of dropouts.
table 1 Sensitivity analysis using different responder definitions in the responder 
analysis
EFFECT
Number of responders using different 
responder definitions (%)
Usual care (n = 66) DGIP (n = 85)* Difference 
[95% CI]
Change GARS < 2.25, MOS20MH ≥ 10 6 (11.8) 23 (30.7) 18.9 [5.2 – 32.6]
Change GARS < 4.5, MOS20MH ≥ 15 5 (9.8) 20 (26.7) 16.9 [ 4.0 – 29.8]
Change GARS < 4.5, MOS20MH ≥ 5 13 (25.5) 32 (43.2) 17.8 [1.3 -34.2]
Change GARS < 6.75, MOS20MH ≥ 10 7 (13.8) 29 (38.7) 24.9 [10.4 – 39.5]
Change GARS < 2.25, MOS20MH ≥ 5 12 (23.5) 27 (36.5) 13.0 [-3.0 – 29.0]
Change GARS < 6.75, MOS20MH ≥ 15 5 (9.8) 22 (29.3) 19.5 [6.4 – 32.7]
* Dutch Geriatric Intervention Programme
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Caregiver outcomes
Our main caregiver-related outcome measure was perceived caregiver burden. We also 
studied the (self-reported) effects on actual workload in terms of hours spent on caring, 
which was assessed by asking the caregivers to estimate the amount of time they spent 
in general on different tasks. These outcomes provide information complementary to 
perceived caregiver burden. The problem with self reports on actual workload – which 
is supposed to provide an objective measure – is that an element of subjectivity may 
influence them. For example, caregivers sometimes indicated they spent time caring for 
their relative 24 hours per day, 7 days per week, and at the same time spent 24 hours 
each day on household tasks, which is of course impossible. It is difficult to exclude 
this element of subjectivity from the self reports. Diaries may provide an alternative, but 
this requires much more commitment and compliance from already highly burdened 
people.
Economic analysis: 
perspectives and assumptions
The perspective of the health care system instead of the wider and more time-elaborate 
societal perspective was judged to be acceptable, because the effect of our intervention 
on patients’ and caregivers’ productivity were judged to be negligible. We focused on all 
cost drivers relevant for the viewpoint taken, this meant that medication, laboratory and 
diagnostics costs were not taken into account, because the influence of our intervention 
on these cost parameters was judged to be negligible as well. 
Comparison with other studies
Patient effects: 
were our results clinically relevant?
The beneficial effects on disability and mental well-being represent a 5 and 10% better 
performance compared to control conditions, respectively. When comparing these results 
with the available literature we conclude that our results are of clinical relevance. Our 
results indicate that it is possible to prevent deterioration of functional skills for about 
three months and to improve well-being for at least half a year with a fairly simple home-
based intervention for frail older patients. Nevertheless, the interpretation of study results 
in terms of clinical relevance is a very difficult issue if results are not overwhelmingly 
large.
The most recent meta-analysis of comprehensive geriatric assessment (CGA) showed 
benefits for Home Assessment Services on mortality, living at home, and on hospital 
admission, and for Outpatient Assessment Services on living at home. However, 
both showed no benefits for physical functioning 8. The two recent meta-analyses on 
preventive home visits found beneficial yet non-significant, and not clinically relevant 
improvements in functional status 9, 10, and the standardised effect size 11 was around 
0.05 10. The large MRC trial on population-based multidimensional assessment of older 
people in the UK found hardly any clinically relevant positive quality of life outcomes, 
but this may be related to the lack of a control group receiving no intervention in this 
trial 12. 
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The magnitude of our effects (approximately 5 to 10%) is in line with treatment 
effects on health-related quality of life of other positive studies incorporating a frail 
population. An evaluation of outpatient geriatric evaluation and management found 
favourable differences in SF-36 mental health and physical functioning scores of about 
five percent and two percent respectively at 12 months of follow-up 13. A trial with 
a model of integrated care and case management for frail older people living in the 
community found favourable differences of 18.1% in basic activities of daily living, 
6.9% in instrumental activities of daily living, and 6.8% in depression 14. A home based 
intervention programme for physically frail older people found approximately 13% 
improvement in disability at seven months follow-up 15. 
Further support for clinical relevance of our study results can be found if we recalculate 
our study results as standardised effect sizes (table 2). Then, we see that most outcome 
measures show beneficial effects above (and for the primary outcome even well above) 
the established threshold of 0.2 as the lowest threshold for a “minimally clinically 
important difference” 11. Despite this criterion being arbitrary, it has been used in 
earlier interpretations: the MRC trial utilised the same threshold as a cut-off for clinical 
relevance 12, 16. 
The recent LOTIS trial also used GARS as the primary outcome measure 17. They used 
GARS with four (GARS-4) instead of three (GARS-3) answer categories and only 13 out 
of 18 items 18, 19. This means that the score can range between 13 and 52. A difference 
of 3 points was taken to be the detectable difference in the sample size calculations, 
table 2 Standardisations of the observed difference: Cohen standardised effect 
size11 and the effect as a fraction of the score range
Observed difference 
(standardised effect 
size)*
Observed difference 
(fraction of score 
range)†
Groningen Activity Restriction Scale-3 3mths 0.40 0.06
Groningen Activity Restriction Scale-3 6mths 0.24 0.04
Medical Outcome Scale-20 subscale mental health 3mths 0.33 0.06
Medical Outcome Scale-20 subscale mental health 6mths 0.42 0.09
Dementia Quality of Life negative affect 3 mths 0.42 0.04
Dementia Quality of Life negative affect 6 mths 0.24 0.03
Dementia Quality of Life positive affect 3 mths 0.24 0.03
Cantril’s self anchoring ladder 3 mths 0.21 0.04
De Jong-Gierveld Loneliness scale 3 mths 0.04 0.01
Medical Outcome Scale-20 subscale physical functioning 
3 mths
0.21 0.04
Medical Outcome Scale-20 subscale role functioning 3 
mths
0.11 0.05
Timed Up and Go Test 3 mths 0.10 0.03
Mini Mental State examination 6 mths 0.14 0.02
* Cohen standardised effect size is calculated as treatment difference/standard deviation
† The fraction of score range is calculated by dividing the measure through the appropriate score range, for the Timed Up and 
Go test it was divided through 60 seconds (because Timed Up and Go test has no score range)
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assuming a standard deviation of 7.5. In terms of score range this difference is 8%. Our 
minimally detectable difference was substantially higher: 12,5%. Some other studies 
applied GARS, though these did not report the minimally detectable differences used 
20-22.
The comparison with other positive studies, the recalculations of our results as 
standardised effect sizes, and the comparison with other studies applying GARS, support 
our conviction that our results are of clinical relevance. However, as in most other studies, 
the results are not overwhelmingly large. In this situation, interpretation of the research 
results in terms of clinical relevance becomes a difficult and sometimes arbitrary matter. 
Frequent use of fewer instruments (to gain more experience with an instrument), input 
from workers in the field and considering the results in relation to patient and caregiver 
opinions is very important.
Caregiver effects
The effect of geriatric models aimed at the patient has not been consistently studied with 
regard to caregiver effects. The literature that is available suggests potential benefits for 
the caregivers 23-26. Our results suggest that potential benefits are possible, but that the 
effect of intervening at the level of the patient on caregiver burden is not the same for 
all caregivers. 
This observation probably relates to the heterogeneity among caregivers in our study. 
Caregivers who lived together with the patient were substantially more burdened, and 
seemed to benefit from this intervention, while caregivers living separately did not benefit. 
Our caregivers who shared a household were older, and more frequently men than the 
caregivers living separately. Other have suggested that the benefits of intervening relate 
to the gender of the caregiver, and that female caregivers sharing a household with the 
patient may benefit the most 27. 
Our observations require further evaluation in larger studies, but lend support to the 
assumption that caregiver characteristics are important. Not every caregiver is the 
same, and these characteristics determine the feeling of being burdened as well as the 
possibilities to deal with this. As society’s policies regarding population ageing increasing 
rely on informal care 28, this may have important public health consequences.
Selection procedure: 
targeting the right patient
The evidence suggests that efficacy of geriatric intervention models including community-
based models, probably benefits from targeting suitable patients 8, 9, 29, 30. Targeting has 
therefore been advocated as a means to improve programmes’ effectiveness by avoiding 
caring for patients unlikely to benefit 31, 32.
“Too ill” or “too healthy” are often heard characterisations of patients unlikely to benefit. 
The issue of appropriate targeting has more recently also been a matter of debate in 
relation to the introduction of Evercare in the UK 33. Evercare identifies patients as suitable 
for intervention based on their past admissions record 34. Population screening is another 
frequently used approach to targeting 35, but this is expensive and not easy to implement 
in daily practice. Generally speaking there is a broad spectrum of targeting approaches 
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from targeting on the basis of – predictive – personal characteristics measured with some 
sort of instrument (age, number and type of chronic diseases, sex, disability levels etc.) 
in a whole population to problem-based approaches to a large extent based on (implicit) 
clinical judgement. Different types of targeting often accompany different types of 
intervention. For example, a population screening approach is much more suitable for 
a programme of preventive home visits than for a geriatric evaluation and management 
unit. The targeting approach based on problems presented at a doctor and on clinical 
judgement is very close to everyday health practice. 
Another predictor of adverse outcomes is the presence of geriatric syndromes 36. To our 
knowledge, a geriatric intervention model with a problem-based type of patient selection 
has not been studied in a randomised way earlier. Our study adds an additional dimension 
to the debate on appropriate targeting by suggesting that specifically targeting frail older 
people with geriatric clinical syndromes can be an effective strategy.
Content of the intervention
The Dutch Geriatric Intervention Programme aimed to provide additional nursing 
assessment and nursing interventions. The intention of our model was that patients or 
caregivers clearly defined the main problem and goal of intervention in cooperation with 
their general practitioners in advance. The intervention would further focus on this aim. 
In practice, general practitioners often negotiated with their patients only a very loosely 
described aim. Therefore, the problem analysis also had a much wider perspective than 
only additional nursing assessment. As a consequence coordination of care also became 
a very prominent part of the interventions; fewer interventions focused, for instance, 
on psycho-education or therapy monitoring. More information on the content of our 
intervention model when used in practice is available in the thesis of van Eijken titled: 
“Strategies for improving community health care for the elderly 37”.
Future health care implications
Finding every patient: 
how to accomplish this, and do we really want to?
There is another, more fundamental issue lying underneath the discussion on effective 
targeting strategies. Williamson et al. pointed at this already long ago when they noticed 
that “most old people do not report their complaints to their doctors until the condition 
is advanced” 38. More than forty years and many health care system reforms later, this 
is still a major issue in geriatric care; why did we not recognise the problems of this 
patient at an earlier, more modifiable stage? Patient compliance is crucial to the success 
of screening based models to identify and handle unrecognised needs. Yet, it is often 
overlooked. Problem-based models have the commitment of the patient, but need to 
ensure that a considerable number of the potentially eligible patients are reached. 
Otherwise, there will be only individual, but not public health, benefits.
Often presented solutions to the problem of unmet needs are approaches based on 
population screening: identification of all persons using a systematic, more or less 
detailed screening method. Preventive home visits and health risk appraisal, and the 
annual health check by general practitioners in the UK are important examples 39-41. The 
advantages of screening are obvious: no one is missed because of its systematic nature 
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and it provides timely intervention if done on a regular base. There are disadvantages 
as well: screening is costly, often inefficient, and may mean medicalisation of old age, 
although this last aspect is not necessary only negative 42. The use of a previously defined 
set of standard criteria for diagnostic screening programmes 43, 44, reveals a crucial aspect 
that is often overlooked, and that is the aspect of patient adherence. Programmes can 
only be effective, if patients comply with the advice that results from them. In the more 
traditional fields of screening this may not be a problem: if a person is confronted with 
the diagnosis of cancer, this person is easily motivated to accept therapy. However, this 
can be different in our field of care; corrections of vision, hearing, or risks in the living 
environment do not carry the same absolute necessity as the treatment of a cancer. One 
can find several examples in literature, where patient non-compliance is suggested as an 
explanation for a negative study result 17, 45. In another example – a randomised study of 
preventive screening for disorders among older people – an intervention was effectively 
started in less than half of the newly diagnosed disorders 46. As a consequence, in order 
to succeed, time and effort has to be spent on seeking the commitment of the persons 
targeted. Many preventive health care programmes too easily take patient adherence for 
granted.
The problem of non-compliance may be dealt with, if we are able to identify persons who 
have that commitment. This can be done, for example, by intervening on conditions they 
(or their doctors) experience as a problem. This characteristic of intervention – solicited 
versus unsolicited – might be an important determinant of successful intervention. 
Our study is an example of the solicited approach. Despite the warning comments of 
Williamson et al. 38, we have shown that problem-based solicited intervention does not 
come too late. It may in fact be better timed, and has the commitment of both the general 
practitioner and the patient, and may therefore be more effective. 
However, some caution is needed when interpreting our results in terms of potential 
benefits for public health. The intervention showed benefits for the individual, but can it 
also improve the health of the population of older people as a whole? Important in this 
discussion are the generally low numbers of patients general practitioners recruited for 
this study. Especially if the general practitioner overlooks a lot of potentially treatable 
persons, this would be a fundamental barrier for being of help to all – not just a few – 
older people. Our study does not provide the exact figures, but general practitioners 
seemed to be selective. We do not know whether this was intentional and based on 
valid arguments or because problems were unknown to them. Maybe, the results of 
a recent study on screening for disorders of older people by general practitioners are 
an indication that the latter is not such a problem: less than half of the disorders found 
on screening were regarded as new information by the general practitioners 46. The 
intervention may also have been withheld from a patient for the wrong reasons, e.g. 
because of too pessimistic views on possible benefits. However, the general practitioners 
were able to select patients eligible for the intervention, not many of the patients who 
were discussed with the geriatricians for referral were rejected as inappropriate.
What next steps can be taken? We should make sure that screening based methods 
are reserved for disorders that satisfy the conditions identified for the conduct of an 
effective preventive screening programme, including the assurance of a sufficient 
level of compliance. In problem-based approaches we must ensure that all potential 
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beneficiaries are offered the opportunity to be treated. Here, there is also an important 
role for the responsible primary care professional. They need to have a sensitive and 
proactive attitude towards older patients’ health disorders. 
Integration versus fragmentation
If one wants to put the scientific knowledge from this study into practice, how should 
this be accomplished? Which type of nurses should participate and where should they 
be stationed? One of the criticisms which might be levelled against our model is that it 
leads to further fragmentation, whereas integration is highly needed. This model offers 
integration if general practitioners and nurses share responsibility for coordination of 
care for vulnerable older people. Unfortunately, in many models piloted throughout the 
Netherlands the role of general practitioners is less prominent than desirable.  
In this project a specialist geriatric nurse based at a hospital conducted the home 
visits. If this model were to be introduced into primary care in exactly the same way, 
the criticism of creating more fragmentation might be justified. However, a study has 
other requirements than regular practice, such as the need for full accessibility of the 
participating professionals for data acquisition and uniform reporting. This was one of 
the reasons for assigning hospital nurses to do the home visits in this research project. 
Of course, implementation of this type of intervention in usual primary care needs 
translation and tailoring to that practical situation. Knowledge translation projects 
probably are an important vehicle to do this 47. Knowledge translation “is defined as the 
exchange, synthesis and ethically sound application of knowledge – within a complex 
system of interactions among researchers and users – to accelerate the capture of the 
benefits of research through improved health, more effective services and products, and 
a strengthened health care system.” The EASYcare/GIDS project is an example of how 
the knowledge generated by the Dutch EASYcare Study can be implemented in dementia 
care in general practice 48.
Although hospital nurses conducted the home visits in this study, primary care nurses 
(home care nurses, or practice nurses) might be the ideal professionals to carry out this 
intervention. In that situation, specialist geriatric nurses and geriatricians are experts who 
can provide teaching of primary care professionals and are available for consultation, a 
model which is very close to the so-called Quattromodel49. 
Preferably, we would entrust home care nurses (based in a locally organised home care 
service) and general practitioners (based in the general practice or primary care trust 
serving the same community) with the prime responsibility for geriatric primary care. 
Both are in a natural position to coordinate care of people with many co-morbidities 50, 
51, and their activities are very much complementary in the care for older people. This 
would mean true integration and multidisciplinary care. However, it will require some 
fundamental choices in the organisation of health care to achieve this in the Netherlands. 
In the Netherlands, one-on-one cooperation between the general practitioner and home 
care nurse was lost in the increase in scale of home care organisations 52. Though this 
probably happened unintentionally, we must to admit that this was a mistake and that 
one-on-one cooperation needs to be re-established. 
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Also, we should admit that – although the disease-centred approach of our health 
care system has been and still is very successful in fairly fit, independent, assertive, 
(cognitively) healthy adults experiencing one single problem – it can be a disaster for 
the vulnerable, cognitively impaired (older) adult with co-morbidity 53. Vulnerable older 
people require a more holistic approach.
A necessary cautionary comment should be added about the general practitioner. An 
inventory by Van der Linden showed that home care organisations, hospitals and nursing 
homes have a more prominent role in transmural care projects than general practitioners 
54. Experiences with the Landelijk Dementie Programma (LDP; National Dementia 
Programme for the Netherlands for the improvement of dementia care in the Netherlands) 
55 are divergent, but generally confirm this picture. Overall, the participation of general 
practitioners in the projects from LDP is smaller than hoped for. We think that in the 
Netherlands general practitioners’ position in care networks is much less prominent than 
expected on the basis of their central position in primary care. Moreover, their voice in 
the debate on geriatric primary care is missed. A systematic analysis of the causes of 
the relative absence of the general practitioner (increasing work loads, time restraints, 
budgeting cuts, lack of organisation, lack of expertise, reluctance, wrong beliefs about 
possibilities, etc.) is needed, but beyond the scope of this thesis. 
The current solution for these shortcomings in our health care system is to fix them 
with rather ad-hoc and uncoordinated initiatives like the introduction of practice nurses 
specialised in geriatrics or outreaching activities by nursing home physicians. However, 
a structural solution requires us to make more radical choices. (Re)establishing the close 
collaboration of home care nurse and general practitioner should be at the core of this 
solution. Some promising steps along this path have already been taken 56. General 
practice is challenged to seriously invest in geriatric primary care, and make this a 
prominent issue, otherwise their position in an important and increasing area of health 
care is marginalised at the expense of further fragmentation of care.
Implications for future research
Future research should focus on the following subjects:
Translation of these study results into clinical practice. How do we implement this •	
knowledge?
Replication of these study results in larger studies to determine which programme •	
characteristics are effective. As the models implemented in clinical practice have 
to satisfy local conditions, it will be difficult to introduce uniform models on wide 
scale. If we know which elements are effective, we can build tailored models using 
these blocks.
Further investigation is required into the role of different caregiver characteristics •	
on caregiver burden, on the effect of intervention at a patient level on caregiver 
burden, as well as their influence on the outcome of interventions to decrease the 
burden of caring.
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There is a need for effective geriatric primary care because vulnerable older people will 
increasingly live independently. Unfortunately, the studies on the effectiveness of geriatric 
primary care models such as geriatric evaluation and management, preventive home visits, and 
intermediate care have given conflicting results. The Dutch Geriatric Intervention Programme is 
a nurse-led, multidisciplinary programme of house calls for vulnerable older people. This study 
evaluates aspects of feasibility, effectiveness and cost-effectiveness of this type of health care for 
vulnerable older people. 
Chapter 1 describes the context against which this thesis is set. The chapter describes 
how vulnerable older people are in need of special attention and why there is the need 
for a major reform of health care for older adults. From literature we conclude that the 
effectiveness of different intervention models for vulnerable older people has not been 
convincingly shown. 
Moreover, effective methods are needed to study the effects of different types of health 
care for vulnerable older people. Certain methodological problems are important 
in the context of our study: problems related to studying older people such as high 
attrition rates, study subjects heterogeneity, and problems related to the selection of 
the best outcome measures. Other problems are related to studying a primary care 
population and studying complex interventions. A crucial problem related to studying 
complex interventions is that very often their evaluation cannot be done blind. As a 
result contamination bias and selection bias may occur. In our study, both contamination 
and selection bias threatened to harm its valid conduct when the regularly available 
randomisation methods for individual and cluster randomisation were used. Pseudo 
cluster randomisation was developed to deal with this dilemma.
Chapter 2 applies the example of intermediate care to discuss disagreeing definitions 
and how this hampers scientific appraisal of the available knowledge. As there is little 
scientific evidence on the benefits of intermediate care, research is especially important. 
A prerequisite for research is agreement on the definition of a concept, which is lacking 
for intermediate care. Commonly used definitions of intermediate care do not help much, 
because several very different definitions are in use. What is needed at the outset is a 
consensus on what constitutes intermediate care. The aim of this debate should not be to 
arrive at a uniform definition of intermediate care, for our inventory on the definitions of 
intermediate care shows that it is impossible to define intermediate care unequivocally 
at the highest conceptual level. For reasons of simplicity, this debate should be limited to 
defining intermediate care for the purpose of scientific appraisal. For the time being we 
believe that intermediate care models can be best classified according to their objectives 
of care and not by their names.
Chapter 3 is a detailed description of the design of our main study. The background 
section identifies elements from the different models available in literature that may 
be related to increased effectiveness. Such elements are: a multidisciplinary approach, 
longer and more intensive follow up, clinical control over the implementation of 
recommendations, and involvement of primary care providers. It further points at the 
debate on participation selection: should populations be selected or unselected, older 
or younger, healthy or vulnerable? In the methods section, the principles of the Dutch 
Geriatric Intervention Programme are described. The Dutch Geriatric Intervention 
Programme used a problem-based selection performed by the general practitioner rather 
summary 123
than population screening to identify patients eligible for participation. The problems 
targeted concerned cognition, nutrition, behaviour, mood, or mobility, and had to require 
nursing assessment, coordination of care, monitoring of therapy, or case management. 
Up to six visits by a specialist geriatric nurse for additional geriatric evaluation and 
management were planned within a three months period. The nurse conducted the main 
part of the intervention. The general practitioners continued their usual medical care 
and intervened in individual cases as agreed upon during interdisciplinary consultations 
with the nurse and geriatrician. The general practitioner kept prime responsibility for 
the care the patient and made the final decisions. We developed guidelines for each of 
the five presenting health problems to structure activities, without losing flexibility in 
tailoring individual interventions.
The chapters 4 and 5 discuss pseudo cluster randomisation: chapter 4 describes 
the method, and chapter 5 the results of an evaluation of the performance when we 
used pseudo cluster randomisation in the Dutch EASYcare Study. Pseudo cluster 
randomisation was used because individual randomisation risked contamination and 
cluster randomisation risked selection bias due to expected treatment preferences 
of participating general practitioners. Pseudo cluster randomisation is a two-stage 
randomisation procedure that first randomises general practitioners in two groups (H 
and L). Then, patients of one general practitioner are randomised in majority to the 
intervention (intervention:control = 80:20) or to the control arm (intervention:control 
= 20:80). Selection bias and enrolment problems in the control groups are prevented 
because patients are randomised individually. Contamination occurs less because 
exposure to the intervention treatment is concentrated in a group of physicians recruiting 
almost exclusively participants who will be included in the intervention group (like 
cluster randomisation). While the assumptions underlying pseudo cluster randomisation 
sound reasonable, they need empirical evaluation. Part of this evaluation could be 
done using data from the Dutch EASYcare Study. This evaluation showed that general 
practitioners had strong treatment preferences which would have affected recruitment if 
cluster randomisation had been applied. There were some indications for the presence 
of contamination in case individual randomisation had been used: 65% of general 
practitioners who recruited more than one patient for our study and had patients in 
the intervention group stated that they had used elements of the intervention in the 
treatment of control participants. 
After the recruitment period ended, a large majority of general practitioners estimated 
that equal numbers were allocated to both treatment arms, and if general practitioners 
estimated asymmetric randomisation ratios they tended to be more uncertain. We 
conclude that for cluster sizes of up to ten, asymmetrical randomisation in a 20:80 (= 
ratio intervention:control) or 80:20 did not lead to predictability of the randomisation 
sequence. The baseline characteristics of the study arms were highly comparable in 
the Dutch EASYcare Study. This gives no indication of selection bias. The variation in 
the number of patients each physician included explained the unbalanced numbers 
of control and intervention group. Overall, there were no indications for enrolment 
rate differences between study arms. We conclude that – when properly used – pseudo 
cluster randomisation provides a good alternative if individual randomisation risks 
contamination and cluster randomisation risks differential recruitment.
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The chapters 6, 7, and 8 present the main findings of the Dutch EASYcare Study. 
The effects on the patient’s health-related quality of life, caregiver burden, and cost-
effectiveness are discussed in the different chapters. The Dutch EASYcare Study 
followed 151 patients (mean age 82 years, 75% women) and 110 caregivers (mean 
age 56 years, 73% women, 58% offspring caregiver) for six months. 85 patients (and 
61 caregivers) were randomised to the intervention programme, and 66 patients (and 
49 caregivers) received usual care. Participants were very vulnerable: they had a mean 
Mini Mental State Examination score of 22 and a co-morbidity score (CIRS-G) of 10.1; 
the latter score is comparable to that of patients admitted to the geriatric ward of the 
Radboud University Nijmegen Medical Centre. After three months, patient outcomes 
showed significant differences in favour of the new intervention. Functional abilities 
(GARS-3) improved 2.2 points (95% confidence interval: 0.3 to 4.2) and well-being 
(MOS-20 mental health) 5.8 points (0.1 to 11.4). After six months the favourable effect 
increased for well-being (9.1 (2.4 to 15.9)), but the effect on functional abilities was 
no longer significant (1.6 (-0.7 to 3.9)). DGIP survival at two years was higher (82% 
versus 73%), although statistical significance was not reached (Log-Rank test p=0.40). 
Overall, perceived caregiver burden showed no significant differences over time; at 
three months this difference was -0.67 (-4.0 to 2.7), and 2.29 (-1.6 to 6.2) at six months. 
However, perceived burden was at baseline more than eight points higher in caregivers 
sharing a household with patients (n = 23) compared to caregivers living separately (n 
= 87). The intervention performed convincingly better in caregivers living together with 
the patient than in caregivers living separately (p for interaction = 0.04). Possibly, this 
difference is explained by baseline differences in perceived burden of both subgroups: 
the intervention decreased caregiver burden in the most burdened group of caregivers.
The average cost of the intervention under study was 998 euros [95% CI 888 – 1108]. 
The increment in total costs resulting from the new intervention was little over 761 euros 
[-3336 – 4687]. Hospitalisation and institutionalisation cost less; home care, adult day 
care, and meals-on-wheels costs were higher. To obtain an interpretable effect measure, 
we considered the treatment a success if a patient’s MOS-20MH score increased more 
than 10 points and the GARS-3 score declined no more than 4.5 points. We used this 
responder definition because the course of GARS-3 scores showed a decline in our 
control group, while fairly steady MOS-20MH scores were observed over a six months 
period. Relative to the score range, both cut-offs represent approximately 10% change 
in score. There was a significant difference in the proportions of successful treatments of 
22.3% [4.3 – 41.4]. The number-needed-to-treat was approximately 5 [2.3 – 18.0]. The 
incremental cost-effectiveness ratio is 3418 euros per successful treatment [-21458 – 
45362]. The new treatment is cost-effective at a willingness-to-pay of 34000 euros.
The final chapter 9 summarises the results and puts them in a broader methodological, 
scientific, and societal context. We conclude that problem-based nursing care effectively 
supported primary health care for vulnerable older people, and did so at reasonable 
cost. 
Despite the careful design of this study, several methodological aspects deserve 
consideration. The most important are the validity of the application of pseudo cluster 
randomisation – an issue that has already been addressed in this summary – and 
the effect of attrition. To study the effect of attrition on the outcomes, we performed 
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a sensitivity analysis assigning the “mean of the other group” to the missing values, 
which is a conservative method. The results of the sensitivity analyses showed the same 
picture as the primary analyses. A drawback is that imputing the mean of the competing 
group seems rather irrational from a clinical point of view. However, the use of other 
strategies like “last-observation-carried-forward” or multiple imputation have stronger 
disadvantages.
An important issue concerns the clinical relevance of these results. The introduction of 
this thesis already pointed at the difficulties involved in finding valid outcome measures 
that were applicable to a very diverse, yet very frail, population of older adults, and 
were also well-known. This also complicates the interpretation of study results in terms 
of clinical relevance, especially if the results are not overwhelmingly large. There were 
beneficial effects on patients’ disability (5% better performance) and mental well-being 
(10% better performance). When comparing these results with the available literature 
we conclude that our results are in the same range as benefits that were judged to be of 
clinical relevance previously. 
Popular targeting strategies which have been used in the past are population screening 
and selection, or targeting patients who have been hospitalised previously. Our study 
adds an additional dimension to the debate on appropriate targeting by suggesting 
that specifically targeting frail older people with incident geriatric clinical syndromes can 
be an effective strategy. However, it is important to remember that problem-based 
models need to ensure that a considerable number of the potentially eligible patients are 
reached. Otherwise, there will be only individual, but not public health benefits. 
If one wants to put the scientific content of this study into practice, how should this be 
accomplished? Which type of nurses should participate in this model and where should 
they be stationed? One of the criticisms which might be levelled against our model is 
that it leads to further fragmentation, whereas integration is highly needed. This model 
offers integration if general practitioners and nurses share responsibility for coordination 
of care for vulnerable older people. Unfortunately, in many models piloted throughout 
the Netherlands, the role of general practitioners is less prominent than desirable. This 
needs improvement. Everyone should be convinced of the importance of the general 
practitioner – as the gatekeeper to our health care system – in the care of community-
dwelling older people, certainly when these older people are vulnerable.

Samenvatting
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Kwetsbare ouderen zullen in de toekomst meer nog dan nu al het geval is zelfstandig willen 
leven. Trouwens, de maatschappij verwacht het eigenlijk ook van ze, want actieve deelname 
aan het maatschappelijke leven door zoveel mogelijk ouderen wordt gepresenteerd als een 
belangrijke oplossing voor het probleem van de vergrijzing. Om dit te bereiken is er veel behoefte 
aan goede en zo nodig gespecialiseerde zorg voor kwetsbare ouderen dicht bij huis. Er wordt 
dan ook door veel mensen gezocht naar de beste manieren om kwetsbare ouderen die zorg te 
bieden, want dat de huidige (ziektegerichte)  zorg niet zondermeer aan de vereisten voldoet 
is al lang geen verrassing meer. Helaas is het juiste recept voor zorg voor kwetsbare ouderen 
die zelfstandig wonen nog niet gevonden. Er wordt nagedacht over bijvoorbeeld preventieve 
huisbezoeken of consultatiebureaus voor ouderen, maar de resultaten van het onderzoek 
naar de waarde ervan leveren een tegenstrijdig beeld op. Het zogenaamde Dutch Geriatric 
Intervention Programme (Nederlands Geriatrisch InterventieProgramma) is een model waarin 
huisartsen een gespecialiseerde verpleegkundige kunnen inschakelen in de zorg voor kwetsbare 
ouderen in hun praktijk. Dit proefschrift, waarin de resultaten van de Dutch EASYcare Study 
worden beschreven, laat zien dat deze nieuwe vorm van zorg voor kwetsbare ouderen ertoe 
bijdraagt dat het welzijn van de ouderen verbetert en hun zelfredzaamheid behouden blijft. 
Bovendien blijkt de nieuwe zorg kosteneffectief (“het product biedt waar voor zijn geld”). 
Om de meerwaarde van de verpleegkundige huisbezoeken betrouwbaar te kunnen 
beoordelen, zijn in de Dutch EASYcare Study twee groepen met elkaar vergeleken. 
De helft van de deelnemende ouderen werd wel door de verpleegkundige bezocht 
en de andere helft niet. Die beide groepen moeten natuurlijk goed vergelijkbaar zijn 
om een eerlijke vergelijking te kunnen maken. Daarvoor worden de deelnemers door 
randomisatie (loting) verdeeld over de groepen. Met de bestaande randomisatiemethoden 
was het echter niet goed mogelijk om tot een eerlijke verdeling van de deelnemers 
over de groepen te komen. Daarom ontwikkelden we een nieuwe methode om 
proefpersonen aan onderzoeksgroepen toe te wijzen. Deze nieuwe methode heet 
pseudoclusterrandomisatie. Wanneer en hoe deze nieuwe randomisatiemethode kan 
worden gebruikt en of de methode ook voldoet aan de verwachtingen is het tweede 
belangrijke onderdeel van dit proefschrift.
Appels met peren vergelijken is vaak een hachelijke zaak. Immers, appels en peren 
zijn niet vergelijkbaar. Evenzo is het in sommige gevallen onwenselijk dat appels en 
peren onder het mom “het is allemaal fruit” op een grote hoop geschoven worden. 
Hetzelfde geldt in wetenschappelijk onderzoek. Vergelijken is belangrijk, maar dan moet 
wel duidelijk zijn waar we precies over spreken. Goede definities van de zorgvormen 
die aan bod komen is dus van groot belang. Aan de hand van het voorbeeld van de 
zogenaamde Intermediate care modellen – dit zijn nieuwe zorgvormen die tussen de 
eerstelijns zorg en de ziekenhuiszorg in staan – laat hoofdstuk 2 zien dat het vaak 
ontbreekt aan heldere definities over wat we precies onder een bepaalde zorgvorm 
verstaan. Er bestaan heel veel verschillende definities van het begrip Intermediate care. 
Dit alles maakt de discussie over de meerwaarde van dit veelbelovende type zorg erg 
moeizaam. Om toch een zinnige wetenschappelijke discussie te kunnen voeren stellen 
we voor om zorgvormen vooral te vergelijken aan de hand van het doel dat ze voor ogen 
hebben en minder aan de hand van hun naam.
Een belangrijk thema dat in hoofdstuk 3 aangesneden wordt is de vraag hoe te voorkomen 
dat de groeiende groep kwetsbare ouderen door de mazen van het zorgstelsel heen 
valt, zoals dat nu soms wel gebeurt. De grofweg meest voorgestelde oplossing is om 
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heel systematisch alle ouderen op de aanwezigheid van kwetsbaarheid en nog niet 
behandelde problemen en ziekten te screenen. Voor gevonden problemen wordt 
vervolgens een oplossing gezocht. Hoewel dit heel aantrekkelijk lijkt, wordt duidelijk 
dat deze aanpak nog veel haken en ogen kent: moeten echt alle ouderen gescreend 
worden of kan beter een selectie gemaakt worden? Welke selectie moet dat dan zijn? 
Moeten dat nog relatief gezonde ouderen zijn, of moeten het juist meer kwetsbare 
ouderen zijn? Verder beschrijft hoofdstuk 3 de opzet van de studie en het model van 
verpleegkundige huisbezoeken dat onderzocht werd. Een belangrijk verschil tussen het 
door ons gebruikte model van verpleegkundige huisbezoeken en andere modellen is 
dat wij ervoor gekozen hebben om de huisarts de huisbezoeken te laten opstarten. De 
huisarts startte de huisbezoeken op het moment dat sprake was van belangrijke problemen 
zoals geheugenproblemen, sombere stemming of vallen. Het grote voordeel van deze 
aanpak is dat de verpleegkundige komt op het moment dat er iets aan de hand is. Andere 
belangrijke voordelen zijn dat de huisarts, de patiënt en de familie gemotiveerd zijn om 
voor de problemen een oplossing te zoeken. Een nadeel is dat mensen die niet met hun 
problemen bij de huisarts komen op deze manier niet geholpen kunnen worden.
De methode van pseudoclusterrandomisatie wordt besproken in de hoofdstukken 4 en 
5. In hoofdstuk 4 wordt de methode uitgelegd en in hoofdstuk 5 wordt beschreven of 
de methode naar behoren werkt. Voorzover te beoordelen blijkt dat het geval te zijn. 
De pseudoclusterrandomisatie methode kan gebruikt worden wanneer het gebruik van 
clusterrandomisatie tot onvergelijkbare groepen leidt en het gebruik van individuele 
randomisatie juist tot contaminatie. Contaminatie zou in de situatie van randomisatie 
van individuele patiënten (individuele randomisatie) waarschijnlijk optreden, omdat de 
huisarts met de verpleegkundige samenwerkte in de uitvoering van de huisbezoeken. 
Het is dan niet uit te sluiten dat de huisarts elementen van de huisbezoeken ook zou 
gaan gebruiken bij deelnemers waarbij de huisarts juist op de oude voet door moet 
gaan. Onvergelijkbaarheid zou juist ontstaan als we huisartsen met al hun deelnemende 
patiënten zouden randomiseren (clusterrandomisatie), hetgeen de gangbare oplossing is 
om contaminatie te beperken. Dit zou kunnen optreden, omdat de huisarts wist of zijn 
patiënten wel of niet door de verpleegkundige bezocht zouden worden. Die kennis kon 
de keuze van deelnemers door de huisarts verschillend beïnvloeden, omdat niet alle 
deelnemers op hetzelfde moment geïncludeerd werden.
De belangrijkste resultaten van de Dutch EASYcare Study staan in de hoofdstukken 
6, 7 en 8. Er zijn 151 deelnemers die – naar verwachting – erg kwetsbaar waren zes 
maanden gevolgd: 85 deelnemers werden bezocht door een verpleegkundige en bij 66 
deelnemers ging de huisarts op de oude voet verder. 
Na drie maanden was het behandeleffect voor zelfredzaamheid 2,2 punten [95% BI 
0,3–4,2] en voor welbevinden 5,8 punten [0,1–11,4] ten voordele van de nieuwe 
interventie. Na zes maanden bleven de verschillen bestaan (zelfredzaamheid 1,6 [-0,7–
3,9]; welbevinden 9,1 [2,4–15,9]), alleen voor zelfredzaamheid niet langer significant. 
Gemiddeld veranderde de mantelzorgerbelasting van de 110 (niet bij iedere deelnemer 
was een mantelzorger aanwezig) deelnemende mantelzorgers niet significant. Er was 
echter een significante interactie tussen behandeling en woonsituatie van deelnemer en 
mantelzorger (p=0,04): mantelzorgers die met de patiënt samenwoonden leken door de 
huisbezoeken minder belasting te ervaren dan mantelzorgers in de controlegroep die 
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samenwoonden, terwijl mantelzorgers die apart woonden mogelijk een verslechtering 
van de belasting ervoeren ten gevolge van de huisbezoeken. 
De verpleegkundige huisbezoeken kostten ongeveer 1000 euro per deelnemer. De 
totale zorgkosten gedurende zes maanden waren ongeveer 750 euro hoger: zoals 
gehoopt werden minder kosten gemaakt voor ziekenhuisopname of opname in 
een verzorgings- of een verpleeghuis en kostten thuiszorg, deeltijdbehandeling en 
tafeltje-dek-je meer. De verpleegkundige huisbezoeken leverden 22 procent [4,3 – 
41,4] meer “succesvol” behandelde deelnemers op, de number-needed-to-treat was 
ongeveer 5 [2,3 – 18,0]. “Succesvol” behandeld waren die deelnemers bij wie de 
zelfredzaamheid niet achteruitging, terwijl het welbevinden verbeterde. De incrementele 
kosteneffectiviteitsratio bedroeg 3418 euro per extra succesvol behandelde deelnemer 
[-21458 – 45362].
Hoofdstuk 9 begint met de vaststelling dat dit type van verpleegkundige huisbezoeken 
een verbetering van de zorg voor kwetsbare thuiswonende ouderen kan betekenen en 
plaatst de resultaten in een breder kader. Het hoofdstuk gaat in op de wetenschappelijke 
beperkingen en maakt de vergelijking met eerder uitgevoerd wetenschappelijk 
onderzoek. 
De verpleegkundige huisbezoeken hadden een positief effect op zelfredzaamheid 
en psychisch welbevinden van kwetsbare ouderen dat ook aanwezig blijft als de 
verpleegkundige de zorg weer helemaal teruggeeft aan de huisarts. Dit lijken bescheiden 
effecten, maar ze zijn wetenschappelijk en klinisch relevant: het betreft een groep 
zeer kwetsbare ouderen bij wie bijkomende gebeurtenissen zoals een longontsteking 
eenvoudig een sterke en vaak blijvende achteruitgang in de kwaliteit van leven opleveren. 
GARS-3 meet 18 (I)ADL-items ([Instrumentele] Activiteiten van het Dagelijks Leven) op 
een 3-punts schaal: 1. zonder moeite zelfstandig, 2. met moeite, maar zelfstandig en 
3. niet zelfstandig. Twee punten verbetering betekent dus op twee van de 18 items een 
verbetering van “niet zelfstandig, score 3” naar “met moeite, maar zelfstandig, score 
2” of van “met moeite, maar zelfstandig, score 2” naar “zonder moeite zelfstandig, 
score 1”, of op één item van “niet zelfstandig, score 3” naar “zonder moeite zelfstandig, 
score 1”. In de praktijk betekent dit dat het mogelijk is de natuurlijke achteruitgang 
in zelfredzaamheid van deze kwetsbare ouderen voor tenminste drie maanden te 
voorkomen, zonder dat deze verbetering na stoppen van de huisbezoeken direct 
verloren gaat. Tegelijkertijd neemt het welbevinden ook op zes maanden vervolgens 
nog duidelijk toe. 
De studie maakt duidelijk dat het effect van de interventie op mantelzorgerbelasting afhangt 
van de leefsituatie van patiënt en mantelzorger. Het effect van het interventieprogramma 
op de mantelzorgerbelasting is aanmerkelijk beter voor mantelzorgers die samenwonen 
met de patiënt. Deze groep ervaart overigens ook duidelijk meer belasting dan de 
mantelzorgers die gescheiden wonen. Het mogelijk negatieve effect op mantelzorgers 
die niet samenwonen met de patiënt wordt wellicht verklaard door het feit dat deze 
interventie juist een verhoogd beroep op de hen doet. 
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Een andere verklaring kan zijn dat zij zich – doordat zij daarmee door de interventie 
geconfronteerd werden – meer bewust werden van de kwetsbaarheid en beperkingen 
van hun naaste. Gezien de toenemende nadruk die ook in het Nederlandse zorgstelsel 
gelegd wordt op mantelzorg, is dit een resultaat dat verder onderzocht moeten worden. 
Een belangrijke vraag is uiteraard hoe de resultaten van dit onderzoek in de praktijk 
gebracht kunnen worden. We denken bijvoorbeeld aan uitvoering van de verpleegkundige 
huisbezoeken door de wijk- of de praktijkverpleegkundige in samenwerking met de 
huisarts. Op die manier kom je ook tegemoet aan het mogelijke commentaar dat dit 
alleen maar tot verdere fragmentatie van de zorg voor kwetsbare ouderen leidt. Daarvoor 
moeten huisartsen zich wel actiever en zichtbaarder met de zorg voor kwetsbare ouderen 
gaan bemoeien, in de praktijk van alledag, maar ook bij het nadenken over de inrichting 
van de zorg. Het belang van de huisarts in de zorg voor ouderen is groot, eerst en vooral 
als het om kwetsbare ouderen gaat.
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Dank jullie wel
Jaren heb ik naar dit moment toe gewerkt en dan is het voor mijn gevoel toch nog 
plotseling zover dat ik mijn werk, ons werk voor iedereen mag verdedigen en aan 
iedereen mag laten zien waaraan ik met zovelen gewerkt heb. Het is dan ook eerst 
en vooral een gevoel van trots waarmee ik naar de verdediging toeleef. Tegelijkertijd 
is er ook nu weer een gevoel van onzekerheid en de mensen die mij kennen zullen 
begrijpen wat ik bedoel. Dit zal ongetwijfeld nog de nodige zenuwen opleveren, maar 
ook daaraan zal ik het hoofd wel weten te bieden. Niet in de laatste plaats juist met 
dank aan jullie. 
Zoals ieder project kent ook dit project een “eigenaar”, zoals dat naar goed 
marketinggebruik heet. Ik noem dat met opzet, want ik ken weinig onderzoekers die 
zo goed aanvoelen wat de maatschappij van onderzoekers verwacht en dat weten te 
vertalen in goed wetenschappelijk onderzoek. Ik ben mijn eerste promotor, professor 
Marcel Olde Rikkert, erg dankbaar dat hij mij vroeg en dat hij mij steeds de ruimte heeft 
gegeven om het onderzoek op mijn manier uit te voeren, ook als hij mijn werkwijze 
misschien wat al te grondig vond. Beste Marcel, dank je wel voor je vertrouwen in mij 
en voor de mogelijkheden die je mij biedt om me steeds verder te ontwikkelen. Toen 
ik besloot mijn koers te wijzigen en mij vooral te richten op een wetenschappelijke 
carrière in plaats van onderzoek en patiëntenzorg te combineren, was dat misschien 
niet wat jij voor mij voor ogen had, maar in plaats van me te bedanken voor betoonde 
diensten en me voor het overige het allerbeste te wensen, zag jij de mogelijkheden van 
mijn betrokkenheid als onderzoeker binnen jouw afdeling. 
Mijn tweede promotor is professor Theo van Achterberg en hij stond gedurende mijn 
promotie weliswaar wat meer op de achtergrond, maar hij speelde absoluut niet de 
tweede viool. Beste Theo, ik waardeer je vooral om je heldere analyses die de discussie 
over mijn werk regelmatig een cruciale wending in de goede richting gaven. Dank je 
wel daarvoor. Bij de opzet van de studie zag ik een groot methodologisch dilemma 
en niet alleen hielp mijn co-promotor dr. George Borm mij daar betrokkenen die 
het probleem niet zo zagen van overtuigen, hij voorzag het probleem ook van een 
oplossing. En dat, George, kenmerkt je voor mij het beste: als iemand die problemen 
van onderzoekers op liefst zo simpele wijze van een oplossing voorziet. Keep it simple! 
George, dank. De multidisciplinaire aanpak die in de verpleegkundige huisbezoeken 
centraal stond weerspiegelde zich ook in de multidisciplinaire samenstelling van de 
groep die deze huisbezoeken geëvalueerd heeft. Daarin was dr. Eloy van de Lisdonk het 
huisartsgeneeskundig geweten. Beste Eloy, dank je wel voor inbreng. Ik ben blij dat ik 
jou als co-promotor vanuit de huisartsgeneeskunde naast me heb staan.
Mijn sparring partner vanuit de Verpleegwetenschappen in dit project was dr. Monique 
van Eijken. Samen met Monique heb ik dit project mogen uitbouwen tot de succesvolle 
studie die zij – denk ik – geworden is. Dat hebben we met veel plezier gedaan. Monique, 
wij verschillen op sommige punten ontzettend van elkaar, maar niet in onze liefde voor 
de oudere mens. Getty Huisman werd gevraagd om even bij te springen om Monique’s 
zwangerschapsverlof op te vangen. Het werd duidelijk heel wat meer dan dat. Getty, 
dank je wel. Andere collega’s van de verplegingswetenschap, dank je wel voor jullie 
belangstelling voor en meeleven met het onderzoekswerk van Monique en mijzelf.
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Met niemand heb ik zo intensief over methoden kunnen overleggen als met dr. Steven 
Teerenstra en volgens mij kan niemand zo precies wiskunde vertalen naar de dagelijkse 
(onderzoeks)praktijk. Beste Steven, dank je voor al je deskundige geduld met een 
statistische leek.
En dan het onderzoeksobject zelf… want dat waren Hanny Hordijk en Marleen Lenkens: 
de interventie bestond feitelijk uit twee verpleegkundigen waarvan de werkzaamheid 
wetenschappelijk getoetst werd. Maar zij waren natuurlijk veel meer. Beste Hanny en 
Marleen, het was voor jullie even wennen, zo’n rol in wetenschappelijk onderzoek, 
waarbij varen op je verpleegkundige intuïtie en expertise alleen niet mocht, maar 
waarbij je je ook steeds moest afvragen of het de wetenschappelijke evaluatie niet in 
weg stond. Mede dankzij jullie expertise kon het project slagen. Het resultaat mag er 
wezen: jullie zijn twee van de weinige verpleegkundigen die echt kunnen zeggen dat 
zij wetenschappelijk bewezen effectief werken! Als dat geen “evidence based nursing” 
is. Dank jullie wel.
Many other contributors to the Dutch EASYcare Study deserve to be acknowledged: 
professor Stuart Parker who helped me so much understanding the complexity of geriatric 
health care, and dr. Anders Wimo who contributed to the economic paper. Verder wil 
ik noemen dr. Eddy Adang die me de beginselen van het gezondheidseconomisch 
onderzoek heeft bijgebracht en sinds wiens begeleiding ik weet wat een “stochast” is. 
Dr. Michel Wensing, professor Myrra Vernooij, Hans Bor, Henk van den Hoogen en Hans 
Wolters voor de inbreng van hun expertise en constructieve kritiek. Niet te vergeten zijn 
de studenten die me als wetenschappelijk stagiaire of studentassistent geholpen hebben: 
Mebeline Boon, Dagmar Oude Lansink, Dagmar Klaassen, Mirjam Louws en Sonja 
Vliek. Op deze plek wil ik als laatste professor Willibrord Hoefnagels nog noemen; hij 
stak me aan met het geriatrische virus en daar ben ik nog altijd blij om.
De “onderzoekerskamer” – waar ik veel van mijn tijd gesleten heb – heeft op vele plekken 
gezeten en even zovele bewoners gekend. Daarmee wisselde de atmosfeer, maar nooit 
de collegialiteit of de stress van een deadline. Toen ik de kamer deelde met Jaap Remmen, 
Lilian Vloet, Willy Colier en Anja Bos was de beroering soms groot; ging het niet om het 
indienen van een artikel, dan ging het wel over opvoedperikelen of politiek. Ook latere 
kamergenoten trokken in en weer uit: Anke Persoon, Lia Middeljans-Tijssen en Jurgen 
Claassen en dat zijn ze nog vast niet allemaal. Met Arenda van Beek, Miriam Reelick, 
Miriam Faes en Marieke Perry is de sfeer tegenwoordig weer studentikoos en uitgelaten 
op de – ondertussen – twee onderzoekerskamers. De diversiteit van de “bewoners” blijft 
ondertussen groot: Leny Theunisse, Jan Oudenes, sinds kort ook Els Meeuwsen en nog 
een hoop min of meer tijdelijke verblijvers. Dank jullie allemaal voor jullie hulp, steun 
en gezelligheid. Eén collega onderzoeker verdient het om apart genoemd te worden en 
dat is dr. Marianne van Iersel, want veel van mijn ervaringen deel ik met haar. Ik vind het 
jammer dat het uitwisselen van de gedoetjes van alledag nu niet meer zo gemakkelijk is, 
als toen we nog samen op de “onderzoekskamer” zaten. Lieve Marianne, dank je wel. 
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De klinisch geriaters, arts-assistenten, verpleegkundigen en alle andere 
afdelingsmedewerkers dank ik voor hun belangstelling en meedenken. Het belang van 
de betrokkenheid van jullie bij het wetenschappelijk onderzoek is groot: als uitvoerders 
van onderzoek, als leveranciers van deelnemers, als afnemers van de resultaten, maar 
vooral ook voor het genereren van vraagstellingen en onderzoeksideeën. Alleen dan 
gebeurt er onderzoek waarop de “kliniek” zit te wachten. 
In onderzoek moeten vaak vele praktische zaken gedaan worden, daarbij kon ik steeds 
weer rekenen op de hulp van Gemma, Cynthia en de andere secretariaatsmedewerkers. 
Voor de laatste loodjes kon ik gelukkig ook rekenen op de hulp van Lian van Druenen 
die ondanks alle drukke bezigheden weer tijd (net als bij de geboortekaartjes van onze 
dochters, proefschrift Maureen etc.) heeft gevonden om een prachtig ontwerp voor mijn 
proefschrift te maken. Dank jullie wel.
Tijdens het begin van mijn onderzoeksperiode miste ik als min of meer enige epidemioloog 
op de afdeling Geriatrie soms een epidemiologische omgeving, dat werd echter al snel 
gecompenseerd door Gerhard Zielhuis, die mij begeleid heeft tijdens mijn opleiding 
Epidemiologie A, en in de uurtjes junior refereren, waarbij er heerlijk epidemiologisch 
gehaarkloofd kon worden.
Een wetenschappelijk onderzoek als dit kan enkel worden uitgevoerd als er deelnemers 
zijn. En deelnemers kreeg ik niet vanzelf, daar had ik huisartsen voor nodig. Vele 
huisartsen hebben met veel kritische betrokkenheid geprobeerd om aan het onderzoek 
bij te dragen: dank jullie wel. Al zijn er deelnemers, dan nog kan de studie alleen 
succesvol worden als de deelnemende patiënten en hun familieleden bereid zijn een 
hoop tijd te steken in het invullen van lange vragenlijsten. Toch deden ze dat steeds met 
veel inzet en betrokkenheid. Terwijl ik hen dus steeds hartelijk wilde bedanken voor 
hun medewerking, kreeg ik als dank niet alleen ingevulde vragenlijsten terug, maar ook 
prachtige verhalen, Merci, Indische hapjes en bovendien werd ook mijn grammatica 
door deelnemers – en terecht – hier en daar bijgespijkerd. Maar nu heb ik echt het laatste 
woord: dank jullie wel. 
Wat zou een mens moeten als het leven alleen maar uit werken bestond. Ik prijs me 
gelukkig met de vele vrienden uit grofweg “Boekel”, “Nijmegen”, “rest van Nederland” 
en “België”. Het zijn er teveel om op te noemen, maar ik ben steeds weer blij met jullie 
vriendschap. Vriendschap waarbij ik mezelf kan zijn in plaats van een uitgebreid CV 
met academische titels en publicaties. Het is fijn om je op deze manier steeds weer 
te mogen realiseren dat er ook nog iets anders dan p-waardes en Hb-gehaltes bestaat! 
Bregje Oostvogels – die altijd aan een half woord genoeg heeft om mijn werkperikelen 
te begrijpen – wil ik wel even apart noemen. Bregje, ik ben blij dat jij mij paranimf wilt 
zijn. 
De meest vertrouwde omgeving is die van mijn familie. Altijd weer kan ik rekenen op 
steun die vanzelfsprekend gevonden wordt, zonder dat daar veel woorden voor nodig 
zijn. Nergens kan ik meer mezelf zijn dan in mijn eigen “nest”. Frank, Wilma, Edwin, 
Hans, Mariska, Marcel, Wendy, Willemijn, Ton, Maria, Bregje, Kerstin, Patrick, Mark, 
Bram, oma Alwine en mijn neefjes en nichtjes: ik ben blij met jullie. Mijn vader en 
moeder verdienen een speciaal plekje, want zij stimuleren mij – steeds nog –  het meest. 
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Ik ben blij dat jullie ervoor gezorgd hebben dat ik op de MAVO terecht kon, om van 
daar uit – onder jullie vleugels – verder te groeien naar waar ik nu sta. Betere raadgevers 
kan ik mij niet wensen.
En dan zijn daar sinds enkele jaren mijn lieve meisjes Veerle en Lize. Nergens zie ik 
zoveel levenslust en nergens ook ontleen ik zoveel levensvreugde aan. Veerle en Lize: 
als ik met jullie speel en knuffel, weet ik zeker dat ik dat ik de juiste keuze gemaakt heb 
om in mijn carrière niet alles te willen. Lieve Maureen, ruim een derde deel van mijn 
leven zijn wij nu bij elkaar en het leven heeft ons aan elkaar vast geklonken. En er is 
niets waarmee ik zo gelukkig ben dan dit…Wij. Kus. 
Iedereen nogmaals… dank jullie wel!
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